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Abstract 
Presently, over 300 proteins or peptide based therapeutic medicines have been approved by the FDA 
owing to advances in protein engineering and technology. However, majority of these protein-based 
medications are unstable or have limited shelf life when in aqueous form. During pre-formulation and 
manufacturing, various technological processes including mixing, dissolving, filling (through pipes) can 
produce strong mechanical stresses on proteins. These stresses may cause the protein molecule to 
unfold, denature or aggregate. To improve stability upon formulation, they may be manufactured as 
freeze dried cakes that requires reconstitution with a buffer or water prior to administration. Although 
it has been successful in improving the stability of protein-based formulations, the freeze drying 
process itself also contributes to protein aggregation. This process introduces other stresses such as 
freezing, thawing and drying. In addition to these stresses, the agitation processes used during 
reconstitution may also destabilize the protein’s native structure. Two key processes used in 
preparation of protein based formulations were studied in this work; mechanical agitation and freeze 
drying. 
The aim of this project was to explore the aggregation of proteins that occur due to the various 
technological processes typical in the production of protein based formulations. The project has two 
parts that relates to liquid and solid formulations. In the first part, the effect of different methods of 
mechanical agitations on BSA protein was investigated. In the second part, the focus was on the effect 
of formulation (i.e. the application of amino acids) on aggregation of protein (BSA) in freeze dried 
formulations. Arginine and lysine were added individually into protein-based freeze-dried formulation 
to study their potential of improving the stability of the proteins during manufacturing, storage and 
reconstitution. In the formulation development, additional excipients were added to prevent moisture 
uptake due to the hygroscopic properties of the amino acids and to provide lyo- and cryo- protection 
for the protein molecule during freeze drying.  
Without further purification, BSA solutions prepared by using sonication, low shear rotor mixer or high 
shear tube/pipe mixing were studied using dynamic light scattering (DLS). Thioflavin T assay and 
turbidimetry analysis were used as complementary studies. In protein-based freeze dried 
formulations, at accelerated storage conditions, the presence of aggregates were studied in samples 
containing arginine or lysine using ThT assay and turbidimetry analysis. Characterisation of the freeze 
dried cakes was performed relative to their moisture sorption, cake shrinkage, mechanical properties 
and morphology using various analytical techniques. 
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In the BSA solution studies, particle size analysis indicated two distributions for non-agitated BSA 
solution that corresponds to the average particle sizes of BSA molecules and their aggregates. Under 
mechanical stresses (all types), the intensity of distribution centered ≈ 7.8 nm reduces and broadens 
as the agitation time increases, indicating a reduction in the amount of “free” BSA macromolecules. 
The second distribution, as a result of increasing agitation time or shear intensity, reveals a significant 
shift towards larger sizes, or even splits into two particle size populations. These particle size growths 
reflect the formation of aggregates due to intensive collisions and, as a result, partial unfolding 
followed by hydrophobic interactions of exposed non-polar amino acids. UV spectra showed that 
aggregation in both low shear and mechanical vibration agitations were lower compared to the high 
shear stress. When compared to non-agitated BSA solution, ThT assay recorded ≈15 times higher 
fluorescence emission from the high shear samples, ≈2 times fluorescence emission from low shear 
and ≈6 times fluorescence emission from mechanical vibrations. Thus all the three agitation methods 
showed a good correlation between the results.  
The second part of this project was performed in three stages. In the initial 2 stages, 2- and 3-
excipients component system were investigated to develop an optimal preliminary formulations 
which will be used in the final protein based 4-components formulations. From the 1st stage 
(ArgHCl/LysHCl + sugar/polyol), among 4 tested excipients (polyol and sugar), mannitol was observed 
to have resisted moisture uptake by the highly hygroscopic ArgHCl/LysHCl amino acids. However, 
mannitol is considered a good cryoprotector but has poor lyoprotection properties. Therefore, in the 
following stage, a 3rd excipient (in a 3-excipients component system) sucrose or trehalose, was 
introduced into the formulation. The formulation was made up of 20% ArgHCl (LysHCl), and various 
ratios of mannitol and sugar were explored. The criteria for selecting the best systems were based on 
ideal physicochemical properties i.e. moisture uptake, shrinkage, mechanical properties, matrix 
structure and appearance, and thermal properties. The final stage was the formulation of a 4-
components system comprising the three excipients and combinations selected from the stage 2 
studies, and the addition of BSA as the model protein. To study aggregation in this system, a freeze 
dried 4-components excipient/protein system was reconstituted and incubated at accelerated storage 
conditions over time. Fluorescence spectroscopy and turbidimetry were used to study aggregation of 
proteins, moisture uptake kinetics with gravimetric balance, and thermal analytical techniques were 
used to characterise the freeze dried cakes with and without BSA protein. 
This study represented a systematic analysis of aggregation of proteins in both liquid and solid 
formulations. Some of the novel aspects of this study include: 
v 
 
1. The new experimental results obtained for aggregation of proteins in solution subjected to 
mechanical agitations. The high shear stress created by syringe agitation, simulated the real 
situation in post manufacturing process during filling through narrow pipes, and has been 
shown here to strongly affect the aggregation of protein macromolecules.   
2. The development of a methodical approach for optimization of multi component (up to 4 
excipients) protein based formulations. 
3. The unexpected non-linear behavior of the physicochemical properties of the 3-excipients 
component system as a function of composition. To the best of my knowledge, this novel 
aspect has not been previously reported in literature.  
4. Application of amino acid in protein based formulations has shown the inhibition of 
aggregation of BSA, with the highest effect observed with ArgHCl. The results of this study 
coincide with the conclusions published previously for aggregation of proteins in solution. 
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Chapter 1. Protein Aggregation – 
Background and Literature Review 
1.1 Background 
Since the late 20th century, different protein based therapeutics (biopharmaceutical) and peptide 
based products have emerged in the drug market. It was reported that, the biopharmaceutical 
products accounted for more than 35% of the 37 new active substances launched in 2001 (Tang et al., 
2004). In 2015, the global sales of biopharmaceutical drugs generated a total revenue of US $174.7 
billion. With a 5 year compound annual growth rate of 7.3%, by 2020, it is predicted to attain 
US $248.7 billion (BCC Research, 2016). 
The biopharmaceutical industry is a fast growing sector within the pharmaceutical industry due to the 
better understanding and potential treatments for autoimmune diseases, different types of cancers  
and various neurodegenerative disorders such as Alzheimer's (Blennow et al., 2006), Huntington's 
(Shao and Diamond, 2007), Parkinson's (Dauer and Przedborski, 2003), and prion (Prusiner, 1991, 
Fontaine and Brown, 2009) diseases.  
These biopharmaceuticals, like the other pharmaceutical products, are approved and licensed through 
regulatory agencies such as the Medicines and Healthcare products Regulatory Authority (MHRA) in 
the UK, and are required to fulfil strict standards of chemical and physical purity, during the 
manufacturing processes through to its shelf life and patient usage. 
From a therapeutic point of view, proteins and polypeptides offers the distinct advantage of specific 
mechanisms of action and are highly potent. However, they are saddled with various hurdles 
originating from immunogenicity (Zuben E. Sauna, 2016, Baker et al., 2010), high molecular weights 
(Mitragotri et al., 2014) and instability (aggregation/denaturation)(Cromwell et al., 2006, Hjorth et al., 
2016). The problem originating from aggregation/denaturation requires a better understanding of the 
protein native molecule itself. However, there are billions of proteins, with each possessing specific 
structure thereby making knowledge transfer limited. Nevertheless, a sound understanding of the 
fundamental structure provides some insight into the instability tendencies of the molecule. 
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1.2 Proteins 
Proteins are organic biomolecular combinations of amino acids organized into a space‐filling, compact 
and well‐defined three‐dimensional structure. They are encoded by genes and form the basis of living 
tissues. The protein chain may contain about 20 various naturally occurring amino acids and each of 
the amino acids has a specific functional groups which could be an acidic, basic, polar, non-polar, 
aromatic or aliphatic molecule (Townsend et al., 1990). The structure and functions of protein has 
been presented in depth in earlier publication (Berg et al., 2002). Briefly, the fundamental structure 
of protein molecule consists of amino acids. 
The amino acids molecular structure is made up of a common backbone of an amine (NH2) and 
carboxyl (COOH) terminal attached to a central α-carbon atom. As shown in Figure 1-1, the central 
carbon atom is attached to a side chain (R group) which is specific for each amino acid. The α-carbon 
is a chiral carbon atom except in the case of the simplest amino acid, glycine and thus all amino acids 
(except glycine) can exist in two different stereoisomers, the L and D, with only the L- form present in 
proteins during translation in the ribosome (Lubec and Rosenthal, 1990). 
 
Figure 1-1 The molecular structure of an α-amino acid in the L- stereoisomeric form. 
The amino acids are further organised in four levels of spatial arrangements; primary structure, 
secondary structure, tertiary structure and the quaternary structure (Lodish et al., 2000). Each level 
of the protein structure becomes increasingly complex in arrangement as shown in Figure 1-2. 
C C 
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H 
R 
H 
H 
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Figure 1-2 The levels of spatial arrangement and molecular bonding of protein molecule. The diagram was 
adapted from (LaMorte, 2014).  
The primary structure of a protein is a basic sequence of amino acids (monomers) (Figure 1-1) bonded 
to each other via peptide bonds to form the polypeptide chain. As shown in Figure 1-2, the next level 
of spatial arrangement is a conformation that adopts the primary structure as a fundamental 
backbone forming α-helices and the β-strands (secondary structure) due to hydrogen bonding 
between the main chain peptides groups. The tertiary structure are tightly packed to optimise its 
thermodynamic stability (Vendruscolo et al., 2003) while maintaining its structural integrity. The 
charges on the side chains from the secondary structures causes further intramolecular bonding. 
These bonds are hydrogen bonds, ionic bonds, and disulphide bonds. Relative to the thermodynamic 
stability, the free energy of a biomolecule is dependent on the effects of hydrophobicity, the energy 
of the hydrogen bonds, the energy of the electrostatic interactions, and the conformational entropy 
resulting from restricted mobility of both the backbone and the side chains (Bedarkar and Blundell, 
1978, Berg et al., 2002). 
The main purpose of the tertiary conformation is therefore not to only form a distinctive three 
dimensional molecule (Creighton, 2005), but to further offer molecular protection in other biological 
environments. The tertiary structure buries the hydrophobic side-chains of non-polar or neutral amino 
acids via the formation of van der Waals forces in its core during its conformation to shield it from the 
effects of aqueous biological media (Berg et al., 2002, Creighton, 2005, Keiderling, 2002, Krimm, 1987, 
Lodish et al., 2000). In contrast, hydrophilic amino acids i.e. those which are acidic or basic are exposed 
on the surface to enhance the solubility of the protein molecule in its aqueous biological surroundings. 
Hence, changing the sequence of one amino acid in the primary structure may dramatically affect the 
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tertiary structure of the entire biomolecule and thus its biological functions. For instance, a 
haemoglobin that has the glutamic acid changed for valine affects the phenotype and function i.e. 
sickle cell formation leading to poor blood circulation. 
Some proteins further form the quaternary structure by combining more than two protein subunits 
(tertiary structure)(Anchordoquy et al., 2001). The subunits could be the same tertiary molecule 
interacting via a non-covalent bond. A typical example is haemoglobin which is made up of 4 α and β 
subunits (Schechter, 2008). 
Thus, the specific conformation of the protein is largely determined by the flexibility of the polypeptide 
backbone and by the specific, consistent intermolecular interactions of the backbone and side chains 
(Creighton, 2005). This unique shape determines many of the functionalities of proteins. Each protein 
play specific biological role in the human body such as enzymatic activities, storage and transport (e.g. 
haemoglobin), structural support (e.g. collagen and myosin) and signalling (e.g. insulin and antibodies 
for immunity or regulation).  
The number of proteins and polypeptides used in therapeutic applications have increased dramatically 
and as a result have driven the development of a variety of improvements in protein expression 
technologies (Li et al., 2006, Warren et al., 2004, Wulfkuhle et al., 2004, Zhang, 2009). Generally, 
pharmaceutical protein based formulation efforts follow one of two fundamental pathway; either 
focus on non-invasive application for therapeutic effects or improving the biological half-life of the 
complex biomolecules (Cromwell et al., 2006, Dobson, 2004, Lee, 2000, Parkins and Lashmar, 2000, 
Wang, 2005).  
Protein denaturation/aggregation is a phenomenon that involves transformation of a well-defined, 
folded structure of a protein, formed under physiological conditions, to an unfolded state under non-
physiological conditions (Deyoung et al., 1993, Stigter and Dill, 1993, Amin et al., 2014). The process 
can occur suddenly and completely over a narrow range of conditions (Shortle, 1996, Amin et al., 
2014). Proteins can have many denatured states but will always have one native state. The tendency 
for proteins to aggregate becomes higher when denaturation occurs. Although in some cases they can 
regenerate to their native state, this process happens extremely slowly.  
In the pharmaceutical industries, the probability of proteins aggregating and/or denaturating 
becomes greater due to the various manufacturing steps such as mechanical agitations originating 
from the manufacturing equipment, transportation, environmental changes and even other excipient 
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interactions. Table 1-1 below summaries three major pharmaceutical formulation processes and their 
associated stresses and degradation pathways. 
Table 1-1 Chemical and physical instabilities encountered by protein-based pharmaceuticals (Sola and 
Griebenow, 2009). 
Process Main Stress Factors Main Degradation Pathways 
Liquid storage Contaminations (e.g. from metal 
ions), extremes of pH, temperature, 
chemical denaturants, high protein 
concentrations, freeze thawing, 
hydrophobic surfaces. 
Fragmentations, chemical hydrolysis, 
oxidation, crosslinking, β-elimination, 
racemization, deamidation, denaturation, 
adsorption, aggregation, inactivation. 
Lyophilisation Ice-water interface, pH changes, 
dehydration, phase separation. 
Aggregation, inactivation 
Solid-phase 
storage 
Contaminations (e.g. from metal 
ions), protein-protein interactions, 
moisture. 
Aggregation, fragmentation, oxidation, 
deamidation, inactivation. 
The presence of any insoluble denaturants/aggregates in a pharmaceutical formulation renders the 
product unacceptable for release and for any therapeutic use. Protein malfunction may be observed 
in various ways. They may become ineffective, over active or act against the human body itself if the 
protein is wrongly coded, denatured or aggregated. Though there are significant academic and 
industrial studies to improve our understanding of protein denaturation/aggregation, these studies 
are still somehow lacking (Chi et al., 2003, Dobson, 2004). It is generally known that proteins and 
polypeptides can be unfolded and hence denatured by heat (Chung-Jung et al., 2002, Prabhu and 
Sharp, 2005, Wallace et al., 2015), cold conditions (Kunugi and Tanaka, 2002, Franks, 1995, Rosa et al., 
2017), high pressure (Meersman et al., 2006, Smeller, 2002, Winter, 2013), and extreme pH (Puett, 
1973, Fitch et al., 2006). The presence of certain ligands, including specific ion interactions with metal 
surfaces may even result in surface denaturation, which then leads to the formation of aggregates.  
Protein aggregation may be categorized as soluble or insoluble. There is no size limitation as to what 
may be considered a “soluble” or “insoluble” aggregation (Shire et al., 2006). However, it may be safe 
to assume that a soluble aggregate is those that are not visible as discrete particles and may not be 
removed by filtration with pore size of 0.22 μM (Shire et al., 2006). In contrast, insoluble aggregates 
are those that can be filtered using the same pore size and are visible as discrete particles.  
Furthermore, denaturation/aggregation may be reversible or irreversible depending on the conditions 
leading to its unfolding. Reversible protein aggregation typically results from relatively weak non 
covalent protein interactions. The reversibility is sometimes indicative of the presence of equilibrium 
between the monomer and higher order forms. This equilibrium may shift as a result of a change in 
solution conditions such as a decrease in protein concentration or a change in pH (Shire et al., 2006). 
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It has also been reported that, reversible aggregation/denaturation occurs when viscosity is increased 
(Liu et al., 2005). 
1.3 Physicochemical factors that may cause protein denaturation 
Various factors have been linked to the propensity for proteins to denature/aggregate. These factors 
may be macromolecule structure related or resulting from external conditions. Proteins 
denaturation/aggregation may occur from a simple physical association between different protein 
molecules without prior changes to its primary structure or via the formation of new covalent bond(s) 
(Amin et al., 2014). Formation of such a bond(s) can either directly crosslink proteins (aggregation), or 
indirectly alter the aggregation tendency of the original protein (Finke et al., 2000).  
1.3.1 Protein structural factors 
Though protein aggregation is strongly dependent on its environmental conditions (Takalo et al., 2013, 
L., 1998, Ross and Poirier, 2004), the amino acid sequence predominantly determines the tendency for 
a protein molecule to readily denature/aggregate. Calamai et al. (2003) showed that the degree of 
hydrophobicity of a protein molecule determines its propensity to form aggregates (Calamai et al., 
2003). Furthermore, through modelling physical protein aggregation, varying the ratio of polar and 
non-polar compositions by few percent shows significant changes in the denaturation/aggregation 
properties of the protein (Warwicker et al., 2014). Other studies has also indicated that the 
aggregation properties are more dependent on the surface content of hydrophobic groups (Münch and 
Bertolotti, 2010, Patro and Przybycien, 1994). 
Istrail et al. (1999) by using a Monte Carlo simulation showed that protein aggregation is also 
dependent on the concentration of adjacent hydrophobic and hydrophilic residues in a sequence. It was 
indicated that generally, having a shorter block of either hydrophobic or hydrophilic chain increased 
the propensity for the protein molecule to denature/aggregate (Istrail et al., 1999). Indeed, the 
sequence of hydrophilic residues for instance in insulin has been shown to be critical in controlling the 
formation of fibrils (Nielsen et al., 2001a, Nielsen et al., 2001b). 
Secondary structures in peptides or proteins may also play a role in controlling aggregation (Shivu et 
al., 2013) and its long term stability. In most instances, protein denaturation/aggregation comprises 
mostly of β sheets whiles proteins with mainly α helix structures are less likely to aggregate. This has 
been ascribed to the stronger dipole moment in α helices when compared to that in β sheets (Querol 
et al., 1996). When analysed, random coils and α helix transitions to β sheets whiles the β sheets forms 
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protein aggregates (Shivu et al., 2013, Szabo et al., 1999). Similarly, in bovine serum albumin and 
lysozyme, it has been shown that the quantitative proportions of the random coils and α helix 
composition are significantly reduced whiles the β sheet compositions increases in 
denatured/aggregated proteins.  
1.3.2 Some external factors 
Relative to biopharmaceutical formulations, protein denaturation/aggregation is significantly induced by 
a wide range of external factors. These factors destabilize the native state, enhance the potential for 
the formation of unfolded intermediates and may later result in the formation of irreversible 
aggregate/denaturants.  
Temperature effects are probably the most common factor that affects protein aggregation. Thermal 
unfolding, misfolding, denaturation or aggregation of a protein may be reversible or irreversible, 
depending on the conditions under which denaturation/aggregation takes place (Sava et al., 2005, Ni 
et al., 2015b). The external thermal conditions, when varied, can also affect the relative composition 
of secondary structures and hence alter the propensity for the protein to aggregate (Vermeer and 
Norde, 2000).  
Proteins and peptides have specific temperatures above which they readily unfold. Generally, 
unfolded protein resulting from the elevated temperature will often denature/aggregate as the 
hydrophobic residues are exposed e.g. bovine serum albumin (Yohannes et al., 2010b). While protein 
unfolding at higher temperatures (heat denaturation) is easily understood, the widespread existence 
of protein unfolding at low temperatures is surprising, particularly as it is unexpectedly accompanied 
by a decrease in entropy (Chung-Jung et al., 2002).  
pH can also affect the rate of protein aggregation by varying the surface charges of the protein 
molecule (Amin et al., 2014, Kohn et al., 1997). To maintain the protein stability, it is therefore ideal 
to select a stable solution pH, predominantly because proteins are stable in a narrow pH range (Talley 
and Alexov, 2010, Fatouros et al., 1997). While various buffering agents may be used to adjust the pH 
during formulation, the susceptibility of proteins to aggregate varies and at different buffer 
concentrations. The total charge on a protein molecule is dependent on the pH. The relationship 
between charge on protein molecule and pH is presented in Figure 1-3. At the isoelectric point (pI), 
the total charge on the protein molecule is zero and this makes the protein susceptible to aggregation.  
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Figure 1-3 Effects of pH on zeta potential (z charge). The plot is labelled with the isoelectric point.   
This relationship (Figure 1-3) has been ascribed to amino acids pendant group protonation or 
deprotonation (dissociation). For instance lysine and arginine are basic with high pKa (between pH 10 
and 11), glutamic acid is acidic with pKa between 3 and 4, while histidine is neutral with pH ≈ 6. The 
negative effects of pH on BSA is observed at pH ≈3.0 where the BSA structure gradually unfolds leading 
to an increase in the structural size and the relative content of β sheet and thus reduce the stability of 
BSA (Li et al., 2016a). At alkaline pH of 12.2 and room temperature, hen egg white lysozyme has been 
reported to also grow into soluble aggregates (Homchaudhuri et al., 2006). 
Concentration The effects of the protein concentration on formulation stability have been reported 
in the literature (Ni et al., 2015b). Poor stability (aggregation/denaturation) have been ascribed to the 
conditions of storage or manufacturing. The aggregate size may also increase as the protein 
concentration increases (Roefs and De Kruif, 1994, Amin et al., 2014).  
Zlateva et al. (1999) reported that increasing the concentration of human IFN-ƴ reduced the rate of 
aggregation (Zlateva et al., 1999). This has been ascribed to potentially an increase in the 
concentration of dimers, which are less susceptible to aggregation. Ni et al. (2015) showed the effects 
of protein concentration amongst other factors on aggregation of whey protein isolate (Ni et al., 
2015a).  
In other instances, an increasing protein concentration in a formulation has been used to actually 
resist the formation of aggregates especially in aggregation that is induced by freezing. Carpenter et 
al. (1990) reported that LDH did not aggregate nor lost its activity during freezing due to an increased 
concentration of the protein (Carpenter et al., 1990). These observations were in part ascribed to the 
potential that, the concentration of protein that accumulate at the ice-water interface is limited and 
therefore, protein aggregation induced at the interface is only in concentrated protein solutions. 
Furthermore, due to the increased amount of protein molecules, there is a high possibility of steric 
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repulsion amongst neighbouring molecules and therefore protein aggregation may also be resisted 
(Allison et al., 1996, Schweitzer-Stenner and Uversky, 2012). It has also been reported that protein-
protein interactions may change monomers to active and stable dimers (Mozhaev and Martinek, 1990, 
Acuner Ozbabacan et al., 2011, Reddy Chichili et al., 2013).    
Excipients in combination or individually are used to stabilize proteins, reduce or eliminate protein 
aggregation/denaturation or to reduce surface adsorption. Excipients used as stabilizers may include 
sugars, polymers, surfactants, salts and amino acids. Excipients are generally pharmacologically inert, 
but can interact with the protein molecule or the container surface during formulation or storage. 
Different excipients are included in protein based formulation for different functions depending on 
the dosage form or method of manufacturing. For instance, sugars (e.g. trehalose, sucrose and lactose) 
are generally used as cryo and lyo protectors during freeze drying of protein based formulation but 
are also used as bulking agents in solid dosage forms. In protein formulation, the inclusion of any 
excipient depends on the initial study to identify any effects of possible preferential interaction with 
surface aromatic hydrophobicity if the pre-formulation or dosage form is a solution (Ohtake et al., 
2011).  
Wen et al. (2017) reported that preferentially excluded excipients (trehalose, sucrose and sorbitol) 
protected protein conformation against damage, but had the potential to also accelerate aggregation 
originating from mechanical stress (Wen et al., 2017). Liu et al. (2013) also indicated that during 
incubation, keratinocyte growth factor 2 (KGF-2) in the presence of heparin or sucrose grew in size to 
form soluble protein aggregates, whiles the inclusion of polysorbate 80 inhibited KGF-2 aggregation 
during agitation but not at storage (Liu et al., 2013). A combination of polysorbate 80 and 
sucrose/heparin eliminated aggregation altogether. Thus, the inclusion of excipients has bilateral 
effects on a protein based formulation.   
Biopharmaceutical manufacturing processes may also invariably cause the native structure of 
proteins to unfold, misfold, aggregate or denature to varying degrees due to the varying 
manufacturing routines involved (Mahler et al., 2010, Mahler et al., 2009). Such routine manufacturing 
steps may include heat-treatment, filtration, mechanical agitation or mixing via shaking, filling, 
freezing, drying, packaging, transportation and even during reconstitution for therapeutic use. 
Relative to mixing (shearing or shaking), the type of agitation technique determines the mechanism 
and rate of aggregation/denaturation. Shaking mechanisms such as sonication uses high frequency 
sound waves to aggressively cause agitation in low viscosity liquids, and can be used to reduce the size 
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of peptide or protein molecule (Soto et al., 2002), in a process called cavitation. Briefly, cavitation is 
the formation of bubbles which collapse to create extremely high local temperatures, high sheer 
forces, and the formation of hydrogen and hydroxyl free radicals (H• and OH•) from water sonolysis 
(Stathopulos et al., 2004, Gong and Hart, 1998).  
Furthermore, shaking process generally creates air-water interface which enhances hydrophobic 
residues to align at the interface and increase susceptibility to aggregation (Maa and Hsu, 1997, 
Wiesbauer et al., 2013, Volkin and Klibanov, 1989). Similarly, the use of shear also causes the 
hydrophobic regions of the protein molecule to be exposed as result of the velocity gradients in the 
moving liquids i.e. in tubes or even rotor blade mixers. This effects may also be observed during 
formulation, transportation and packaging.  
1.4 Some principle mechanisms of protein denaturation/aggregation 
Different experimental techniques and conditions have resulted in the proposal of various 
mechanisms for proteins to aggregate or denature. Protein aggregation may occur following 
distinctive mechanisms. Although proteins have a similar polypeptide backbone (Figure 1-2), the 
mechanism for unfolding, misfolding, denaturation or aggregation is not mutually exclusive. The same 
protein molecule may be denatured and/or aggregated following more than one mechanism. 
In contrast to the traditional definition of protein denaturation/aggregation proposed (Deyoung et al., 
1993, Stigter and Dill, 1993), it has been widely accepted that the intermediates of unfolded or folding 
protein molecules are precursors of the protein denaturation/aggregation process (Fink, 1998, Fields 
et al., 1992, Hatami et al., 2017). However, Uversky et al., (1999) suggested that due to the 
hydrophobic side chain of protein molecule being either protected from contact with water or 
randomly scattered to improve thermodynamic properties, a completely folded or unfolded protein 
molecule may not aggregate easily (Uversky and Dunker, 2010). Hence, protein 
denaturation/aggregation process is predominantly initiated by adjacent hydrophobic groups in the 
folding/unfolding intermediates. Various publications has associated the initiation of the 
denaturation/aggregation of recombinant human growth hormone (rhGH) (Bam et al., 1998) and 
human lysozyme variants (Booth et al., 1997) to intermediates. Similarly, it has been shown via 
simulations that the initiation of the aggregation process is due to interactions of partially folded 
intermediates (Istrail et al., 1999). 
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The hydrophobic effect is explained as a primarily entropic effect arising from the rearrangement of 
hydrogen bonds between solvent molecules around non polar solute (Zhang et al., 1994, Katsir et al., 
2010). The hydration process is energetically unfavorable, and therefore drives non polar solutes 
together thereby decreasing their solvent exposed surface area. Generally, hydrophobic effect is 
considered as a product of entropy and van der Waals interactions between solute molecules 
(enthalpy effect) (Makhatadze et al., 1995, Makhatadze and Privalov, 1995b, Makhatadze and 
Privalov, 1995a). Thus at low temperature, it is entropic and enthalpic at high temperatures leading a 
complex temperature dependence of its strength (Schellman, 1997). Nevertheless, the hydrophobic 
force has always been considered as a major factor in protein folding (Dill, 1990) as it leads to a rapid 
collapse of the polypeptide chain, thereby largely reducing the configurational space to explore. 
Without doubt, the hydrophobic interaction is also a major stabilizing force contributing to the 
thermodynamic stability of the folded state.  
Another area of active research is the effects of electrostatic interactions such as ion pairs and salt 
bridges in proteins (Kumar and Nussinov, 2002). Compared to hydrogen bonds and hydrophobic 
forces, electrostatic interactions are largely specific, thus plays an essential role in specifying the fold 
of a protein, the flexibility and hence its functions. It has been shown through computational and 
experimental studies that salt bridges can be stabilizing or destabilizing. In contrast, genome‐wide1 
and structural comparisons of thermophiles2 and mesophiles3 showed that salt bridges enhanced 
thermal stability of proteins from thermophilic organisms (Razvi and Scholtz, 2006, Szilagyi and 
Zavodszky, 2000, Li et al., 2005). 
1.4.1 Mechanism I - Native monomer-monomer interactions 
The monomers of protein molecules have the intrinsic ability to interact with each other due to the 
self-complementary monomeric structure of its surfaces as shown Figure 1-4. However, this self-
                                                          
1 Genetic variations in different people that may be related to a trait. 
2 A thermophile is an organism that flourishes at relatively high temperatures, between 41 ˚C and 122 °C 
(BERENGUER, J. 2011. Thermophile. In: GARGAUD, M., AMILS, R., QUINTANILLA, J. C., CLEAVES, H. J., IRVINE, W. 
M., PINTI, D. L. & VISO, M. (eds.) Encyclopedia of Astrobiology. Berlin, Heidelberg: Springer Berlin Heidelberg.) 
3  A mesophile is an organism that thrives optimally typically between 20 °C and 45 °C. The ideal temperature 
usually at 37 °C (GOMEZ, F. Ibid.Mesophile. 
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association is completely reversible. For instance, insulin is well known for its monomer-monomer 
interactions (Nettleton et al., 2000).  
 
Figure 1-4 Schematic representation of a native monomer-monomer interactions. Image was adapted from 
(Philo and Arakawa, 2009)  
In biopharmaceutical formulations containing high concentration of protein, the constant formation 
of oligomers resulting from the law of mass action4 (Piispanen, 1993) may result in the formation of 
even bigger aggregates which are irreversible. These larger molecules may interact with others via 
covalent or even disulphide linkages although in some proteins like Transforming Growth Factor-β 1 
and Nerve Growth Factor, disulfide bridges between monomers is required to form a stable protein 
structure (McAuley et al., 2008, Trivedi et al., 2009, Giulivi C. and Davies K.J., 1994). Interleukin-1 
receptor antagonist (rhIL-1RA) has been reported to have the ability to form a reversible dimer-dimer 
interaction at high concentrations but will further grow into irreversible dimers and trimers (Alford et 
al., 2008b, Alford et al., 2008c). 
1.4.2 Mechanism II – Conformational changes induced aggregation 
It is well established that aggregation proceeds conformational changes of the native monomer. In 
some proteins, the propensity for a reversible monomer-monomer association is very low. However, 
a brief monomer-monomer encounter may result in a strong interaction between the partially 
unfolded or altered monomers. The conformational changes may occur or be promoted by external 
stresses such as vibrations, agitations, shear or even heat. However, the inclusion of some excipients 
can help to stabilize the native conformation.  
The conformational changes may also be due to the difference in covalent bonding which originates 
from chemical degradation such as the oxidation of methionine (Mulinacci et al., 2013), deamidation 
                                                          
4 The principle of law of mass is the proposition that the rate of a chemical reaction is directly proportional to 
the concentrations of the reacting substances (BAGSHAW, C. R. 2013. Law of Mass Action. In: ROBERTS, G. C. K. 
(ed.) Encyclopedia of Biophysics. Berlin, Heidelberg: Springer Berlin Heidelberg.) 
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(Takata et al., 2008), or proteolysis. Such chemical changes may result in the formation of favourable 
binding sites on the surface, or could even alter the electric charge so that monomer-monomer 
interaction is improved. However, some proteins such as glycoproteins may be modified to 
unglycosylated proteins (Philo and Arakawa, 2009) and yet not affect the bulk material relative to 
aggregation.  
 
Figure 1-5 Schematic representation of a chemically modified or conformationally changed native monomer 
that may lead to higher irreversible aggregated oligomers. Image was adapted from (Philo and Arakawa, 
2009) 
Thus, this mechanism may result from conformational changes originating from partial unfolding or 
via chemical modifications e.g. oxidation (Figure 1-5). The major variation between this 
conformationally modified native monomer and that originating from a brief monomer-monomer 
encounter is that the former produces larger aggregates. Furthermore, chemically modified 
aggregates may be particularly immunogenic (Hermeling et al., 2006). 
Conformational changes may also occur as a result of a monomer binding to a surface. This mechanism 
may also be referred to as the surface induced aggregation. For instance in a finished 
biopharmaceutical product, surface induced aggregation is initiated when the native monomer binds 
reversibly to a surface of the storage vial possibly via an electrostatic attraction. However, in a system 
of air-liquid interface, such a reversible interaction may occur via hydrophobic interactions. The newly 
conformed monomer aggregates on the surface or when released into the bulk of the protein solution.  
The conformation change induced aggregation have been ascribed to many proteins such as 
recombinant human interferon-gamma (Kendrick et al., 1998) and recombinant human granulocyte-
colony stimulating factor (Krishnan et al., 2002b, Raso et al., 2005) and has been discussed in depth 
previously (Chi et al., 2003, Wang, 2005, Krishnamurthy and Manning, 2002). 
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1.4.3 Mechanism III – Critical Nuclei Controlled Aggregation 
This mechanism may be considered as the most common route of aggregation amongst many 
biopharmaceutical products.  The mechanism is dependent on the formation of critical nucleus via the 
chemical process of nucleation as shown in Figure 1-6. 
 
Figure 1-6 Schematic representation of a chemically modified or conformationally changed native monomer 
that may lead to higher irreversible aggregated oligomers. Image was adapted from (Philo and Arakawa, 
2009) 
Depending on the rate of the formation of the so-called critical nuclei, the rate of formation of visible 
aggregates may also vary from one vial to the other even within the same manufactured batch. The 
lag phase is usually initiated by a native monomer that initially has a low propensity to form small 
oligomers. Although the process is not thermodynamically favoured, nevertheless these native 
monomer associates to form large oligomers with time. In macroscopic sample, the lag phase will not 
only be a waiting time for a single nuclei formation but rather, a period full of parallel processes in 
folds. For instance, there will be millions of primary nuclei formed from the free flowing monomers or 
the monomer-monomer associates. This mechanism also represent the period for which there is the 
formation of the critical nuclei, perhaps nuclei growth and nuclei proliferation to reach a visible 
aggregate (Arosio et al., 2015). In amyloid fibril formation, the proliferation occurs via secondary 
nucleation and the fibrils provide a catalytic surface for new aggregates to be formed. The fibrils may 
also break to provide new ends for elongation and at least two or sometimes four microscopic 
processes occur during the lag phase i.e. primary nucleation and elongation or primary nucleation, 
elongation, secondary nucleation and fragmentation (Eden et al., 2015, Arosio et al., 2015, Buell et al., 
2014). This is a homogeneous system whiles in a heterogeneous system, particulates from other 
source, for instance silicate from glass vials, particles from equipment parts may act as nuclei. Stainless 
steel particles from piston pumps to fill vials were shown to have acted as nuclei for aggregation in 
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IgG particle formation  (Tyagi et al., 2009) and monoclonal antibody (Bee et al., 2009a). It was shown 
that in the presence of silica particles aggregation occurred in recombinant human platelet-activating 
factor acetylhydrolase (rhPAF-AH) (Chi et al., 2005). The presence of silicone oil (Thirumangalathu et 
al., 2009, Jones et al., 2005) has also been associated with the induction of the protein aggregation.  
1.5 Some analytical technologies to study protein aggregation 
Although academic and industrial efforts has helped to improve the understanding protein 
aggregation, this exercise is still incomplete due to the complexity of the aggregation/denaturation 
process and the protein molecule itself (Chi et al., 2003). The characterization of protein molecules 
before and after aggregation/denaturation is the key to formulation development, manufacture and 
subsequent storage of the formulated product. Several measurements technologies for qualitative 
analysis alongside chemometrics are used to determine and quantify the relative percent 
aggregation/denaturation or the protein activity after manufacturing stress. Ideally, these 
technologies should be applicable to in-line processing/manufacture if it is the ultimate intention to 
use the technology for process optimization. Some of these measurement technologies used are X-
ray crystallography (protein crystallography) (Pullara et al., 2007, Dessau and Modis, 2011), Nuclear 
magnetic resonance spectroscopy of proteins (protein NMR) (Liu and Song, 2009), thermal analytical 
techniques (Matheus et al., 2006, Bertrand-Harb et al., 2002, Sasahara et al., 2006), spectroscopic 
technologies such as circular dichroism (CD) (Greenfield, 1999, Keiderling, 2002), Fourier Transform 
Infrared (FT-IR) (Cordeiro et al., 2006, Dzwolak et al., 2002, Oberg and Fink, 1998, Swamy et al., 1996, 
van de Weert et al., 2001), Fluorescence spectroscopy (Gasymov and Glasgow, 2007), UV/Vis 
spectroscopy (LaClair and Etzel, 2009) and dynamic light scattering spectroscopy (DLS) (Li et al., 2011, 
Jachimska et al., 2008).  
Each of these measuring technologies has a limitation. The emerging trend of industrial dependency 
on process analytical technologies (PAT) has led to an increase use of the optical spectroscopies 
because it offers a potential solution for on-line/in-line analysis without necessarily being invasive The 
following section attempts to review some of these technologies and identify its limitation during its 
use in protein characterisation.  
1.5.1 Circular Dichroism 
Circular Dichroism (CD) spectroscopy has been used extensively for quantitative and qualitative 
analysis of protein secondary structure and its unfolding processes (Kallenbach et al., 2013, Tilstra and 
16 | P a g e  
 
Mattice, 2013, Venyaminov and Yang, 2013). CD application is based on its ability to record the 
turbidity/absorption of the protein solution alongside the differential absorption between left- and 
right-circularly polarised light. The method is advantageous because the sample amount is relatively 
small and non-destructive especially via chemical degradations originating from far UV and maybe 
possible to use for online analysis (Joshi et al., 2014).   
However, it gives less specific structural information when compared to protein crystallography and 
protein NMR spectroscopy, for example, both of these tools have the ability to present the atomic 
resolution data of the protein. Another disadvantage is the fact that CD is usually used to study 
proteins in solution, and whiles it may complement methods that study the solid state, it is also limited 
on the basis that many proteins are embedded in membranes in their native state, and solutions 
containing membrane structures are often strongly scattering (Greenfield, 1999, Keiderling, 2002, 
Bondos, 2006). Furthermore, there may be excipients, solvent and light interference and the data 
obtained may be complicated when interpreting (Joshi et al., 2014). 
CD has been used to monitor protein aggregation during thermal unfolding (Benjwal et al., 2006), to 
study the potential that partially folded oligomers are precursors to aggregation (Mitraki and King, 
1989, Rees et al., 1992), specific intermolecular interactions are required before aggregation can occur  
and β sheets increase is an indication of aggregation (Greenfield, 2006). 
1.5.2 Nuclear Magnetic Resonance  
Protein NMR has been used extensively to determine the structure of various proteins (Kay, 2005, 
Sanfelice et al., 2012). The protein is purified, placed in a strong magnetic field, and then probed with 
radio waves. A distinctive set of observed resonances may be analysed to give a list of atomic nuclei 
that are close to one another, and to characterize the local conformation of atoms that are bonded 
together. This list of restraints is then used to build a model of the protein that shows the location of 
each atom. When NMR is compared to CD spectroscopy, although both technologies are relatively 
sensitive to secondary structural changes, NMR is limited to small or medium proteins, since large 
proteins present problems with overlapping peaks in the NMR spectra. 
A major advantage of NMR spectroscopy over solid state technologies (e.g. X-ray crystallography) is 
that it provides information on proteins in solution, as opposed to those locked in a crystal or bound 
to a microscope grid, and thus, NMR spectroscopy is the premier method for studying the atomic 
17 | P a g e  
 
structures of flexible5 proteins. A typical NMR structure will include an ensemble of protein structures, 
all of which are consistent with the observed list of experimental restraints. The structures in this 
ensemble will be very similar to each other in regions with strong restraints, and very different in less 
constrained portions of the chain. Presumably, these areas with fewer restraints are the flexible parts 
of the molecule, and thus do not give a strong signal in the experiment. Protein NMR have been 
successfully used to study protein-ligand interactions (Goldflam et al., 2012, Cala et al., 2014), protein 
stability (modification/mutation)(Julien et al., 2009), protein–protein interactions in the early stages 
of amyloid assembly, study the conformational ensemble of intrinsically disordered proteins 
(Karamanos et al., 2015). NMR diffusion-ordered spectroscopy (DOSY) was also been used to study 
2.1 mM lysozyme solution in 0.5 M NaCl solution and the study concluded that after 70 hours, 
crystallization/aggregation indicated by a decrease in both translational and rotational diffusion 
coefficients was observed (Poznański et al., 2005). 
1.5.3 Thermal analytical techniques 
Thermal analytical techniques have been used to study protein aggregation and protein stability by 
measuring the enthalpy changes during unfolding. Protein aggregation is characterised by varying 
thermodynamics due to the different types of chemical bonds between peptides. The application of 
thermal analytical techniques such as differential scanning calorimetry (DSC) to study protein 
aggregation/denaturation has been described in detailed. Briefly, it was reported that thermal 
transition in the protein molecule was synonymous with the protein partition function, suggesting 
that the thermogram can be used to identify the states in denaturation and has been used extensively 
for such purpose (Chiu and Prenner, 2011, Sanchez-Ruiz, 2010) 
Protein based formulation contains both the native molecule and traces or denatured strands. Usually, 
a high thermal transition midpoint (Tm) is an indication of a stable protein molecule. Thermal 
analytical technologies measures change in heat capacity (ΔCp) and enthalpy (∆H) of unfolding that 
occurs as a result of heat-induced denaturation.  
Furthermore, when protein sample is heated, there is an initially high baseline until enough heat is 
absorbed by the protein molecule. The absorbed heat causes the protein to thermally unfold over a 
                                                          
5 Relative to polypeptide chains, flexibility describes concerted changes that affect a few degrees of freedom, 
which can modify the overall structure without deleterious effects. Flexibility in protein molecules is intrinsic, 
functional and a significant feature of molecular recognition (JANIN, J. & STERNBERG, M. J. E. 2013. Protein 
flexibility, not disorder, is intrinsic to molecular recognition. F1000 Biol Rep, 5, 2.). 
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temperature range which is specific for that protein, resulting in an endothermic peak. As more 
hydrophobic side chains are exposed during the unfolding process, the water molecules reorganize 
and restructure around the protein. A drop in baseline is observed after the unfolding process is 
completed. The recorded data can be analysed to provide a complete thermodynamic characterization 
of the unfolding process (Freire and Biltonen, 1978) 
The main drawback of this technology is that all proteins have maximum thermal threshold. The 
relatively high temperatures usually required for these studies results in the disruption of the native 
structure of the protein molecule thereby making it not reusable. 
1.5.4 Fourier Transform Infra-red spectroscopy  
Fourier transform infrared spectroscopy (FTIR) is a non-destructive but sensitive technique which has 
been widely used to study molecular changes originating from protein unfolding and aggregation 
(Flores-Fernandez et al., 2009, Costantino et al., 1995, Doglia et al., 2008, Kong and Yu, 2007, Wei et 
al., 2003). The resulting spectrum indicates the molecular absorption (or transmission), illustrating a 
molecular fingerprint of a sample with absorption peaks, which correspond to the frequencies of 
vibrations of bonds between the atoms making up the material.  
Peptide groups in proteins gives up to 9 characteristic bands referred to as amide A, B, I to VII of which 
the amide I and II are the most prominent (Krimm and Bandekar, 1986). Amide A and B bands are 
observed at local maxima ≈3500 cm-1 and ≈3100 cm-1 respectively. These bands originates from Fermi 
resonance between 1st overtone of amide II and/or contributions from  N-H stretching vibrations  
(Grdadolnik, 2002). The three amide bands useful for protein analysis are listed in Table 1-2 below.  
Table 1-2 The relevant characteristic infrared bands of peptide linkages compiled from (Bandekar, 1992, 
Grdadolnik, 2002, Krimm and Bandekar, 1986). 
Designation Frequency /cm-1 Description 
Amide I 1700 - 1600 C=O stretching vibrations 
Amide II 1580 - 1500  C-N and C-C stretching vibrations, in plane NH bending 
Amide III 1330 - 1215 Complex bands which depends on force field, side chains and hydrogen 
bonding 
Increasingly, the Amide III band has become relevant in characterising proteins. This is because, the 
effects of water bands is substantially negligible in protein samples compared to the effects observed 
in the Amide I and II regions. Furthermore, the Amide III bands show a clear transmittance within its 
band and the structural turns can be monitored easily without spectral deconvolution. The bands for 
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the individual secondary structures where they are observed by this technology is listed in Table 1-3 
below. 
Table 1-3 The bands at which the secondary structures are observed by FTIR spectrum. 
Turns Frequency /cm-1 
α helix 1330 - 1290 
Uncoiled strands 1290 - 1250 
β sheet 1250 - 1190 
For quantitative analysis, different methods have been developed to estimate the relative 
contributions of the various components in the secondary structures using amide I or III bands. Such 
methods includes Fourier self-deconvolution (FSD) curve fitting (Ma et al., 2008), second derivative 
analysis (Susi and Byler, 1983, Liao et al., 2002) and partial least-squares analysis (Kinalwa et al., 2010). 
The methods of quantifying a protein secondary structure is based on the assumption that any protein 
can be considered as a linear sum of a few fundamental secondary structural elements, and the 
percentage of each element is only related to the spectral intensity (the molar absorptivity of C=O 
stretching vibration for each secondary structural element is essentially the same).  
Attenuated total reflectance FTIR has been used previously to study the conformation of aggregated 
proteins both in vivo and in vitro. Shivu et al. (2013) used this technology to study various protein 
aggregates, including amyloid fibrils, folding aggregates, soluble oligomers and protein extracts from 
stressed cells (Shivu et al., 2013) 
Generally, there is an increased in the conversion of β sheets from α helix structure during the process 
of protein aggregation. This observation has been presented in various independent research 
publications (Flores-Fernandez et al., 2009, Shivu et al., 2013, Sokolowski and Naumann, 2005). 
1.5.5 Dynamic light scattering spectroscopy   
Dynamic light scattering (DLS) is a technology used to measure the hydrodynamic size and size 
distribution of particles in homogeneous system and its polydispersity (Lorber et al., 2012, Li et al., 
2011). Detailed operating procedures and principles have been explained in depth in previous 
publications (Arzenšek, 2010, Ferré-D'Amaré and Burley, 1997, Lorber et al., 2012, Dzakpasu and 
Axelrod, 2004). Briefly, the technology measures scattered light originating from particles dissolved 
or dispersed in solution. The fundamental working principle of the technology is based on particles in 
solutions undergoing Brownian motion. The larger the particle, the slower the Brownian motion will 
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be. The variations in recorded particle size are dependent on the fluctuations of scattered light 
intensity due to changes in physical properties such as temperature, viscosity. 
The constant motion of the particles changes the phase of the scattered light, which is observed as a 
constructive or/and destructive interferences among light scattered from the various particles. The 
phase change relies on the particle motion relative to the wavelength (λ) of scattered light (Arzenšek, 
2010, Lorber et al., 2012). As the shape, size and weight of the particles determines the velocity of 
their motion, a defined correlation can be obtained. Thus, the acquired data from particle size analysis 
is actually the intensity of the scattered light as a result of the particles in motion, measured by a 
photocurrent as a function of time (Lomakin, 2001). From the time correlation function, distinctive 
information that relates the diffusion properties of particles within the sample to time may be 
deduced. This relationship (Tscharnuter, 2000, Pecora, 2013) may be represented mathematically as 
Eqn. 1-1. 
 𝑮(𝝉) =  ∫ 𝑰(𝒕). 𝑰(𝒕 + 𝝉)𝜹𝐭
∞
𝒐
 Eqn. 1-1 
where G(τ) is the correlation function and τ is delay time. 
This correlation is a second order statistical method for estimating the degree of randomness within 
the accumulated data (Pecora, 2013, Pecora, 1964). However, autocorrelation convolutes the 
intensity of the recorded signal as a function of time with itself through an exponential function 
(Pecora, 2013) such as shown in Eqn. 1-2. 
 𝚪 = 𝑫𝒒𝟐 Eqn. 1-2 
where q is 
4.𝜋.𝑛
𝜆0
. 𝑆𝑖𝑛
𝜃
2
 where n is dispersant refractive index, λ0 laser wavelength and 𝜃 is the  detection 
angle.  
The rate of the intensity fluctuation is directly proportional to the translational diffusion coefficient 
(D) of the particles which according to the Stokes-Einstein relation as shown in Eqn. 1-3 is also 
proportional to the measured hydrodynamic radius. Therefore, particle size analysis is a measure of 
the particle diameter of a theoretical hard sphere which possesses the same diffusion coefficient as 
the studied particle.  
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𝑫 =
𝒌𝑩𝑻
𝟔𝝅𝜼(𝑻)𝑹𝒉
 Eqn. 1-3 
Where kB is the Boltzman constant, T is the absolute temperature (K) and ƞ(T) is the viscosity of the 
suspending liquid. This parameter is strongly dependent on the temperature of the liquid samples and 
hence should be kept constant during the measurements. Rh is the hydrodynamic radius of the particle 
(Tscharnuter, 2000). 
Protein molecules in solution are generally non-spherically shaped particles and mostly in motion. In 
DLS, the hydrodynamic diameter of such particle is an estimated diameter of a sphere which possesses 
an equivalent translational diffusion speed as the non-spherical biomolecule (Arzenšek, 2010). The 
hydrodynamic diameter of a protein is always overestimated due to the fact that the particle being 
measured is solvated and therefore will have a hydration layer (Tscharnuter, 2000). 
Any change in the particle shape that inherently affects the diffusion speed will invariably also affect 
the hydrodynamic size. For instance changing the length of a rod-shaped particle will directly affect 
the size, whiles a change in the diameter of the rod will have relatively less effect on the diffusion 
speed.  
Nevertheless, DLS has been used in to study protein size changes due to aggregation (Ni et al., 2015a, 
Ferré-D'Amaré and Burley, 1997, Folta-Stogniew and Williams, 1999, Jachimska et al., 2008, Li et al., 
2011, Pike et al., 1996) with all studies recording similar particle size which are in agreement to what 
has been measured using other technologies and reported in the literature. It should be mentioned 
that while DLS is ideal for detecting presence of small quantities of aggregates in a sample, occasionally 
a few proportion of large particles may also originate from poor buffer preparation. Therefore to 
prevent the scattered light coming from small particles being swamped by the large particles, it is 
advisable to filter all samples prior to analysis.  
1.5.6 Fluorescence spectroscopy 
This analytical technology has been used to study protein folding, dynamics and physicochemical 
interactions (Abdelhameed et al., 2017, Andersen et al., 2017, Biancalana and Koide, 2010). It has 
been successfully applied to explore the composite mechanisms of protein aggregation (Lakowicz, 
2013, Biancalana and Koide, 2010) including amyloid fibril formation and the interaction of 
amyloidogenic proteins with membranes (Espargaro et al., 2012, LeVine, 1995, LeVine III, 1999, Naiki 
et al., 1989, Sen et al., 2009, Wolfe et al., 2010).  
22 | P a g e  
 
The principles of this technology has been reviewed in depth elsewhere (Sauer et al., 2011, Lakowicz, 
2013). Briefly, proteins possess relatively rare three aromatic amino acids; phenylalanine, tyrosine, 
and tryptophan which are all fluorescent (Lakowicz, 2006, Nhu Ngoc Van and Morris, 2013). 
Tryptophan is the most dominating intrinsic fluorophore and makes up ≈1 to 2 mole percent in 
proteins (Lakowicz, 2006, Suntsova et al., 2002, Nhu Ngoc Van and Morris, 2013). In most protein 
molecules, few tryptophan residues may be present and this is advantageous in fluorescent 
spectroscopy because it removes complexity in protein emission studies.  
A significant characteristic of intrinsic protein fluorescence is the relatively high sensitivity of 
tryptophan in its local region. During emission studies, variations in the spectra of tryptophan often 
occur as a result of aggregation/denaturation, substrate binding or any conformational transitions. 
These physicochemical interactions affect the local regions around the indole ring.  
Figure 1-7 shows 1-anilinonaphthalene-8-sulfonic acid (ANS) (a) and Thioflavin T (ThT) (b), which binds 
non-covalently and are used for extrinsic fluorescent probing of protein folding and amyloid fibril 
formation (Lakowicz, 2013, Munishkina and Fink, 2007).  
    
Figure 1-7 Molecular structure of (a) 1-anilinonaphthalene-8-sulfonic acid (ANS) and Thioflavin T (ThT) (b) 
When bound to hydrophobic regions of a protein molecule, the quantum yield of ANS increases up to 
100 fold (Farris et al., 1978, Munishkina and Fink, 2007, Schonbrunn et al., 2000). ANS generally binds 
to exposed hydrophobic regions originating from partially unfolded and intermediates of a protein 
aggregates. During aggregation, the hydrophobic regions are exposed to solvent thereby increasing 
ANS binding and subsequent increase on fluorescence signal. The binding of ANS is accompanied by a 
blue shift of the emission maximum (from ≈530 nm to ∼475 nm) (Royer, 2006). 
Another dye used for protein aggregation study is ThT, which was first introduced in 1959 (Vassar and 
Culling, 1959) and indicated an enhanced fluorescence when bound to amyloid in kidney tissue 
sections. ThT is used as a specific probe for the presence of amyloid fibrils (LeVine, 1995, Naiki et al., 
1989, Biancalana and Koide, 2010). As shown in Figure 1-7b, ThT has two rings of a conjugated 
benzothiazol and aminobenzol rings arranged in an almost planar orientation (ϕ ∼ 30 °) (Voropai et 
al., 2003) to maintain the minimum energy conformation. Its structure indicates the presence of both 
polar and a nonpolar functional groups. In an aqueous solution, there is a formation of micelles with 
a b 
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its non-polar dimethylaminophenyl groups protected in the core whiles the charged benzothiazole 
groups become exposed.  
ThT binds to β-sheet in proteins yielding an intensified fluorescence signals when compared to an 
unbound ThT (Khurana et al., 2005). During excitation, the rings rotate to obtain the most stable 
excited state conformation (ϕ ∼ 90 °) (Munishkina and Fink, 2007), characterised by low fluorescence 
efficiency. ThT has two excitation peaks at ∼ 335 nm and ∼ 430 nm with two corresponding emission 
peaks at 483 nm and between ∼ 425 nm and 455 nm.  
Fluorescence spectroscopy technology requires relatively small sample size (pM–nM range) but yields 
a spectrum with high signal-to-noise ratio. This technology is ideal for studying fast protein 
conformational changes since the lifetime of the fluorescence emission is within nanosecond range. 
1.5.7 Turbidimetry studies of proteins using UV/Vis spectroscopy 
UV/Vis spectroscopy is an analytical tool that has been used to study proteins and relative 
quantification of the aggregated/denatured proportions. Proteins have distinct spectral features and 
wavelengths at which maximum absorption is recorded with UV/Vis spectroscopy. The technology 
measures solutions within the ultraviolet and visible spectral regions. 
Absorption or reflectance within the visible range is related to the colour of the chemicals and can be 
detected in the spectrum. In the absence or absorption of any of the light wavelengths, the remaining 
wavelength combination is observed or perceived as the "complimentary" colours whiles in the 
presence of all the visible light wavelengths, light appears to be  "white" (Clark et al., 1993). Table 1-4 
below shows the perceived colours of absorbed colours at the various wavelengths. 
Table 1-4 Colours of visible radiation and the complementary colours observed at their various wavelengths. 
Table was adopted from (Burns, 1993).  
Absorbed Wavelength (nm) Absorbed Colour Transmitted Colour 
380 - 435  Violet Green - yellow 
450  Indigo Yellow 
480  Blue Orange 
490  Blue-green Red 
520 - 565 Green Purple 
565 - 590 Yellow-green Dark blue 
590 - 625 Orange Blue 
625 - 740 Red Green 
Light photons has specific energy that relates to a certain wavelength represented as Eqn. 1-4 below 
(Perkampus et al., 2013, Clark et al., 1993). 
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 𝑬 = 𝒉𝒗 Eqn. 1-4 
where E is photon energy, h is the Planck’s constant and v is the frequency (or velocity or wavelength)  
Within the electromagnetic regions, molecules go through electronic transitions from the ground state 
to the excited state when a photon of coloured light is absorbed by a compound. This occurs due to 
electron promotion from an occupied orbital to an unoccupied orbital resulting in the higher energy 
compound in an excited state. 
Although the technology is sensitive to measure varying absorbance, this parameter is not ideal for 
comparisons between different solutions since it does not take into account the path length of the 
solution the light is passing through. However, these two variables are correlated through the Beer-
Lambert Law. 
In protein studies, the maximum absorbance is recorded at 280 nm. This florescence properties 
recorded as UV-vis absorbance originates from tryptophan, tyrosine and phenylalanine amino acid 
residues in the protein molecule.  
Turbidimetry relates to the scattering of light by particles with sizes greater than the wavelength of 
the incidence beam. It measures the optical density or the apparent absorbance of the solution but 
not the real absorbance. Turbidimetry measurements are recorded at wavelengths > 300 nm which is 
significantly larger than the diameter of the protein molecule in the native conformation reported to 
be ≈10 Å. As a result of protein unfolding, aggregation/denaturation or adsorption, the size of the 
protein molecule is increased often to a size comparable to the wavelength. This causes scattering to 
occur and it’s measured as the apparent absorbance at 360 nm. The measured value is dependent on 
the optical density which is directly proportional to the size of the protein molecule, the concentration 
and the surface properties.     
Although these measurements are simple and nonspecific, they yield rich source of information when 
samples are compared following varying experimental treatments. For instance because of its high 
sensitivity for small particles, turbidimetry is capable of detecting the formation of particles in liquid 
formulations at the early stages during stability studies. 
However, turbidimetry measurements lacks the ability to provide information about molecular sizes, 
concentration, or the aggregate type and as such cannot be directly used as quantitative tool, 
determine aggregate size and perhaps its distribution without some probably grievous assumptions. 
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Consequently, turbidimetry measurements are mainly qualitative for assessing protein aggregation 
during protein formulation development. 
Turbidimetry was used to measure the aggregation induced by heat (Kim et al., 1992). The method 
was also used to observe an increased apparent absorbance from 0.015 to 0.166 following the removal 
of an excipient from a diafiltration buffer at 350 nm using UV/Vis spectroscopy (Cromwell et al., 2006). 
The authors concluded that the presence of the excipient has the potential to enhance the stability 
profile of the formulation during diafiltration by reducing the formation of protein aggregates. 
Similarly, turbidimetry has been used to study the conformation and self-association of Human 
Recombinant Transforming Growth Factor-β3 in aqueous solutions (Pellaud et al., 1999) with 
promising observations in the reported literature. Lyutova et al. (2007) also used turbidimetry as a 
complementary tool to study the effects of arginine on the kinetics of protein aggregation using 
alcohol dehydrogenase (ADH) and insulin as model proteins (Lyutova et al., 2007). 
Turbidimetry measurements have also been carried out by different groups and the results published 
(Anzai et al., 2016, Sant'Anna et al., 2016, Necula et al., 2007, Dolado et al., 2005). It have been used 
to monitor the growth of different protein aggregation reactions, such as cytoskeletal fibre formation 
(Voter and Erickson, 1984), and helical fibre formation by sickle cell HB (Moody et al., 1996).  
Table 1-5 summarises some of the analytical technologies that have been used to determine protein 
aggregation in the past decades. 
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Table 1-5 Summary of some of the analytical technologies for studying protein aggregation / denaturation. 
Technology Principle Observations  Size range Advantages Disadvantages 
Visual 
inspection 
Visualization Turbidity, 
presence of 
visible 
particles 
>50 μm – 
mm 
Easy and quick 
Gives initial 
perception on 
particle size, colour 
and shape 
Low resolution, particle 
sizing discrimination, 
subjective, trained 
personnel needed 
Optical 
microscopy 
Microscopic 
imaging 
Size and 
morphology of 
particles 
>1 μm – mm Easy to perform, 
Some information 
on particle size, 
shape and 
coloration 
Resolution is limited, 
sample handling may 
actually cause protein 
aggregation 
Flow imaging Microscopic 
imaging 
Concentration
, size and 
morphology of 
micron sized 
particles 
1  – 400 μm Potential to 
differentiate 
between aggregate 
and other particles, 
maybe used to 
determine shape  
Not enough 
information to 
characterise aggregate, 
not the entire sample 
is analysed 
Fluorescence 
microscopy 
Detection of 
induced 
fluorescence 
Amyloid 
proteins 
>1 μm – mm Very sensitive, 
selective for 
protein aggregates 
Requires dye, cannot 
be used for 
quantification analysis 
Dynamic light 
scattering 
Fluctuations in 
scattered light 
intensity due 
to Brownian 
motion 
Hydrodynamic 
size 
aggregates 
0.001 – 
5 μm 
Non-destructive if 
intended for liquid 
formulation, very 
sensitivity, requires 
minute amount of 
sample 
Data analysis 
complicated, not ideal 
for quantification, 
cannot differentiate 
between monomer, 
dimer and oligomers, 
very sensitive to 
presence of dust 
Size exclusion 
chromato-
graphy (SEC) 
Separation by 
molecular 
sieving 
Hydrodynamic 
size 
1 – 50 nm Robust, sensitive, 
precise, maybe 
used alongside 
other 
instrumentation for 
online analysis 
Sample requires 
dilution in specific 
mobile phase which 
might affect protein 
native structure, 
resolution is limited to 
IR, large size may block 
columns 
 
SDS-PAGE Separation in 
a gel by size in 
an electric 
field 
Apparent 
molecular 
weight 
kDa – MDa Sample analysis is 
easy, identify 
between disulphide 
mediated and non-
disulphide 
mediated covalent 
aggregates 
Non covalent 
aggregates not 
detected, staining is 
required, complicated 
for quantification 
Electron 
microscopy 
Visualization Size and 
morphology of 
protein 
aggregates 
nm – mm For large particle 
size range, high 
resolution, can 
detect chemical 
composition of 
particle using 
energy dispersive 
X-ray analysis 
Sample preparation 
may damage native 
protein, not for 
quantification, time 
consuming, equipment 
is costly, interpretation 
requires expert 
personnel 
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Atomic force 
microscopy 
Topographical 
scanning 
Size and 
morphology of 
nm-sized 
particles 
nm range, 
vertical 
resolution 
0.01 nm 
For molecular 
resolution, ideal for 
morphological 
particle 
characterisation 
Time consuming, 
equipment is  
expensive, not entire 
area is analysed, 
requires expert 
personnel to interpret 
data 
SAXS/SANS Scattering of 
X-ray/neutron 
beam 
Size and shape 
of aggregates 
in solution 
nm range High resolution Time consuming, 
requires expert 
personnel to interpret 
data 
Infrared 
spectroscopy 
Absorbance of 
infrared light, 
vibrational 
spectroscopy 
Secondary 
structure 
N/A Non-destructive, 
little interference 
from light 
scattering, possible 
to combine with 
other microscopic 
tools  
Low sensitivity, protein 
concentrations 
>1 mg/mL needed 
Raman 
spectroscopy 
Vibrational 
Raman and 
Raman optical 
activity 
Secondary 
structure 
chemical 
analysis  
N/A Non-destructive, 
solid state analysis, 
little interference 
from light 
scattering; possible 
to combine with 
other microscopic 
tools 
Low sensitivity 
UV/Vis 
spectroscopy 
Absorption 
(and 
scattering) of 
light 
Optical 
density 
(presence of 
aggregates/pa
rticles), shifts 
in folding 
state 
N/A Easy to use, non-
destructive, 
commonly used as 
online tool for 
aggregate 
detection 
Limited information on 
particle properties 
Fluorescence 
spectroscopy 
Detection of 
induced 
fluorescence 
(intrinsic or 
extrinsic) 
Tertiary /  
quaternary 
structure 
N/A Uses multiple 
fluorescent 
techniques and 
possible for online 
analysis  
Low resolution, sample  
not reusable, 
background 
interference from 
impurities and 
fluorescent excipients 
Circular 
dichroism 
spectroscopy 
Difference in 
the absorption 
of left- and 
right-handed 
circularly 
polarized light 
Secondary/ 
tertiary/ 
quaternary 
structure 
N/A low protein amount 
required (far UV), 
sample does not 
need dilution, 
online tool  
Interference by light 
scattering from other 
particles, resolution is 
relative, data analysis 
is complicated and 
time consuming, other 
excipients and solvents 
may interfere with 
data acquired 
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1.6 Some excipients included into a protein based formulation to 
enhance protein stability  
The rate of protein denaturation/aggregation may be controlled or prohibited by either modifying the 
structure of the protein molecule or through the inclusion of excipients to the biopharmaceutical 
formulation. A variety of excipients/additives are available for use, such as sugars and polyols, amino 
acids, amines, salts, polymers, and surfactants. 
In the previous years, various research groups have reported that protein denaturation/aggregation 
may be a fundamental property depending on the polypeptide chains and possibly associated with 
their common peptide backbone that does not depend on specific amino acid sequences. In addition, 
it has been shown that even the toxic effects of protein aggregates, mainly in their pre-fibrillar state, 
result from common structural features rather than from specific sequences of side chains. These data 
lead to hypothesize that every polypeptide chain, in itself, possesses a previously unsuspected hidden 
dark side leading it to transform into a generic toxin to cells in the presence of suitable destabilizing 
conditions. The major view with modifying the structure of the protein molecule is not only to enhance 
its stability profile but to also ensure the native protein activity is preserved. Although the modified 
acidic fibroblast growth factor (aFGF) lost its activity as shown by (Middaugh and Volkin, 1992), an 
improved understanding of protein structure has led to successful modifications such as reported (Cho 
et al., 2011, Prescher et al., 2004) and has been explained in depth (Baslé et al., 2010).  
Salts ability to destabilise or stabilise the protein native structure is complex, due to in part the 
intricate ionic interactions on fully exposed surfaces, and on the partially or totally buried interior of 
proteins. Salts effects is dependent on its concentration, type and the nature of ionic interactions; 
importantly also is the charged residues in proteins (Amin et al., 2014, Kohn et al., 1997). For instance 
Chan et al., showed that in the presence of 75 mg/mL of NaCl, the melting temperature of 
recombinant human deoxy ribonuclease (rhDNase) decreased from 67.4°C to 65.3°C but increases to 
70.1°C when concentration of NaCl was increased to 200 mg/mL (Chan et al., 1996).  
The electrostatics in a protein molecule or polypeptide chain can be affected by salts through non-
specific (Debye-Hückel) electrostatic shielding or via specific ion binding to the protein molecule 
(Stellwagen and Stellwagen, 2003, Zhang, 2012). At low concentrations, salts affect electrostatic 
shielding and weaken ionic repulsion. Therefore, this shielding effect may be either stabilizing when 
there are major repulsive interactions leading to protein unfolding, or destabilizing when there are 
major stabilizing salt bridges or ion pairs in the protein. At high concentrations, electrostatic shielding 
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is saturated; the dominant effect of salt, like other additives, is on solvent properties of the solution. 
The overall effect on protein stability is dependent on the relative effect on free energy of unfolded 
and native states (Beauchamp and Khajehpour, 2012, Goto and Fink, 1989). It was shown that the 
presence of salt resulted in change to a conformation that have the properties of a molten globule, 
i.e. a dense state that possesses a native-like secondary structure but have a disordered side chains 
(tertiary structure) (Goto and Fink, 1989).   
The stabilizing salts seem to increase surface tension at water-protein interface and strengthen 
hydrophobic interaction by keeping hydrophobic groups away from water molecules, inducing 
preferential hydration of proteins (Kohn et al., 1997, Kristjansson and Kinsella, 1991). The salt effect 
strongly depends on the solution pH, which dictates charged state of ionisable groups.  
Polymers have also been used to inhibit protein denaturation/aggregation by increasing the viscosity 
of the bulk solution so that there is limited protein backbone mobility, sterically hindering protein–
protein interactions, preferential exclusion in binding regions, and through surface interaction 
bindings. For instance, trehalose glycopolymers have been successfully used to protect β-
galactosidase against lyophilisation stresses while same effect was observed for horseradish 
peroxidase and glucose oxidase which were incubated at 70 °C and 50 °C respectively (Lee et al., 2013). 
Zhu et al. also encapsulated bovine serum albumin (BSA) in injectable poly (DL-lactide- co-glycolide) 
(PLGA) 50/50 co-incorporated with magnesium hydroxide and observed that BSA structural losses and 
aggregation was inhibited for over one month following the elimination of microclimate pH. Similar 
was done for delivery of angiogenic basic fibroblast growth factor and bone-regenerating bone 
morphogenetic protein-2 (Lee et al., 2013). 
Polyethylene glycol (PEGs) is a group of polymers used as protein cryoprotectants and crystallizing 
agents in aqueous solution at relatively high concentrations. PEGs have hydrophobic and hydrophilic 
regions. As a result they can easily interact with hydrophobic side chains of proteins, promoting 
unfolding, especially at high temperatures (Farruggia et al., 1997).  
The varying effects of different molar ratios of PEGs on the native conformation of proteins was 
studied using bovine serum albumin as the model protein (Rawat et al., 2010, Lee and Kim, 2002). 
Rawat et al. reported that co-lyophilisation of BSA with PEG at optimum BSA:PEG molar ratio leads to 
the formation of the stable protein formulation. Circular dichroism spectroscopy analysis indicated 
that a conformational change had occurred in the protein after interactions with PEG with the most 
stable protein structure contained in 1:0.75 BSA:PEG molar ratio. These observations were ascribed 
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to a strong physical adsorption of PEG on the hydrophobic core of the protein (BSA) and a further 
surface adsorption (Rawat et al., 2010). Lee et al. also showed that protein microarrays, PEG 200 at 
30% (w/v) was the most efficient stabilizer giving over 4-fold improvement in protein stability 
compared to without the stabilizer (Lee and Kim, 2002).  
Surfactants are additives that have been included in biopharmaceutical formulation to inhibit protein 
aggregation via various mechanisms. They may be grouped into two categories; non-ionic and ionic. 
Generally, low concentrations of non-ionic surfactants are preferred compared to ionic surfactants. 
This is because, they have the ability to prevent/reduce protein surface adsorption and/or 
denaturation/aggregation as a result of their relatively low critical micelle concentrations (CMC) 
(Seddon et al., 2004).  
One mechanism of surfactants is by accumulating competitively at the hydrophobic interfaces and 
thus reduces adsorption at this interface (Randolph and Jones, 2002, Serno et al., 2010).  Other 
proposed mechanisms are protein-specific, for instance, polysorbate 20 inhibits agitation-induced 
aggregation in recombinant human growth hormone (rhGH) via binding to hydrophobic sites on the 
protein’ surface and may further sterically hinders intermolecular interactions (Bam et al., 
1998). Surfactants may also act as chemical chaperones by transiently binding to physically orientated 
protein molecules (Randolph and Jones, 2002). Certain surfactants such as poloxamers also act by 
increasing the viscosity of the protein solution. This helps to restrain the molecular mobility of the 
protein backbone (Wang and Johnston, 1993). 
Surfactants may sometimes have a negative effect on the protein based formulation. For instance, 
non-ionic surfactants may reduce protein aggregation induced by agitation, but they may also 
decrease the unfolding free energy of protein in bulk solution causing protein aggregation in bulk 
solutions (Mahler et al., 2010). Ionic surfactants are generally avoided as they have the potential to 
bind with both the polar and non-polar groups in proteins and cause denaturation (Won et al., 1998). 
They may also decrease the unfolding free energy of protein in bulk solution (Mahler et al., 2010). 
Nevertheless, Rozema et al. indicated that ionic surfactants can also be used if the resultant binding 
is reversible (Rozema and Gellman, 1996).   
Amino acids have also been used to stabilise the native structure of proteins during biopharmaceutical 
manufacture. Approximately 15 different amino acids (Shiraki et al., 2002, Das et al., 2007, Arakawa 
et al., 2007, Liu et al., 2007), have been studied relative to their influence on the stability on the native 
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structure of the protein molecule during thermal unfolding-induced aggregation and dilution-induced 
aggregation from denatured state (Shiraki et al., 2002). 
From these studies, various mechanisms have been proposed. Liu et al. (2007) proposed that l-
arginine reduced protein conformational movement during the refolding process (Liu et al., 2007). In 
another study, it was proposed that l-arginine interacts favourably with the majority of amino acid 
side chains (increasing the solubility of amino acids in solution) but is limited when interacting with 
amino acids side changes on the protein surface owing to the exclusion of arginine from the protein 
surface. It was concluded that in comparison to guanidine hydrochloride (which interacts more 
favourably with the protein surface) such limited binding by arginine plays a major role in its ability to 
suppress aggregation and or denaturation (Arakawa et al., 2007). It was also proposed that the 
hydrophobic regions originating from the three methylene groups on L-arginine interact with the 
hydrophobic surface in the protein molecule thereby reducing the potential for protein-protein 
interactions (Das et al., 2007). 
Amino acids such as proline are known as natural osmolytes that can stabilize proteins. Proline has 
also been reported in the literature to aid in protein refolding (Samuel et al., 2000, Kumar et al., 1998, 
Chattopadhyay et al., 2004). It was reported that in concentration exceeding 1.5 M, proline forms a 
loose but highly ordered molecular aggregate(s). This assembly possess an amphipathic character and 
is crucial for proline to function as a protein folding aid (Samuel et al., 2000, Kumar et al., 1998). In a 
separate study, analysis of aggregated proteins in a molecular chaperone dnaK deficient strain at 42 
°C by two-dimensional gel electrophoresis concluded that high proline concentrations reduce the 
protein aggregation defect of the dnaK-deficient strain. This is ascribed to proline ability to act as a 
major chaperone (Chattopadhyay et al., 2004). Bozorgmehr and Monhemi (2015) also reported an 
enhanced protein thermal stability in the presence of 3 mol/L proline. It was also noticed that the 
proline molecules were excluded from the protein surface. In the same time, water molecules in the 
hydration shell around the protein increase, thus inducing thermodynamic stabilization of the protein 
(Bozorgmehr and Monhemi, 2015).  
Multiple amino acids have also been studied to identify its probable synergistic effect to enhance the 
stability profiles of biopharmaceutical formulation. For instance, a combination of L-arginine 
(positively charged), L-glutamic acid (negatively charged), and L-isoleucine (nonpolar) have been 
observe to have improved the stability of recombinant factor VIII (FVIII) during freeze drying and 
storage. This profile is similar to what has been identified when albumin is used as the stabilizing 
excipient (Paik et al., 2012).   
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1.7 Protein based formulation design and product characterisation 
Protein based pharmaceutical drug may be formulated as a solid or liquid depending on its stability 
profile and therapeutic effects. Biopharmaceutical formulations are prepared following distinctive 
design steps to achieve the required dose and stability profile of the active protein molecule. Different 
protein molecules require different formulation approaches and usually present different technical 
challenges. 
The traditional route of pharmaceutical administration has been the oral route which makes up 
between 50% and 60% of all the pharmaceutical prescribed medication (Thakur and Kashi, 2011). 
Relative to biopharmaceutical products, there are some major disadvantages that render this 
administration route unfavourable. Some of these disadvantages include physical and enzyme 
degradation of the active protein (polypeptide) drug molecule, drug interactions with membranes and 
gastrointestinal barriers and potential liver deactivation during first pass metabolism in the liver 
increasing risks of toxicity and side effects. Figure 1-8 shows that of the 300+ peptide based 
therapeutic medicines approved by the FDA as off 2015, the favourable route of administration is not 
the oral route. Thus, biopharmaceutics has predominantly considered parenteral administration as an 
obvious route of administration with a vast majority of the available biopharmaceuticals administered 
via the intravenous, subcutaneous or intramuscular route (Cleland et al., 2001).  
 
Figure 1-8 Plot of FDA approved protein and peptide based therapeutics as off 2015. Data was adapted from 
(Raghava et al., 2017). 
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The majority of these dosage forms are prepared via the removal of water at very low temperatures 
and pressures via the process of freeze drying. Table 1-6 lists some freeze dried protein based drugs 
currently approved and marketed. 
Table 1-6 Some freeze dried protein based drugs approved for marketing by the FDA (Biologics License 
Agreement) between 2011 and 2016. Table adapted from (Food and Drug Administration) 
Trade Name Company Protein Class Excipients 
Adcetris 
  
Seattle Genetics Brentuximab 
vedotin 
Antibody-drug 
conjugate 
735 mg trehalose  
58.8 mg sodium citrate dihydrate 
2.21 mg citric acid 
2.1 mg polysorbate 80 
52.5 mg active drug 
Benlysta GSK Belimumab
  
Monoclonal 
antibody 
400 mg sucrose 
13.5 mg sodium citrate 
2.0 mg citric acid 
0.8 mg polysorbate 80 
Entyvio  Takeda Vedolizumab
 
  
Monoclonal 
antibody 
131.7 mg L-arginine hydrochloride 
23 mg L-histidine 
21.4 mg L-histidine mono 
hydrochloride 
3 mg polysorbate 80 
Myalept Bristol-Myers 
Squibb 
Metreleptin Hormone 44 mg glycine   
22 mg sucrose 
3,23 mg glutamic acid 
0,2 polysorbate 20 
11.3 mg protein  
Nulojix  Bristol-Myers 
Squibb 
Belatacept Fusion protein 500 mg sucrose   
34.5 mg monobasic sodium 
phosphate 
5.8 mg sodium chloride 
250 mg  protein 
Voraxaze BTG 
International 
Glucarpidase Enzyme 10 mg lactose monohydrate 
0.6 mg Tris-HCl 
0.002 mg Zinc acetate dihydrate 
 
1.7.1 Freeze drying in biopharmaceuticals 
Freeze drying is another manufacturing approach that has been implemented to extend the stability 
of protein based pharmaceutical products. Although time consuming and a financial drain on 
manufacturing budgets, the process pays for itself if implemented to a specific product using optimal 
parameters. The fundamental understanding of this unit process is the separation of liquid water from 
a solution at sub-ambient temperatures in the form of a solid ice, and its subsequent removal by 
vacuum sublimation, leaving the solutes in their amorphous, or almost amorphous states. Although 
simple definition, it hides significantly complex issues relating to the physicochemical changes of the 
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solute that may accompany the stages during the process. The freeze drying process primarily consists 
of three stages (Liapis and Roberto, 2006, Adams, 2007, Jennings, 1999); freezing, primary drying and 
secondary drying.  
The freezing stage is the first stage and entails freezing a liquid (aqueous) formulation to produce a 
solid matrix suitable for drying. Through this stage, the solvent is separated from the solute in the 
form of ice crystals. The formation of ice crystals traps the solutes into the interstitial region between 
the ice crystals. This stage is extremely significant in that it impacts the drying characteristics of the 
following two stages and the properties of the final freeze dried product. The temperature required 
to achieve an optimal (if not total) freezing of the formulation is dependent on the solvent and the 
excipients. Generally, freezing must be carried out below glass transition prime (Tg′) of frozen 
amorphous materials or below eutectic crystallization temperature (Teu) to ensure total solidification 
of the sample (Tang and Pikal, 2004, Jennings, 1999). Table 1-7 lists the Tg’ and their collapse 
temperature of some commonly used excipients in freeze drying protein based formulations.  
Table 1-7 List of some excipients and their corresponding Tg’ and collapse temperatures. The data was 
adapted from (Yang et al., 2010). 
Excipient Glass Transition Temperature Prime  (˚C) Collapse Temperature (˚C) 
Mannitol -35 -1.4 (in crystalline state) 
Trehalose -29 -28.5 
Sucrose -32 -31 
Lactose -28 -30.5 
Histidine -33  
Glycerol -65  
Although freeze drying improve the protein stability during storage, the process itself does generate 
many stresses especially from freezing and dehydration that can destabilize the native structure of 
the protein molecule. It is well known that during the freezing of a sample, there is a phase separation 
into ice and cryo-concentrated solution (Padilla et al., 2011, Crowe et al., 2004, Padilla and Pikal, 2011). 
This high concentration of particulate system may induce aggregation and in some cases may be 
irreversible. Ice crystallisation may also exert additional mechanical stress onto the protein structure. 
In a typical protein based pharmaceutical formulation intended for freeze drying, due to the harsh 
conditions the native structure will be exposed to, a cryoprotectant (Abdelwahed et al., 2006b) is 
included to offer significant protection to the active biomaterial against the effects of ice formation 
during the freezing stage (Fuller, 2004). In biopharmaceutical manufacturing, cryoprotectants are 
categorised into two groups; membrane permeating which can freely diffuse across the membrane 
and a non-membrane permeating which cannot permeate the cell membrane. List of some 
cryoprotectants is presented in Table 1-8. The most commonly mentioned cryoprotectants in the 
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literature are mainly polyols and sugars (disaccharides): trehalose (Chacón et al., 1999, Crowe et al., 
2004, Crowe et al., 1996, Liao et al., 2002, Carpenter et al., 1986), sucrose (Abdelwahed et al., 2006a, 
Liao et al., 2002, Carpenter et al., 1986), lactose and mannitol (Townsend and Deluca, 1988, Crowe et 
al., 1987). It should be noted that these sugars are known to vitrify at a specific temperature denoted 
Tg′ (Franks, 1972, Pikal, 2010).  
From the literature, trehalose seems to be a preferable cryoprotectant potentially due to its less 
hygroscopicity, the fact that it lacks an internal hydrogen bounds which allows for the flexible 
formation of hydrogen bonds with proteins during freeze-drying and has a higher Tg′ (Crowe et al., 
1996, Crowe et al., 1992). However, the degree of protection is dependent on their concentrations in 
the formulation. Changing proteins’ environmental properties often lead to inhibition of protein 
aggregation.  
Table 1-8 List of some cryoprotectants used in academic research or licensed protein based freeze dried drugs. 
Table was adapted from (Wang, 2000b, Bhattacharya and Prajapati, 2016). 
Name Category Reference 
Dimethyl sulfoxide (DMSO) Membrane permeating (Lale et al., 2011) 
Glycerol Membrane permeating (Villaverde et al., 2013, Bruyas et al., 2000) 
Proline Non-membrane permeating (Pemberton et al., 2012, Zhang et al., 
2016) 
Propylene glycol Membrane permeating (Lale et al., 2011) 
Sucrose Non-membrane permeating (Liu et al., 2013, Roughton et al., 2013) 
Arginine Non-membrane permeating (Mohammed et al., 2007a, Ain-ai, 2009, 
Arakawa et al., 2007, Ishibashi et al., 2005, 
Lyutova et al., 2007, Zhao et al., 2015) 
Lactose Non-membrane permeating (Nag and Das, 2013) 
Trehalose Non-membrane permeating (Eroglu et al., 2002, Duong et al., 2006, 
Crowe et al., 2004, Liao et al., 2002) 
It has been proposed that, during the freezing stages of freeze drying, cryoprotectants replaces the 
dehydrated water molecules by forming hydrogen bonds with the amine proteins molecules and 
thereby helping to retain the native state of proteins (Ashwood-Smith, 1987, Vemuri et al., 1994, 
Anchordoguy et al., 1987, Allison et al., 1999). In other instance, permeating protectants provide 
intracellular protection through preferential exclusion from the surface of protein molecules thereby 
stabilizing the native structure (Sieme et al., 2016). Both, permeating and non-permeating protectants 
form a protective glassy state during freezing, preserving biomolecular and cellular structures. 
The second stage is a primary drying, which may precede an annealing step to ensure set parameter 
has been equilibrated in the freeze drying chamber and samples. The fundamental function of this 
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stage is to reduce (or remove) ice from the interstitial region through sublimation at low pressure of 
the freeze drying chamber while maintaining the product temperature at a low target level.  
The moisture content of freeze dried cake is a good indicator of other associated physical and chemical 
properties of the finished product. There are two categories of moisture that may be encountered in 
freeze dried product; residual moisture and bound water. The major variation between these two 
forms of moisture are interactions that exist between them and the excipients. Bound water is 
associated with the stability of the active component or other excipients.  
The residual water (moisture) is the main reason why the secondary drying is included as the third 
stage in freeze drying. The fundamental purpose of this stage is to further reduce the bound water 
until the residual moisture content reaches its targeted level. Indeed, it is because of this stage that a 
product that would have been stored effectively ≈4 °C such as a vaccine for few weeks can now be 
stored at ambient temperatures for months.  
To further protect the proteins from the effects of the drying stress, lyoprotectant (Roy and Gupta, 
2004, Townsend and Deluca, 1988) are included. Townsend and Deluca (Townsend and Deluca, 1988) 
proposed that lyoprotectant formed a rich water source environment around the protein molecule 
because during the freeze drying process, the protein configuration is altered resulting from the loss 
of bridging water in the molecular.  
These additives stabilize proteins by preferential interactions, a widely accepted concept of protein 
stabilization (Arakawa et al., 2007, Arakawa and Kita, 2000, Arakawa and Timasheff, 1984). Other 
mechanisms are also operable, such as increased rate of protein folding (Wang, 2005, Wang, 2015), 
reduction of solvent accessibility and conformational mobility (Hoofnagle et al., 2001, Kendrick et al., 
1997). Unfortunately, there is no single pathway to follow in selection of a suitable stabilizer(s), in part 
as a result of the lack of understanding of how these excipients interacts to stabilise the molecule and 
the multiple mechanisms through which the native structure of the protein molecule can be altered. 
Freeze dried protein based drugs are generally amorphous cakes with relatively high porous matrix 
system to improve reconstitution times for use. The section below discusses some of the 
physicochemical properties of the protein molecule after the freeze drying process, approaches to 
avoid stress damages and optimisation.   
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1.7.1.1 Physicochemical characterisation of freeze dried cakes 
The quality of the freeze dried cake may be assessed on a microscopic and macroscopic scale to 
ascertain physical characteristics. An ideal freeze dried cake has a consistent texture, an intact matrix 
and a non-reduced volume. A formulation may be rejected based on visual inspection to ascertain if 
shrinkage or matrix collapse has occurred i.e. reduction of the final volume of the cake when 
compared to the volume of the initial frozen matrix. This phenomenon could potentially be an 
indication of using the poor freeze drying parameters during the primary or secondary drying stages, 
poor formulation type or an excessive moisture content in the final dried cake (Pikal and Shah, 1990).  
Furthermore, bound water, may be used to predict the stability and physical properties of the finished 
product (Jennings, 1999, Matejtschuk, 2005, Matejtschuk, 2007). For instance, surface water (an 
example of bound water) is involved in defining the configuration of the protein molecule and its 
functionality.  
1.8 Gap in knowledge 
Presently, the formulation of biopharmaceuticals is hinged on identifying physiochemically stabled 
medium (liquid or solid) to enhance the stability profile of the formulation and final product. Many 
biopharmaceuticals in liquid form have shown poor stability profiles even when stored between 2 °C 
and 8 °C and thus preferably are likely to be manufactured into a solid form for clinical trials or 
commercial sales as shown in Figure 1-8. Presently, a minute percentage of plasma products, such as 
Hizentra® which contains 20% immune globulin solution for subcutaneous injection (IGSC) has shown 
to be stabile even at room temperature (up to 25 °C) for up to 30 months (CSL Behring, 2010). 
As mentioned in the earlier sections, combination or single amino acids have shown the potential to 
improve the stability of biopharmaceuticals either in solutions or solids. L-arginine and L-lysine have 
individually shown to be good stabilisers in solution biopharmaceuticals. However, their inclusion into 
freeze dried (solid) biopharmaceutical formulation has been marred by the poor moisture resistivity 
characteristics of these two amino acids. However, the inclusion of such individual amino acid at low 
proportions could offer the possibility of increasing the protein drug dose in the formulation.   
In addition to the major harsh conditions such as freezing, freeze thawing and drying, three of the 
many steps involved in freeze drying, the type of agitation, also presents an additional deleterious 
stress to the native protein conformations. Indeed as has been mentioned, irrespective of the 
agitation technology used for the formulation, there is a possibility of generating irreversible 
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aggregation/denaturation following any of the mechanisms. Furthermore, while some protein 
formulation may require high speed rotation, there is the potential for the bio solution to foam 
thereby reducing the protein and other excipient proportions.  
Given the importance of agitation in defining the presence of any traces of aggregates that may act as 
nuclei, or conformationally modified molecules, there is a requirement to understand the effects of 
agitation and possible mechanism of aggregation. Of those technologies discussed above, it appears 
that dynamic light scattering technology offers an ideal opportunity to study the physical properties 
and characterise precisely the extent of particle growth in a liquid formulation. However, very little 
literature and work has been done with this technology in studying simple formulations that were 
initially agitated using low revolutions per minute, or via ultra sonification or even reconstitution by 
the patient in syringe/vial just before administration.  
The rationale is based on the fact that if aggregation can be alleviated during the agitation process 
before further manufacturing steps such as freeze drying, then the manufacturer can focus on 
enhancing stability issues originating from the freeze drying only. Moreover, a successful inclusion of 
low proportions of individual amino acids to yield significant stability enhancement could not only 
mean potential to increase active protein drug loading but also reduce wastage and some 
manufacturing steps.    
Although it is envisaged that the DLS technology will yield a rich source of information, the complexity 
of samples (i.e. monomer, dimer and trimer mixtures), large datasets, and possible outliers will be 
challenging when making precise and accurate quantifications for future predictions. For this reason, 
ThT assay and turbidimetry studies will complement the DLS studies.  
1.9 Aim 
Given the importance of mixing in part for defining the stability of biopharmaceutical formulations, 
this project aims to understand the initial particle size growth that originates from the process of 
mixing which is could cause protein unfolding, denaturation and/or aggregation during or after 
product storage. In a following on study, a systematic approach will be used to develop freeze dried a 
biopharmaceutical formulation containing amino acid/s, lyoprotector and cryoprotector. The purpose 
of the included excipients is to help enhance the stability of the final formulation under harsh storage 
conditions.  
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1.9.1 Objectives 
 Determine size growth which can directly be ascribed to the formation of aggregates or 
denaturants of a model protein using dynamic light scattering and other complementary 
technologies such as UV-Vis turbidimetry measurements and Thioflavin T assay. 
 Characterise the physicochemical properties of the final multi excipient component system 
comprising of a model protein, lysine or arginine, a robust moisture resistant excipient, an 
ideal cryoprotector and a lyoprotector.   
 Measure the formation of large protein particles in the reconstituted BSA based freeze dried 
formulation using UV-Vis and fluorescence spectroscopies (relative quantitative or qualitative 
characterization). 
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Chapter 2. Method Development, 
Calibration and Validation 
2.1 Experimental design, data acquisition and data analysis 
In this chapter, some of the technologies used to study protein stability (aggregation/denaturation) 
were calibrated and validated using standards and further optimised for this study.  
2.1.1 Aim  
The aim of this section was to identify key parameters, sample preparation protocols and a sound 
understanding of the data recorded by some analytical technologies for studying particle size growth 
or intrinsic properties of the secondary structures of proteins or the presence of amyloids/aggregates. 
The section is also aimed to validate sample preparation and data acquisition approaches by this 
technology in the experiments which will be presented in later chapters of this project. 
2.1.1.1 Objectives 
 Individually analyse particle size of standard materials and protein molecule in solution at 
varied conditions (i.e. concentration, temperature, mixture of different particle size 
population) using dynamic light scattering technology. 
o Measure the particle size populations of three different standard latex beads 
individually or in combinations. 
o Analyse various methods for presentation of the acquired data (i.e. intensity, volume, 
surface area or number) to identify the most suitable (sensitive) approach for the 
current study. 
o Determine the qualitative degree of sensitivity of the equipment for acquiring the 
particle sizes of BSA in solution by incubating BSA solution at different temperatures 
to promote unfolding, misfolding and/or aggregation which will result in particle size 
growth. 
 Measure the intrinsic properties of protein in solution exposed to various experimental 
conditions (i.e. concentration, temperature) using UV/Vis spectrophotometry. 
 Measure the FTIR spectra of powder and solution of hen egg white lysozyme or bovine serum 
albumin (BSA) and estimate the area under the amide bands. 
 Record the FTIR spectra of hen egg white lysozyme or BSA incubated at specified % RH for up 
to 5 days and determine spectral differences as an indicator for aggregation. 
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 Measure the intrinsic properties of proteins in solutions and ThT dye before and after varying 
conditions of data acquisition (e.g. temperature, pH) and potential effects of other excipients 
(e.g. sucrose) on ThT emission. 
 In all measurements, compare the acquired data for freshly prepared samples (solutions or 
purchased powdered protein) and samples exposed to various experimental conditions (i.e. 
varied concentration, temperature) and identify the fundamental differences between the 
data sets that can serve as a scientific proof of the effects of the variables on the protein 
molecule being studied. 
 Correlate observations from the previous points to the process or mechanism of protein 
unfolding, misfolding and/or aggregation/denaturation. 
 
2.1.2 Materials 
Standard latex beads with nominal diameter 20 nm, 90 nm and 300 nm were purchased from Thermo 
scientific. Tris base and potassium nitrate (both ACS reagent grade) were purchased from Sigma-
Aldrich Co, Dorset, UK. All materials were used for analysis without any further purification. 
Crystalline chicken egg-white lysozyme and BSA (Sigma Aldrich) without further purification were used 
as model proteins. These two proteins were chosen as they differ in aspects such as size, stability, and 
structure. Lysozyme (14 400 Da) consists of 129 amino acid residues with four disulfide bonds 
(Creighton, 2005). BSA (67 000 Da) is much larger than lysozyme with 583 amino acid residues, 17 
disulfide bonds, and one free cysteine. However, they are both made up of α helixes (van de Weert et 
al., 2001). 
2.1.3 Buffer preparations 
Individual Tris buffer strengths of 10 mM and 20 mM with pH 7.2 were prepared by dissolving 10.221 
g and 2.423 g of Tris base in 850 mL of double distilled water. The solutions were stirred continuously 
for up to 15 minutes using a magnetic stirrer (130 RPM) to achieve a homogeneous mixture. The pH 
of the solutions were adjusted to 7.2 by the dropwise inclusion of 1 M HCl and the buffer was made 
up to 1 L using a double distilled water. The pH of the solution was checked using a calibrated pH 
meter (calibration performed with pH 4, 7 and 12 standard buffer solutions). 
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For other liquid formulation studies, 0.053% of sodium phosphate monobasic monohydrate and 
0.165% of Sodium phosphate dibasic heptahydrate (both from Sigma, Aldrich) were dissolved in a 
double distilled water to make 10 mM phosphate buffer solution (PBS) with pH 7.0 and stored at 4 °C 
for 15 minutes before sample preparation. 
2.1.4 Particle size analysis and validating dynamic light scattering measurements 
2.1.4.1 Experimental work 
2.1.4.1.1 Standard latex nano beads solution preparation 
A drop of standard latex beads was added to 8 mL solution of triple filtered (filter pore size 0.22 µm) 
10 mM TRIS buffer (pH 7.2. All samples were prepared in a freshly cleaned 10 mL Schott vials and 2 mL 
aliquots were transferred into a freshly prepared cuvette (washed with a mixture of triple filtered Tris 
buffer) and capped immediately to avoid dust particles. All samples were equilibrated for 15 minutes 
at room temperature before DLS data acquisition. 
2.1.4.1.2 Optimising protein concentration for DLS data acquisition 
10 mg/mL BSA stock solution were prepared using a triple filtered 10 mM of Tris buffer with pH 7.2. 
The triple filtered 10 mM of Tris buffer (pH 7.2) was used to dissolve the stock solutions via single step 
dilution to achieve the required concentrate in 2 mL aliquots (Table 2-1). All samples were directly 
prepared in a standard plastic cuvette and capped immediately. The samples were initially stored at 
4 °C before data acquisition to ensure sample equilibrium.  
Table 2-1 Proportions of 10 mg/mL BSA stock solution and buffer mixed together to yield varying 
concentrations. 
Expected Concentration (mg/mL) Volume of stock (mL) Volume of Buffer (mL) 
0.1 0.02 1.98 
0.2 0.04 1.96 
0.5 0.10 1.9 
1.0 0.2 1.8 
2.0 0.4 1.6 
3.0 0.6 1.4 
4.0 0.8 1.2 
5.0 1.0 1.0 
8.0 1.6 0.4 
10 0.0 2.0 
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2.1.4.1.3 Effects of temperature on protein particle size studied by DLS 
8 mg BSA powder was transferred directly into a regular glass cuvette which has been initially rinsed 
using triple filtered buffer (10 mM of Tris buffer (pH 7.2). The BSA powder was made up to 2 mL aliquot 
using 10 mM of Tris buffer (pH 7.2) and capped immediately. The contents were gently swirled until a 
homogeneous mixture was observed. The sample was initially stored at 4 °C before data acquisition. 
The protein particle sizes were measured from 30 °C to 70 °C in increasing intervals of 2 °C. The method 
used for data acquisition is described in the section below.  
2.1.4.1.4 DLS data acquisition  
The particle size distribution in samples was measured using a Zetasizer Omni (Brookhaven) dynamic 
light scattering (DLS). The measurements were carried out at the fixed wavelength of 659 nm and an 
angle of 173 ° (back scattering) in a regular glass cuvette. All samples were measured at 25 °C and a 
sampling time of 120 seconds. Samples were measured up to four (4) repetitions for statistical 
comparison at a time interval of 15 seconds. To remove signals affected by dust, an algorithm is 
provided for such analysis in the software and as appropriate cut off value set up (Table 2-2). 
Table 2-2 Algorithm dust cut off values that may be implemented by the Zetasizer Omni (Brookhaven) dynamic 
light scattering instrument user to remove the effects of dust on the measured data. 
Particle size (nm) Algorithm Dust Cut off Value 
< 10 and globular proteins 10 
20 - 50 20 
50 - 250 30 
250 - 500 40 
> 500 50 
The results were analysed with the Non Negatively constrained Least Squares (NNLS) and data fitted 
with multi modal distribution. The data presented in this work is local maxima of the various 
distributions relating to the observed populations. The broadness of each distribution is further 
presented as estimated full width half maximum (FWHM) as shown in Figure 2-1. 
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Figure 2-1 Representation of how the full width and half maximum is estimated. 
 
2.1.4.2 Results and Discussions 
2.1.4.2.1 Standard latex beads 
In two separate studies, the particle size distribution of three individual standard latex beads and a 
mixture of two standard latex beads were measured using DLS and the results are presented below. 
The correlation curve (Figure 2-2) is the raw data measured using the DLS technology. The plot 
indicates a single exponential decay function for a mono size particle dispersion and an increasing 
apparent gradient as the nominal particle size increases. It may also be observed that, as the particle 
size increases, the gradient also increases. The time at which the correlation of the signal starts to 
decay gives valuable information about the mean diameter of the sample while the angle of decay (θ) 
is used to estimate the polydispersity of the sample. The baseline also gives information about the 
presence of large particles.  
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Figure 2-2 Shows the correlation curve of standard beads with varying nominal diameter. Each measurement 
was repeated up to seven (7) times. (n=4x3)  
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In a system containing a mixture of 90 nm and 300 nm standard latex beads the correlation curve 
indicates two exponential decays and can be observed from the correlation curve as shown in Figure 
2-3.  
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Figure 2-3 Shows a typical multimodal correlogram of 90 nm and 300 standard latex beads prepared in triple 
filtered 10 mM TRIS buffer (pH 7.2). (n=3x3) 
The analysis of this function provides the diffusion coefficient (D) of the particles also referred to as 
the diffusion constant. From Eqn. 1-3 then, the hydrodynamic radius can be estimated.  
The fundamental result from deconvoluting the correlation curve is the intensity distribution. This 
distribution is dependent on the scattering intensity of each particle size present in the sample under 
analysis. For macromolecules, the particles scattering intensity is proportional to the square of the 
molecular weight (Brunner and Dransfeld, 2012). As such, the intensity distribution can be somewhat 
misleading, in that a small amount of aggregation may dominate the distribution. However, the data 
weighted by intensity is sensitive for the detection of larger particles. 
As shown in Figure 2-4 and Figure 2-5, the graphs indicates the presence of various size distributions 
corresponding to the sizes of the various standard beads measured. The broadness of the distribution 
originating from 20 nm standard beads was observed to be larger compared to the distribution 
recorded for bigger size beads (Figure 2-4). According to the equipment software, the maximum peak 
intensity was ascribed 100% and other peaks were normalised (scaled) correspondingly.   
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Figure 2-4 Individual plots of light scattering intensity, volume, surface area and number vs. particle size (nm) 
weighted distributions of 20 nm, 90 nm and 300 latex beads prepared in triple filtered 10 mM TRIS buffer (pH 
7.2). Data has been shifted upwards 100 units for clarity. (n=4x3) 
 
The estimated average diameter recorded for these standard latex beads are presented in Table 2-3. 
The standard deviation recorded for all measurements was relatively low. It must be noted that the 
data representing 300 nm beads showed a large variation between the recorded and the estimated 
centroid. This may be ascribed to a positive skewness in distribution.  
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Table 2-3 Comparing DLS intensity weighted diameter and estimated diameter for the varying standard latex 
beads. 
Beads size (nm) Recorded Diameter (nm) Estimated Centroid (nm) 
20 23.1 23.98 
20 21.5 24.62 
20 22.1 24.05 
Average 22.23 24.22 
Standard Deviation 0.81 0.35 
90 94.5 94.48 
90 92.8 92.77 
90 93.3 93.31 
90 93 92.98 
90 93.52 93.78 
Average 93.42 93.46 
Standard Deviation 0.66 0.68 
300 318 277.75 
300 329 282.55 
300 302 273.27 
300 298 278.07 
300 299 282.88 
300 308 273.33 
Average 309.00 277.97 
Standard Deviation 12.26 4.21 
 
In Figure 2-5, two distinct populations centred ≈97 nm and ≈318 nm were observed. In all 
presentations (weighted against intensity, volume, surface area and number), these positions does 
not change while the relative amplitude varies. There is also no significant variation in the distribution 
broadness irrespective of how the data are presented. 
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Figure 2-5 Individual plots of light scattering intensity, volume, surface area and number weighted 
distributions vs. particle size diameter (nm) of a combination of 90 nm and 300 standard latex beads prepared 
in triple filtered 10 mM TRIS buffer (pH 7.2). (n=3x3) 
Although the principal size distribution measured by DLS is presented as an intensity distribution, this 
may be converted to other forms of distribution via the Mie theory6. The converted distribution 
describes the relative proportion of the various components in the sample under study relative to its 
volume or mass. Thus, to perform such a conversion, there are some assumptions that must be 
accepted.  
 All particles must be spherical and homogeneous 
 During the conversion from intensity distribution, there is no error 
 The real and imaginary refractive indices of the particles are known 
Relative to number and volume distribution, an apparent number is assigned to each particle observed 
to build a number distribution. Each particle has equal weighting once the final distribution is 
calculated. For instance a system containing three different particle size population of; three particles 
are 0.5 μm, three are 0.8 μm, and three are 1.1 μm in diameter.   
                                                          
6  The theory describes the scattering of an electromagnetic plane wave by a homogeneous 
solution of spheres. 
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Figure 2-6 Schematic comparison of number and volume weighed hydrodynamic diameter of a system 
containing three varied particle size. 
In a number weighted presentation, each particle size accounts for 1/3 of the total particle size 
population as shown in Figure 2-6 (right). The number weighted presentation therefore shows no bias 
toward a particular size and thus makes it insensitive to the presence of different size populations. 
However, in a volume weighted presentation (Figure 2-6 left), 68 % of the total volume originates from 
the larger particles with sizes of 1.1 μm whiles 6.3% originates from the 0.5 μm particles (Table 2-4). 
Therefore, volume weighted presentation is biased toward larger size particles. Comparatively, the 
surface area weighted presentation will indicate population distributions with relatively high areas for 
the smallest particles while those with large particle size will see a corresponding decrease in their 
area. These proportional changes is similar to what is observed in Figure 2-5. 
Table 2-4 Calculated percentage volume and area of particles with different sizes  
Population size (μm) Percentage Volume Percentage Area 
0.5 
𝑉𝑜𝑙    =  
(0.5)3
0.53 + 0.83 + 1.13
 100 
                 =        𝟔. 𝟑% 
𝐴𝑟𝑒𝑎 =  
(0.5)2
0.52 + 0.82 + 1.12
  100 
                   =        𝟏𝟏. 𝟗% 
0.8 
𝑉𝑜𝑙    =  
(0.8)3
0.53 + 0.83 + 1.13
  100 
                 =  𝟐𝟔% 
𝐴𝑟𝑒𝑎    =  
(0.8)2
0.52 + 0.82 + 1.12
  100 
                   = 𝟑𝟎. 𝟒𝟖% 
1.1 
𝑉𝑜𝑙       =  
(0.5)3
0.53 + 0.83 + 1.13
  100 
                  =   𝟔𝟕. 𝟕% 
𝐴𝑟𝑒𝑎       =  
(0.5)2
0.53 + 0.83 + 1.13
  100 
                     =   𝟓𝟕. 𝟔𝟐% 
Generally, with the same total volume or mass, molecules with smaller particle sizes have larger 
surface area.  
0
0.5
1
1.5
2
2.5
3
3.5
0.5 μm 0.8 μm 1.1 μm
P
ro
p
o
rt
io
n
 
Particle size population 
0.5 μm    0.8 μm  1.1 μm 
68 | P a g e  
 
2.1.4.2.2 Effects of protein concentration 
To optimise DLS measurements, the sample concentration is one parameter that has been considered. 
The data recorded for the correlation curve (Figure 2-7) shows that, except 0.1 mg/mL and 10 mg/mL 
samples, generally all the measured samples showed a similar correlation between time (Log τ) and 
the cumulant (C). Similar to Figure 2-3, Figure 2-7 showed the presence of two distributions (except 
0.1 mg/mL and 10 mg/mL samples). These two populations were centred on ≈ 7.5 nm and between 
20 nm and 100 nm (Figure 2-8) and had a relative intensity of 100 % and ≈50 % respectively. However 
in samples containing 0.1 mg/mL and 10 mg/mL, a third distribution was observed ≈800 nm (also 
identified on Figure 2-7) with 100% relative intensity. It may also be noted that, the two distributions 
initially identified at ≈ 7.5 nm and between 20 nm and 100 nm, in 0.1 mg/mL samples were recorded 
with amplitude ≈30% and 50% respectively. Similarly in 10 mg/mL these two distributions also 
recorded a relative intensity of ≈86% and 17% respectively. 
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Figure 2-7 The correlation curve of different concentrations of BSA in triple filtered 10 mM TRIS buffer (pH 
7.2). (n=3x3) 
While increasing the sample concentration, the chances of a scattered photon colliding or interacting 
with another macromolecule and be rescattered increases in an effect generally called the multiple 
scattering. As shown in Figure 2-8, Figure 2-9 and Table 2-5, the increase in sample concentration 
resulted in the apparent increase in polydispersity and distribution width (in 10 mg/mL samples). 
Furthermore, due to the randomness of the multiple scattering, the correlation curve initially decays 
faster although with smaller slope (Figure 2-7 10 mg/mL sample). Under dilute conditions 
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(< 0.1 mg/mL), the minute scattering intensity also reduces the correlogram intercept, as well as 
increase the apparent polydispersity of the distribution. 
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Figure 2-8 The intensity weighted distribution of varied proportions of BSA in triple filtered 10 mM TRIS buffer 
(pH 7.2). (n=3x3) 
Table 2-5 Recorded effective diameter (z-Average for all populations) and polydispersity of the various 
concentrations of BSA in triple filtered 10 mM TRIS buffer (pH 7.2). (n = 3x3) 
Sample Concentration 
(mg/mL) 
Average Effective 
Diameter (nm) 
Standard Deviation 
(Effective Diameter) 
Average 
Polydispersity 
0.1 269.56 27.61 0.37 
0.4 22.25 0.03 0.3 
0.8 14.81 0.38 0.26 
1 10.89 0.08 0.23 
2.5 10.43 0.3 0.23 
3 13.34 0.01 0.25 
4 11.1 0.22 0.24 
5 15.11 0.53 0.26 
6 12.61 0.56 0.25 
8 18.42 0.53 0.27 
10 218.41 2.2 0.39 
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Figure 2-9 Plot of the recorded average effective diameter and the polydispersity of the various proportions 
of BSA in triple filtered 10 mM TRIS buffer (pH 7.2). (n=3x3) 
From this section of the study, the main conclusion was that the optimised concentration of BSA in 
triple filtered 10 mM TRIS buffer (pH 7.2) was between 1 mg/mL and 6 mg/mL. Therefore, in future 
experiments, the concentration of BSA in triple filtered 10 mM TRIS buffer (pH 7.2) will be 4 mg/mL.  
2.1.4.2.3 Effects of temperature on protein particle size 
The effects of temperature on the native structure of BSA has been studied immensely with different 
analytical technologies and widely reported previously in the literature (Borzova et al., 2016). The DLS 
measurement of the effects of temperature on BSA in solution was studied and used as part of 
validation of the DLS technology for this project. The intensity weighted presentation of 4 mg/mL BSA 
solution incubated from 30 ˚C to 70 ˚C is presented in Figure 2-10. The plot indicates two distinctive 
distributions observed at ≈8 nm and ≈70 nm for all samples incubated below 58 ˚C. In both 
distribution, it is also observed that the broadness of these distributions sturdily increases but the 
relative intensity (amplitude) does not change significantly. The measurements originating from 58 ˚C 
and 60 ˚C showed a third distribution centred at 2.57 nm (±0.23 nm), while those initially observed ≈8 
nm shifted to 10.07 nm (±0.42 nm) and that at 70.51 nm (±8.56 nm) did not shift significantly. 
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Figure 2-10 Intensity weighted hydrodynamic radius of BSA particle size as the incubation temperature is 
increased from 30 ˚C to 70 ˚C in intervals of 2 ˚C upwards. The plot is offset 50 or 100 units upwards for clarity. 
(n=3x7)  
The log effective diameter (z-Average7) is the most stable parameter to report during quality 
assessment in accordance with ISO protocols in the industry (International Organization for 
Standardization, 2017). As shown in Figure 2-11, the recorded z-Average remains practically 
unchanged (average 7.62 nm ±0.32 nm) from 30 ˚C to 56 ˚C. However, at 58 ˚C it drops significantly to 
2.78 nm (±1.11 nm) and shifts to >1000 nm (± >130 nm) as temperature is elevated to 70 ˚C (Figure 
2-11). Table 2-6 lists some published temperatures at which BSA aggregates. Due to the variation in 
technological sensitivity, not a single temperature can be considered as the temperature of 
denaturation in BSA but a temperature range. From Table 2-6, in comparison to the data presented, 
the observations at 58 ˚ C may be ascribed to the onset of the protein unfolding/aggregation or protein 
aggregation/denaturation itself. 
 
                                                          
7 Defined by ISO 22412 as the harmonic intensity averaged particle diameter (INTERNATIONAL ORGANIZATION 
FOR STANDARDIZATION 2017. Particle size analysis — Dynamic light scattering (DLS). ISO 22412:2017. 
Switzerland.) 
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Table 2-6 List of some BSA aggregation temperature using different technologies reported in the literature. 
Technology Used Reported BSA aggregation 
temperature 
Reference 
Asymmetrical Flow Field-Flow 
Fractionation 
Between 60 ˚C and 63 ˚C  (Yohannes et al., 2010a, Borzova 
et al., 2016) 
Gel electrophoresis 58 ˚C,  60 ˚C and 65 ˚C (Aoki et al., 1973, Arakawa and 
Kita, 2000) 
Differential scanning 
calorimetry 
56 ˚C to 59.5 ˚C (Michnik, 2003, Borzova et al., 
2016) 
Circular Dichroism 58 ˚C (Verdugo et al., 2017) 
Dynamic Light scattering  60 ˚C (Borzova et al., 2016) 
Indeed Borzova et. al. reported that dynamic light scattering technology was not sensitive enough to 
identify only the primary aggregates which acts as seeds only for the mechanism of nucleation and 
growth to occur and result in secondary aggregation (Borzova et al., 2016).  
Generally, the initial step during protein aggregation is the unfolding of the native form into precursors 
(Fields et al., 1992, Fink, 1998). Borzova et. al. indicated that the precursors  results in the formation 
of two forms of the unfolded protein with different propensity to aggregate (Borzova et al., 2016).  
 
Figure 2-11 Plot of the estimated effective diameter (2 x hydrodynamic radius) as the incubation 
temperature is increased from 30 ˚C to 70 ˚C in intervals of 2 ˚C. (n=3x7) 
The recorded polydispersity8 gradually increases from 0.25 at 30 ˚C to 0.29 at 58 ˚C and then drops to 
≈0.17 at 70 ˚C (Figure 2-12). This observation is significant because polydispersity less than 0.2 in 
                                                          
8 During the cumulant analysis, a single particle size mode is assumed and a single exponential fit is applied to 
the autocorrelation function. The polydispersity describes the width of the assumed Gaussian distribution. 
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protein formulation is an indication of a monodisperse sample (Khurshid et al., 2014). A monodisperse 
protein sample is often a good indicator of the propensity for the protein molecule to crystallise which 
can also affect the flexibility in the protein molecule.   
 
Figure 2-12 Plot of the polydispersity in 4 mg/mL BSA solution as incubation temperature is increased from 
30 ˚C to 70 ˚C in intervals of 2 ˚C. (n=3x7) 
2.1.4.3 Concluding Remarks 
 DLS measurements of the standard beads and protein aggregates indicate that the 
technology is sensitive to identify varying particle sizes. 
 The distribution of each particle population may be weighted against different parameters 
(i.e. intensity, volume, surface area and number) with each approach possessing its distinct 
pros and cons. 
 Generally to compare the recorded particle size with one which was measured by different 
technologies the z-Average is ideal. 
 Although, in a bimodal system, the z-Average is the average of the entire distributions, it is 
still useful in determining the emergence or shift in size distributions due to size growth. 
 For systematic study of a bimodal system, it may be ideal to consider the individual average 
population size recorded by DLS technology and compare as the experimental variables (e.g. 
temperature, pH or concentration) is changed.  
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2.1.5 Intrinsic properties of BSA/Lysozyme in the UV-Vis spectrum  
The concentration of protein based formulations can be estimated by direct measurement of 
absorbance of the formulation solution at 260 nm and 280 nm. The absorbance observed at these 
wavelengths can be attributed to the presence of peptide bonds (260 nm) and amino acids with 
aromatic rings (280 nm). It is well known that pH of solution can affect the native structure of the 
protein and may unfold the 3D or even 2D structure of the protein. As a result the amino acids which 
absorbs at 280 nm may shift to different environments and slightly change the position and amplitude 
of the UV absorbance. Therefore, the control of pH and ionic strength are important and these 
parameters must be kept constant. 
2.1.5.1 Methods 
2.1.5.1.1 Concentration and Turbidimetry studies  
In a triple filtered, freshly prepared 10 mM TRIS buffer (pH 7.2), a lysozyme stock solution with 
concentration of 1 mg/mL was formulated. Via single step dilution (Table 2-7) with 10 mM TRIS buffer 
(pH 7.2), the required concentrations in 2 mL aliquots were further formulated directly in a 1 cm path 
length regular plastic cuvettes, capped and sealed with parafilm immediately. Similarly, 2 mL aliquot 
of 2 mg/mL lysozyme solution was formulated in a separate cuvette (no dilution). 
Table 2-7 The proportion of stock solution and buffer required to make the apparent concentration.  
Apparent Concentration 
(mg/mL) 
Concentration of stock 
solution (mg/mL) 
Stock Volume (mL) Buffer Volume (mL) 
0.01 1 0.02 1.98 
0.02 1 0.04 1.96 
0.05 1 0.1 1.9 
0.1 1 0.2 1.8 
0.2 1 0.4 1.6 
0.25 1 0.6 1.4 
0.3 1 0.7 1.3 
0.5 1 1 1 
0.9 1 1.8 0.2 
1 1 2 0 
2 2 2 0 
 
All samples were initially incubated at 4˚C for 20 minutes, and shaken gently from time to time to 
ensure the protein was well dissolved. Before data acquisition, the cuvette was gently swirled 
manually to ensure no lysozyme particle has been adsorbed onto the cuvette wall or undiluted.  
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2.1.5.1.2 Effects of temperature on BSA solution studies 
The temperature effects on the physicochemical properties are one which has been well studied and 
the observations well published. In this work, the effects of temperature on BSA apparent absorbance 
at 360 nm were studied. In a triple filtered, freshly prepared 10 mM TRIS buffer (pH 7.2), 0.6 mg BSA 
was dissolved into 2 mL aliquot and manually agitated (gentle rotation up and down movement) for 3 
minutes. The solution was initially incubated at 4 ˚C for 20 minutes and shaken gently in time intervals 
to ensure the protein was well dissolved before UV-vis absorbance measurements. The sample was 
further incubated at 60 ˚C for up to 180 minutes. In intervals of 60 minutes, the apparent absorbance 
at 360 nm was recorded. After every measurement, the sample was gently rotated for up to 1 minute 
and measured again. The process was repeated for three times. 
2.1.5.1.3 Spectra acquisition of BSA   
UV-vis absorption spectra of BSA in solution samples were recorded between the wavelengths of 250 
nm and 400 nm. Data were acquired using a Thermo-Scientific UV/Vis Evolution 60S 
spectrophotometer at room temperature (25 °C). In all measurements, quartz cuvettes with path 
length of 1 cm were used. 
2.1.5.2 Results and Discussions 
Lysozyme with various concentrations was formulated in 10 mM TRIS buffer (pH 7.2). 2 mL aliquots of 
each concentration were initially incubated at 4 ˚C for 20 minutes before UV-vis absorption spectra 
recorded. Figure 2-13 shows the recorded spectra which is in an agreement with what has been 
published in the literature (Li et al., 2016b, Krishnamoorthy et al., 2012, Ramachandran et al., 2012). 
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Figure 2-13 The UV-vis absorption spectra of varied lysozyme proportion in 10 mM TRIS buffer (pH 7.2). 
Samples were measured between 250 nm and 400 nm at 25 °C. Inset is the apparent absorbance at 360 nm.  
(n=2x3) 
As expected, it was observed that increasing the lysozyme concentration also resulted in the increase 
of UV-vis absorption at 260 nm and 280 nm whiles the apparent absorbance at 360 nm showed no 
significant trend (increasing or decreasing) as shown in Table 2-8 and compliments the data acquired 
with DLS technology (Figure 2-8). It was identified that of the 582 amino acid residues, 3 amino acid 
residues exhibits fluorophore characteristics between 260 nm and 280 nm (Brown, 1975, Chudzik et 
al., 2016, Peters, 1985, Varlan and Hillebrand, 2010). The dominant residue which significantly absorbs 
at 280 nm is the 1 mole percent tryptophan residues (Lakowicz, 2006) with contributions from tyrosine 
and phenylalanine residues.  
Table 2-8 Recorded UV-vis absorption spectra of various concentrations of BSA solution at 260 nm, 280 nm 
and 360 nm. (n=3x3) 
Concentration (mg/mL) Absorbance 260 nm Absorbance 280 nm Absorbance 360 nm 
0.01 0.031 0.032 0.005 
0.02 0.047 0.057 0.003 
0.05 0.087 0.135 0.004 
0.1 0.177 0.265 0.006 
0.2 0.329 0.537 0.002 
0.25 0.401 0.599 0.003 
0.3 0.474 0.793 0.002 
0.5 0.79 1.306 0.004 
0.9 1.451 2.378 0.007 
1.0 2.329 2.664 0.006 
2.0 2.872 3.255 0.015 
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A plot of the recorded absorbance against the apparent concentration is presented in Figure 2-14 and 
shows a linear relationship between the concentration of BSA solution measured and their UV-vis 
absorbance at 280 nm.  
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Figure 2-14 A plot of the UV-vis absorbance recorded at 280 nm for various lysozyme apparent concentrations. 
The linear plot is fitted with 95 % confidence bands (blue dash lines). (n=3x3) 
The law proves a direct correlation between the absorbance (A) of a molecule, the concentration (c) 
and the path length (l) of the sample (Rodger, 2013) and is linear for relatively small concentration. In 
contrast, at high concentrations, the Beer Lambert relationship results in a non-linear relationship as 
the recording for 2 mg/mL samples indicated (Figure 2-14). For majority of materials including micro 
and small molecules, a linear correlation exist between their UV-vis absorbance usually <1 a.u. and 
relatively small concentrations whiles some materials may show such linearity up to absorbance of 2 
a.u.  In other instances, as observed in this work (Figure 2-14 circled), some materials start to deviate 
slightly from the linearity with a tendency of levelling. The reason for this non linearity relates to the 
optical density of macro molecules and a limitation of the UV/Vis spectrophotometer itself.   
The concentration was estimated (Table 2-9) using extinction coefficient (E1% at 280) of 26.4 (Losso 
et al., 2000) and a path length of 1 cm. The theoretical and apparent concentrations were fitted using 
a simple linear relationship (Figure 2-15).   
Lysozyme  
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Table 2-9 Concentration of lysozyme in solution estimated based on the recorded absorbance at 280 nm using 
Beer-Lamberts equation. The molar absorptivity used for these calculations was 26.4 (Losso et al., 2000) and 
path length 1 cm. (n=3x3) 
Apparent Concentration (mg/mL) Absorbance at 280 nm Theoretical Concentration 
0.01 0.032 0.012 
0.02 0.057 0.022 
0.05 0.135 0.051 
0.1 0.265 0.100 
0.2 0.537 0.203 
0.25 0.599 0.227 
0.3 0.793 0.300 
0.5 1.306 0.495 
0.9 2.378 0.901 
1.0 2.664 1.009 
2.0 3.255 1.233 
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Figure 2-15 A plot of the calculated concentration against the various lysozyme apparent concentrations. The 
linear plot is fitted with 95 % confidence bands (blue dash lines). (n=3x3) 
As was shown in Figure 2-10 and Figure 2-11, particle size analysis indicated the molecular size of BSA 
began to grow after incubation at 58 ˚C and above. In this section, 0.3 mg/mL BSA solution incubated 
at 60 ˚C for up to 180 minutes showed an increasing apparent absorbance at 360 nm as presented in 
Figure 2-16 inset.  
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From Figure 2-16, the absorbance at 280 nm increased similar to the effects of increasing protein 
concentration. However, in this instance, this increase relates to shift upwards in baseline as the 
incubation time increased i.e. due to scattering by large particles at 280 nm.  
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Figure 2-16 The UV-vis absorption spectra of 0.3 mg/mL (pH 7.2) BSA solution incubated at 60 °C for 180 
minutes. Samples were measured between 250 nm and 400 nm at 25 °C. Inset is the apparent absorbance at 
360 nm.  (n=2x3) 
As observed in Figure 2-16 (inset), protein aggregation is dependent not only on incubation 
temperature but also on time. However, the aggregation processes may not follow a linear 
relationship and therefore extrapolation to predict aggregation at higher and lower storage 
temperatures maybe challenging. 
2.1.5.3 Concluding Remarks 
From these studies, the maximum BSA/Lysozyme concentration that may be used for UV-vis 
spectrophotometry study for this project should be <0.9 mg/mL. The literature concentration and 
apparent concentration were in agreement with each other. This validates the use of absorbance at 
280 nm to estimate concentration in future studies. However, the apparent concentration or optical 
density at 360 nm is only a useful parameter in identifying the presence of aggregates but not a 
quantitative tool to estimate the degree of aggregation. 
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2.1.6 Infra-Red Intrinsic properties of BSA/Lysozyme  
2.1.6.1 Experimental work 
2.1.6.1.1 BSA/Lysozyme solution preparation 
For liquid formulation studies, 0.1 mg/mL of BSA or lysozyme was prepared using a 10 mM PBS 
solution with pH 7.2. The effects of varying concentration were also studied using samples with 
intervals of 0.02 mg/mL. All samples were initially incubated at 4 °C for 20 minutes to ensure the 
protein was well dissolved and sample equilibrium before data acquisition. 
2.1.6.2 Methods 
The IR spectra of the BSA/Lysozyme solution were recorded using an FT-IR Platinum-ATR spectrometer 
(Bruker Tensor OPUS 27 FTIR) from 4,000 cm−1 to 1000 cm−1 with a resolution 2 cm−1 and 100 scans. 
2.1.6.2.1 Spectra acquisition of BSA/Lysozyme – Effects of sample positioning and scan accumulation  
In many academic studies, the material under investigation by FTIR is incorporated into a KBr pellet 
which is transparent when analysed with FTIR. This method is more suitable for small molecules and 
was considered unsuitable in this work because; 
 Stresses from the pressing process could potentially affect the physical structure of the BSA 
or lysozyme molecule.  
 The presence of moisture in the environment and the KBr/protein pellet itself may be 
detrimental to the quality of the KBr pellet.  
 It is envisaged that in the cause of this project, after freeze drying protein based formulation 
cakes, the stability profile will be explored using FTIR. Relative to samples with bound water 
e.g. these freeze dried cakes, pressing them into KBr pellets could potentially dehydrate the 
freeze dried product and therefore what will be studied maybe a secondary effect but not 
direct consequence of the variables from freeze drying the BSA solution in the first place.  
In contrast, using ATR module of the FTIR presents a better, non-invasive opportunity to study the 
protein samples without the need to compress protein into discs. 
To acquire the FTIR spectra of the crystalline BSA and lysozyme, ≈10 mg of the crystalline powder was 
placed directly on to the ATR crystal and held in place with a “crank down arm”, to ensure a good 
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contact between the sample and the ATR crystal. This was important because evanescent wave9 
protrudes a distance of ≈0.5 μm - 5 μm beyond the crystal and therefore a good contact between 
sample and crystal will yield a better resolution spectrum. The infrared spectra of the proteins were 
recorded using an FT-IR Platinum-ATR spectrometer (Bruker Tensor OPUS 27 FTIR) from 4,000 cm−1 to 
400 cm−1 with a resolution 2 cm−1 and 100 scans.  
To identify optimised sample loading positions, the effects of moving samples in between 
measurement and scan accumulations were also studied using similar resolution within the same 
wavelength.  
2.1.6.2.2 Effects of % Relative Humidity in solid state BSA/Lysozyme 
To study the effect of moisture on stability of chicken egg white lysozyme in solid state, ≈20 mg of 
unprocessed, freshly purchased protein powder was placed in an aluminium foil and incubated in 
desiccators kept at constant levels of % RH by vapour equilibration in individual desiccator salt slush. 
The FTIR spectra of the samples were recorded after 1, 2 and 5 days to determine any physicochemical 
changes at the amide III band. Table 2-10 below indicates the salts and the recorded % RH achieved 
(Young, 1967, Greenspan, 1977).   
Table 2-10 Salts used to achieve % RH by vapour equilibration in desiccators.  
Salt Expected % RH Recorded % RH 
Lithium chloride 11.3 11 
Potassium carbonate 43.16 43 
Sodium chloride 75.29 75 
Potassium chloride 85.06 84 
Potassium nitrate 94.58 97 
FTIR analysis was performed in the amide III spectral region because water and water vapour have an 
insignificant contribution in this spectral area (Griebenow and Klibanov, 1995a). The amide III spectral 
region has the advantage as structural transitions can be monitored easily without spectral 
deconvolution since the α-helix (ca. 1330–1290 cm-1), random coils (ca. 1290-1250 cm-1) and β-sheet 
(ca. 1250–1215 cm-1) components of the secondary structures are well defined (Griebenow and 
Klibanov, 1995a).  
                                                          
9 In electromagnetics, an evanescent wave is an oscillating electric or magnetic field that does not propagate as 
an electromagnetic wave but whose energy is spatially concentrated in the vicinity of the source. 
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2.1.6.2.3 FTIR spectrum normalisation 
To compare the spectral features between two samples exposed to the same conditions and make 
quantitative assessments of bands where there are significant variations, as with all spectroscopic 
methods, the shift in baseline which occur as a result of signal to noise ratio was subtracted at the 
onset and endpoint of well characterised bands.    
2.1.6.3 Results and Discussions 
2.1.6.3.1 FTIR Spectra of liquid and solid lysozyme and BSA 
A typical FTIR spectrum of lysozyme and BSA in their native form is shown in Figure 2-17 below. The 
spectra indicate the distinctive features of lysozyme/BSA previously reported in the literature (Kong 
and Yu, 2007, Haris and Severcan, 1999, Pelton and McLean, 2000).  
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Figure 2-17 FTIR spectra of SOLID native BSA and lysozyme measured between the frequencies of 4000 cm-1 
and 1000 cm-1. Spectra were measured using 2 cm-1 resolution and 300 scan accumulations. (n=9) 
The spectra shows the Amide I, Amide II and Amide III bands in their respective band regions earlier 
mentioned in Chapter 2. The spectra also show the amide A band between 3400 cm-1 and 3000 cm-1. 
However, the position of this band is also ascribed to water as shown in Figure 2-18 below and because 
protein molecules have bound water, generally this band is also called the water band.  
The FTIR spectrum of 5 mg/mL solution is presented in Figure 2-18. It is observed that this spectrum 
shares significant variations when compared to solid state measurements but have been masked due 
to the over dominating effects from water. Although low molarity of phosphate buffer was used, the 
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spectrum of a low concentration protein solution and the buffer are almost the same, and similar to 
the FTIR spectrum of water, which has been reported in the literature (Bouhekka and Bürgi, 2012, 
Lappi et al., 2004).  
 
Figure 2-18. FTIR spectra of 5 mg/mL lysozyme in 10 mM phosphate buffer and 10 mM phosphate buffer 
measured in the frequency range from 4000 cm-1 to 1000 cm-1, using 2 cm-1 resolution and 300 scan 
accumulations. (n=9) 
2.1.6.3.2 Effects of scan accumulations on FT-IR spectra 
To optimise the FTIR spectra of BSA and lysozyme, the number of scan accumulation was varied in 
ascending and descending orders for the solid native protein. Figure 2-19 shows the FTIR spectra of 
lysozyme in the region from 1800 cm-1 to 1000 cm-1. 
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Figure 2-19. FTIR spectra of lysozyme powder between 1800 cm-1 and 1000 cm-1. The data shown is the average 
of three separate measurements without altering the sample position on the ATR crystal. Measurement was 
done in (a) ascending and (c) descending order of the number of scans. b and d have the baseline subtracted 
and the bands normalised by the peak height of the amide I band. 
As shown in Figure 2-19 (a), the number of scan accumulation exceeding 30 had no significant effect 
on the resolution of major bands of interest in this study i.e. amide I, II and III bands. The resolution 
and amplitude of bands recorded with 10 scan accumulation were generally poor and not well defined 
(circled on Figure 2-19 (a)). Thus, the bands especially those between 1200 cm-1 and 1120 cm-1 may 
be mistakenly identified by the user as equipment or background noise. Although there is no baseline 
drop in decreasing scan accumulation from 100 and 50, there is a significant spectra baseline drop 
from 50 to 30 and 10 scans (Figure 2-19 (a)). When all plots are normalised by the amplitude of the 
AMIDE I PEAK, there was no significant shift in positions of the three bands. In samples corresponding 
to increasing accumulation (Figure 2-19 (c)), there is no shift in spectra baseline, band position, band 
and amplitude of the spectra.  
From this experiment, it was concluded that the measurements were stable (less variations) using 
between 30 and 50 scan accumulations. This made it easier to subtract the baseline with less error 
and normalise the three major amplitudes of the maximum absorption band (i.e. amide III in this case) 
2.1.6.3.3 Effects of sample position on FTIR spectra 
Generally, ATR is dependent on total internal reflection resulting in an evanescent wave. Infrared light 
is beamed through an ATR crystal to produce at least one reflection from the internal surface in 
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contact with the sample. This reflection forms the evanescent wave which extends into the sample. 
The number of reflections may be varied by changing the angle of incidence.  
The depth of penetration is determined by the wavelength of light, the incidence angle and the 
refractive indices for both the ATR crystal and the sample. Thus, when the position of the sample on 
the ATR crystal is altered, it is also expected that the baseline of the spectrum being recorded will be 
altered as shown in Figure 2-20 (a). Furthermore, the amplitude recorded for these spectra also varies 
when compared with the repeats. When the baseline is subtracted and the spectra is normalised by 
height, there is no significant shift in these bands as observed in the normalised plot (Figure 2-20 (b)). 
In contrast, Figure 2-20 (c) shows no change in baseline, amplitude of bands and band region positions 
for samples that were not moved during FTIR recordings.  
 
Figure 2-20. FTIR spectra of BSA between the regions of 1800 cm-1 to 1000 cm-1. The position of the samples 
were (a) moved or (c) not moved. All samples were recorded using 30 scan accumulations and 2 cm-1 
resolution. B and d are normalised by the peak height of amide I band for direct position comparison. (n=9) 
Indeed as shown on Table 2-11, the highest standard deviation and % CoV was recorded in samples 
that were moved between measurement repeats.  
Table 2-11. Comparing the standard deviation and % CoV of the band intensities corresponding to amide I and 
II of the FTIR spectra of a native state BSA. The samples position was fixed or changed on the ATR crystal 
during the repeated measurements (n=9). All samples were recorded using 30 scan accumulations and 2 cm -1 
resolution. (n=3x3) 
 
Amide I Amide II 
Sample Positioning Std. Deviation % CoV Std. Deviation % CoV 
Not moved 0.006 0.106 0.003 0.177 
Moved 0.010 0.186 0.015 0.916 
Overall 0.022 0.409 0.014 0.876 
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From these studies, it was concluded that, sample positioning affects the amplitude but not the peak 
shape and position of absorption bands. The shifts in baseline or amplitude variations is related to the 
bulk density of powder “under the clamp down” mechanism and the positioning of the ATR surface 
crystals relative to the sample powder during data acquisition. To avoid these variations, it is possible 
to subtract the baseline and normalise by a selected peak height.   
2.1.6.3.4 Effects of relative humidity on long term storage of crystalline lysozyme 
Bruker Tensor Opus 27 FTIR was used to explore the effect of storage conditions at varying % relative 
humidity on the native structure of lysozyme. Dry lysozyme powder was stored in a desiccator with 
various % RH and was measured on day 0, 1, 2 and 5.  
The initial moisture content and moisture content after storage was estimated using thermo 
gravimetric analysis (TGA). Between 5 and 15 mg of the sample was loaded into a TGA aluminium pan 
(without holes in the lid) and hermetically sealed. The samples were loaded into the crucible and the 
aluminium pan manually pierced immediately before the measurements to help escape of trapped 
gas during heat application. The sample was heated from 25 °C to 300 °C at a heating rate of 10 °C/min 
under nitrogen atmosphere using Pyris TGA (Perkin Elmer, Wellessey, USA) equipment to monitor the 
decreasing sample weight. The moisture content was estimated using Eqn. 2-1. 
 
% 𝑀𝑜𝑖𝑠𝑡𝑢𝑟𝑒 𝑐𝑜𝑛𝑡𝑒𝑛𝑡 =  
𝑊1 − 𝑊2
𝑊2
∗ 100 Eqn. 2-1 
where W1 is the initial weight of sample and W2 is the weight of sample after moisture evaporation. 
The onset and end temperatures for moisture evaporation were determined using the Pyris software. 
The estimated moisture content in each sample from day 2 onwards (day 0 and 1 – TGA equipment 
not functioning) is presented in Table 2-12.  
Table 2-12. Thermogravimetric analysis of solid lysozyme stored at varying % RH in days 2 and 5. (n=3) 
 
Day 2 / % moisture content Day 5 / % moisture content 
RH 11% 5.56 4.9 
RH 43% 8.94 8.79 
RH 75% 12.95 12.78 
RH 84% 14.56 14.76 
RH 97% 17.25 29.7 
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The data presented in Table 2-12 indicates that as % relative humidity increases, the moisture 
absorbed by lysozyme is increased significantly. There is not much difference in absorbed moisture 
day 2 and day 5 except at the extremely high 97% relative humidity. 
From the FTIR spectrum, area corresponding to the amide III region (1330 cm−1 and 1190 cm−1) was 
selected for further analysis and the observations presented in Figure 2-21 and Figure 2-22.  
 
Figure 2-21 FTIR spectra of chicken lysozyme measured at day 0 in the region of 1330 cm-1 to 1190 cm-1 after 
baseline subtraction and normalised by height. The data was acquired by using 50 scan accumulations and 
2 cm-1 resolution.  
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Figure 2-22 FTIR spectra of chicken lysozyme of 1330 cm-1 to 1190 cm-1 normalised by height After baseline 
subtraction. The samples were stored at various % RH for 5 days. The data was acquired using 50 scan 
accumulations and 2 cm-1 resolution. 
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As presented in Figure 2-22, an increase in relative humidity changes the spectral characteristics 
irrespective of the day. For instance after 24 hours of storage, all spectra revealed a distinct peak 
emerging between 1210 cm-1 and 1190 cm-1 (β-sheet region). For quantitative analysis, the area under 
the curve (AUC) for 3 regions corresponding to α helix, random coils and β sheets were estimated for 
all the spectra and presented in Table 2-13 and Figure 2-23. The estimated AUC for α helix and random 
coils increases whiles the region corresponding to β sheet decreases as the moisture increases. 
However, there is no significant wavelength shift in the peak observed at 1230 cm-1 (β sheet region). 
Similar observations in the spectral features have been reported elsewhere (Flores-Fernandez et al., 
2009) and the spectra variations were ascribed to secondary structural changes due to 
denaturation/aggregation.   
Table 2-13 Estimated peak area (AUC) of the bands corresponding to α helix, random coils and β sheets within 
the amide III region of lysozyme incubated at different % RH and room temperature for up to 5 days.  
Sample ID Time/ hr RH/% α helix Random coils β sheets 
Day 0 Native, RTP 0 0 0.337 1.249 2.151 
Day 1 RH 11%, RTP 24 11 0.345 1.271 2.133 
Day 2 RH 11%, RTP 48 11 0.36 1.295 2.063 
Day 5 RH 11%, RTP 120 11 0.362 1.267 2.091 
Day 1 RH 43%, RTP 24 43 0.356 1.277 2.059 
Day 2 RH 43%, RTP 48 43 0.37 1.308 2.017 
Day 5 RH 43%, RTP 120 43 0.363 1.276 2.011 
Day 1 RH 75%, RTP 24 75 0.412 1.391 1.864 
Day 2 RH 75%, RTP 48 75 0.401 1.37 1.86 
Day 5 RH 75%, RTP 120 75 0.41 1.387 1.843 
Day 1 RH 84%, RTP 24 84 0.413 1.405 1.878 
Day 2 RH 84%, RTP 48 84 0.417 1.397 1.86 
Day 5 RH 84%, RTP 120 84 0.406 1.383 1.916 
Day 1 RH 97%, RTP 24 97 0.563 1.744 1.742 
Day 2 RH 97%, RTP 48 97 0.598 1.805 1.695 
Day 5 RH 97%, RTP 120 97 0.628 1.844 1.623 
On average, for all samples incubated below 97% RH, an absorption band centred at ≈1237 cm-1 was 
recorded. In addition, the measured spectra for samples incubated above 97% RH revealed a visible 
split of the local maximum point, identified at ≈1230 cm-1 and ≈1240 cm-1 with an additional shoulder 
around ≈1210 cm-1. Furthermore after 24 hours of incubation, there is no significant increase in the 
areas corresponding to α helix and random coils or decrease in β sheets (Figure 2-23). It was observed 
that on day 5, samples incubated at 97% RH were highly viscous sticky paste. However, the recorded 
FTIR spectra did not reveal any significant variation to what was recorded after 2 days.      
90 | P a g e  
 
 
0 20 40 60 80 100 120
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0 20 40 60 80 100 120
1.2
1.3
1.4
1.5
1.6
1.7
1.8
1.9
0 20 40 60 80 100 120
1.6
1.7
1.8
1.9
2.0
2.1
2.2
0 20 40 60 80 100
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
2.2
 
 11% RH
 43% RH
 75% RH
 84% RH
 97% RH
E
s
ti
m
a
te
d
 P
e
a
k
 A
re
a
 (
a
.u
.)
Time (mins)
a b
E
s
ti
m
a
te
d
 P
e
a
k
 A
re
a
 (
a
.u
.)
Time (mins)
c
E
s
ti
m
a
te
d
 P
e
a
k
 A
re
a
 (
a
.u
.)
Time (mins)
d
sheets
Random coils
E
s
ti
m
a
te
d
 P
e
a
k
 A
re
a
 (
a
.u
.)
Relative Humidity (%)
helix
 
Figure 2-23 Plot of the average estimated area under the curve of the regions corresponding to α helices (a), 
random coils (b), β sheets (c) and the maximum peak area changes after 24 hours (d) in the amide III band of 
the FTIR spectrum of chicken lysozyme stored at various % RH for 5 days. (n=9) 
2.1.6.4 Discussion 
As explained in the earlier sections, although the amide I and II has been frequently used for protein 
aggregation studies, previous publications (Griebenow and Klibanov, 1995b, Cai and Singh, 2004, Xie 
and Liu, 2003, Barth, 2007) has cited that the amide III spectral band has the advantage that structural 
transitions can be monitored easily without spectral deconvolution. The absorption of α-helix (1330 – 
1290 cm-1) and β-sheet (1250 – 1215 cm-1) secondary structures are well separated in this region.  
The mass/volume of sample was relatively small (less than ≈40 mg) and was spread thinly and evenly 
on a foil. The recorded data indicates that moisture uptake in samples were relatively high within 2 
days except for samples incubated at 97% RH. However, there was no significant increase in sample 
mass after 2 days. In samples incubated at 97% RH, almost close to pure water conditions, the samples 
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continued to accumulate moisture after 2 days and increased the moisture content of the sample to 
about twice the initial content (Table 2-12). The Amide III region was split into bands corresponding 
to α helix, random coils and β sheets of the secondary structures. This crude method is only an 
approximation since for quantitative analysis i.e. AUC, there is a partial numerical contribution from 
the region corresponding to the random coils towards both the regions ascribed to α helix and β sheets 
structures. A plot of the estimated percentage peak area against time is presented in  
Figure 2-24. 
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Figure 2-24 Bar chat presentation of the estimated percentage AUC of the different bands ascribed to the 
secondary structures of protein. 
As may be observed from  
Figure 2-24, the AUC of the region ascribed to β sheets reduces significantly as the relative humidity 
and time increase. Generally, it is known that β sheets are stabilized by hydrophobic interactions and 
backbone hydrogen bonding. However, α helices are largely stabilized by backbone hydrogen bonding 
which are significantly local interactions. This is more dominate in α helix than β sheets which are 
stabilized by long range contacts. In view of this, β sheets are relatively weaker in terms of stability 
when compared to α helical structure. 
During the incubation period, probably the hydrophobic residues could be exposed. Consequently the 
protein molecule aggregates to prevent exposure of its hydrophobic regions which is more 
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thermodynamically favourable. In other words, the fact that α helix is relatively stronger than β sheets 
and in the presence of moisture the intramolecular mobility of protein increases although the proteins 
are still not in solution but only compact, could lead to some unfolding and aggregation especially at 
the surfaces of the protein.  
2.1.6.5 Concluding Remarks 
By normalisation, the number of scans accumulated is observed to only enhance the spectra features 
but does not affect/alter the position and amplitude of the absorption bands corresponding to amide 
I, II and III as shown in Figure 2-19 and Figure 2-20. Thus for optimisation, it may be feasible to use up 
to 50 scan accumulations rather than 100 scan accumulation. The positioning of samples on the ATR 
has insignificant effect on the band characteristics, as shown in Figure 2-20. Repeated measurements 
of samples may be carried out over a period of time assuming atmospheric conditions and raw 
materials are treated similarly prior to FTIR data acquisition. The sample positioning only affects the 
amplitude but not the FTIR band positions and can be avoided by normalisation. To induce protein 
aggregation, protein powder can be stored at high relative humidity.  
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2.1.7 Thioflavin T Assay 
In the last few decades, protein fibrillization/aggregation has been studied with the fluorescent dye, 
Thioflavin T (Vassar and Culling, 1959, LeVine, 1995, Naiki et al., 1989, Biancalana and Koide, 2010). 
As explained in Chapter 1, the intrinsic protein fluorescence characteristic is due to the presence of 
the dominant tryptophan sensitivity in its local region to conformational changes in protein. ThT assay 
is based on the alteration in fluorescence characteristics of ThT in solution depending on the 
hydrophilicity/hydrophobicity of environment. ThT molecules alone show a weak fluorescence signal 
in aqueous solution (at neutral pH) as well as at the presence of non-aggregated proteins. When bound 
to amyloid fibrils, free ThT molecules in the aqueous environment forms micelles with its non-polar 
dimethylaminophenyl groups protected in the core whiles the charged benzothiazole groups become 
exposed (Figure 2-25). This results in a remarkable strong fluorescence upon binding to amyloid fibrils 
(Groenning, 2010, LeVine, 1995, LeVine III, 1999). In a typical ThT fluorescence assay, ThT in micro 
molar concentrations is added to the samples containing fibril/aggregated structures, and the ThT 
fluorescence emission is monitored at ≈490 nm when excited at ≈440 nm.   
 
Figure 2-25 The molecular structure of Thioflavin T with the benzothiazole group highlighted. 
As ThT emission only becomes prominent when ThT binds with aggregates/amyloids fibrils but not 
with folded, unfolded, or partially folded monomeric proteins, its fluorescence signature is highly 
specific. Furthermore, ThT fluorescence intensity is proportional to the weight concentration of fibrils 
formed from a specific protein assuming temperature, ThT concentration, ionic strength and pH are 
kept constant. 
However, the literature reports of various chemical substances and other handling conditions that 
may interfere with ThT absorbance/fluorescence by enhancing or suppressing its effect. For instance, 
it has been reported that some low level molecular weight chemical substances such as Basic Blue 41, 
Azure C and Tannic acid suppresses the ThT fluorescence signal of ThT bound to insulin fibrils without 
impacting on the insulin fibrillization process (Noormagi et al., 2012). Kumar et al.(2008) also reported 
that in an anionic, micellar microenvironment of SDS, the maximum ThT absorption in a buffer 
generally observed at 412 nm is shifted to 428 nm inside the micelle, with an increase in the peak 
molar absorptivity (Kumar et al., 2008). 
Benzothiazole 
group 
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Although ThT assay is a good approach to determining the presence of aggregates in a protein based 
solution, its fluorescence can be retarded or overly enhanced by the presence of some conditions. In 
this section of the work, the effect of acidic and basic pH on the conformation of the ThT molecule 
and its absorption and fluorescence properties will be studied.  The effect of acidic conditions will be 
investigated by using HCl solution, whereas the basic pH will be achieved using the free base form of 
L-arginine.  
2.1.7.1 Experimental 
2.1.7.1.1 Materials 
Thioflavin T dye, bovine serum albumin (BSA) used as the model protein and free base L-arginine were 
obtained from Sigma. 10× PBS buffer (pH 7.2) was obtained from Gibco. Unless otherwise specified, 
all materials and reagents used were of analytical grade. 
2.1.7.1.2 Methods 
Solution preparation – BSA stock solution with concentration of 10 mg/mL and 0.1 mg/mL were 
prepared individually in 150 mM phosphate buffer solution (pH 7.2). Similarly, stock solution of sugar 
was prepared in 150 mM phosphate buffer solution (pH 7.2). The stock was diluted down to 2, 10 and 
50% v/v for later studies. 
ThT stock solution (1 mM) was prepared with double distilled water or 150 mM PBS buffer (pH 7.2) 
and triple filtered using a 0.2 μm filter. All stock solutions were stored at 4 °C. To prevent photo 
bleaching, small aliquots of ThT stock solution were added to the working reactions just before 
fluorescence measurements. Furthermore, all samples containing ThT were stored in the dark. The 
final concentrations of ThT ranged between 10 μM and 100 μM.   
Inducing protein aggregation - The concentration of BSA solution was measured using a standard 
spectrophotometric methodology as described in the earlier section. To induce protein aggregation, 
the BSA solution was incubated at room temperature (22 °C) or at 45 °C for 2–5 days. The formation 
of aggregates was assessed using turbidimetry assay at 360 nm. 
Fluorescence absorbance of ThT in an acidic environment was performed by initially adding ThT to 
prepared protein solution at low pH and then further titrating HCl into the ThT solution. The pH of 
aqueous/buffer solutions were recorded with a Thermo-Scientific Orion semi micro electrode 
connected to a Mettler Toledo MP 220 pH meter calibrated with standard buffers (Fisher Scientific) of 
pH 4, 7, and 12. Acid and alkaline errors were not accounted for when measuring pH <2 or >9. 
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Effect of excipients (sugar or polyol) on ThT fluorescence - ThT assay was performed on BSA solution 
containing varied proportions of sugar and polyol. Aliquots of 2 mL were transferred directly into a 
cuvette and equilibrated at room temperature for three (3) minutes. To the sample, 20 µL ThT was 
added and the solution mixed gently to prevent bubbles. The solution was excited at 445 nm through 
a 2.5 nm slit and the response scanned through 5 nm at speed of 100 nm/min. The data was acquired 
in triplicate to help smoothing the plots and the average presented. This approach was repeated in 
triplicate for further statistical analysis. 
2.1.7.1.3 Data acquisition 
UV-Visual spectroscopy was used to measure spectra of ThT solutions in the range from 240 nm to 
500 nm. Thermo-Scientific UV-Vis Evolution 60S spectrometer with 1 cm path length cuvettes at room 
temperature (22 °C) was engaged in this study. The absorption spectrum of the solvent was subtracted 
from the solution absorption spectrum. 
Fluorescence measurements were recorded with a LS55 spectrofluorometer (Perkin-Elmer, UK) 
equipped with a thermostatted cell holder conn to a temperature control water bath to maintain and 
vary temperatures when required. All samples were measured in 1 cm path length quartz cuvettes. 
Data was acquired from 2 mL aliquots of sample solutions mixed with appropriate volume of ThT just 
before measurements. Unless stated, the temperature of all samples was kept at 25 °C by the 
thermostatted cell holder. ThT emission spectra were recorded in 0.5 nm increments by exciting the 
sample at 445 nm and recording the emission between 455 nm and 650 nm with an excitation and 
emission slit widths set at 2.5 nm and 5 nm respectively.  
2.1.7.2 Results and Discussions 
2.1.7.2.1 Effect of arginine concentration on pH of aqueous and buffer solution 
Generally, arginine is known to increase the pH of water or even buffer solutions. To confirm this 
statement, individual solutions of 0.5 M Arg and 0.5 M Lys were prepared with double distilled water. 
In 9 mL volume of water or 0.15 M PBS, small volumes (Table 2-14) were replaced with equal volume 
of 0.5 M Arg or 0.5 M Lys solution and the resulting pH recorded as described in section above.  
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Table 2-14 Volumes of water or 0.15 M PBS solution replaced by 0.5 M Arg or 0.5 M Lys and the recorded pH. 
  pH 
Concentration of 
amino acid (mM) 
0.5 M Arginine in 
0.15 M PBS 
0.5 M Arginine in 
Water 
Lysine in 
0.15M PBS 
Lysine in Water 
0 10.77 11.24 9.65 9.69 
0.11 7.88 9.23 8.09 8.91 
0.33 8.46 9.68 8.63 9.04 
0.67 8.94 9.81 8.94 9.1 
1.11 9.14 9.92 9.07 9.2 
1.66 9.27 10 9.16 9.28 
3.86 9.52 10.19 9.32 9.39 
8.20 9.74 10.36 9.42 9.5 
16.13 9.93 10.51 9.5 9.53 
31.25 10.11 10.65 9.55 9.56 
58.82 10.27 10.79 9.58 9.6 
90.91 10.38 10.87 9.59 9.61 
125.00 10.46 10.93 9.59 9.62 
166.67 10.53 10.98 9.6 9.63 
209.68 10.57 11.02 9.6 9.63 
250.00 10.61 11.04 9.6 9.63 
 
A plot of the recorded pH against the concentration of 0.5M Arg/water or 0.5M Arg/PBS combinations 
is presented in Figure 2-26. 
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Figure 2-26 The impact of 0.5 M Arg or Lys on the pH of 9 mL water or 0.15 M PBS solution.  
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Figure 2-26 indicates that, the inclusion of arginine or lysine to water or PBS initially causes a significant 
decrease in pH and then plateaus ≈11 pH when the concentration of Arg or Lys is increased.  
 
2.1.7.2.2 UV-vis absorbance of ThT solutions with acidic and basic pH 
The effects of pH changes due to the inclusion of acidic or alkaline solution were studied with UV-vis 
spectroscopy and the recorded data presented in Figure 2-27. In both conditions, two significant 
spectra changes are observed. In acidic conditions, within the range measured, two absorption peaks 
are observed centred 308 nm and 413 nm. However, in basic conditions, the absorption peak observed 
308 nm (in acidic conditions) is identified as broad feature with relatively high baseline. In both 
conditions, as the absorption peak at 413 nm decreases, the peak or characteristic feature at 308 nm 
increases. 
  
Figure 2-27 The UV–vis absorption spectra of the effects of (a) acidic and (b) alkaline pH changes on ThT 
aqueous solutions measured at room temperature. The ThT concentration in acidic condition was 20 μM and 
pH 5.5 changed to 1.05. In alkaline conditions, the pH was 10.45 upon the addition of 12.45 mM Arginine and 
the final ThT concentration was 10 µM. Plot was adapted from (Hackl et al., 2015).  
The effects of inclusion of an alkaline or acid on ThT in time was also studied and the data presented 
in Figure 2-28. In an alkaline condition, there is a gradual decrease in relative absorbance. The 
maximum decrease occurs when the concentration of the alkaline solution (arginine) is higher. 
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Figure 2-28 ThT relative absorbance at 413 nm in aqueous solutions containing (a) containing L- arginine, mM: 
(1) 1.2; (2) 6.2; (3) 25; (4) 49.5 and (b) changing the pH to acidic.  
It is also observed that when the pH of the solution was changed to acidic conditions, there was an 
immediate drop in the relative absorbance.  
 
2.1.7.2.3 ThT fluorescence in solutions with acidic and basic pH 
To observe the effects of pH on ThT fluorescence emission, the protein (BSA) solutions at different pH 
were used, since free ThT has very low fluorescence emission signal. The BSA in solution was initially 
aggregated following the method described in section 2.1.7.2.1. Various concentrations of Arg were 
added to the BSA solution. The inclusion of Arg resulted in a pH shift from 7.2 to ≈9.2–11, depending 
on the concentration of Arg in the solution. The BSA/Arg solution were transferred into the 
fluorescence spectroscopy sample compartment and equilibrated at 25 ˚ C for 5 minutes. 20 μL aliquot 
of 10 mM ThT solution was added to the BSA/Arg solution and sample was measured immediately to 
prevent photo bleaching affecting the emission intensity. The recorded ThT fluorescence spectra of 
BSA/Arg solution or aggregated BSA are presented in Figure 2-29.  
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Figure 2-29 ThT fluorescence emission of aggregated BSA (1) and aggregated BSA with Arg. Both samples were 
prepared in 150 mM PBS solution (pH 7.2). The arrow indicates the direction of time. Plot was adapted from 
(Hackl et al., 2015). 
Similar to what was published in the literature (Hudson et al., 2009, Leonid, 2017), Figure 2-29 
indicates a typical spectra of ThT fluorescence emission in the presence of amyloids/aggregates. The 
emission maxima was identified ≈487 nm and is ascribed to the fluorophore properties of tryptophan, 
tyrosine and phenylalanine residues. However, as the concentration of the Arg content is increased, 
the intensity of the Emax at 487 nm decreases. The fluorescence emission of ThT in a BSA/Arg 
combination solution was studied in time. A plot of the recorded maximum intensity at 487 nm against 
time indicates a gradual decrease of the Emax as presented in Figure 2-30 (a) below.  
 
Figure 2-30 (a) Relative ThT fluorescence emission at 487 nm with time of aggregated BSA solution and varying 
concentrations of Arg. (b) Using a 2nd order exponential decay function, the rate constants for the ThT emission 
signal of the various Arg concentration was estimated. Data is fitted with concentration at the bottom axis 
and pH at the top axis. Plot was adapted from (Hackl et al., 2015). 
Rate constants calculated from the curves in Figure 2-30 (a) using 2nd order exponential decay function 
shown in Figure 2-30 (b) indicates that, the rate constants of fluorescence emission decay increase 
with increasing pH (due to increasing Arg concentration). This increase is relatively pronounced in 
solutions with pH > 10. 
a 
b 
100 | P a g e  
 
To compare these observations to acidic environments, the pH of 0.05 mg/mL BSA prepared with 
10 mM PBS (pH 7.2) was reduced by the inclusion of HCl and similarly 20 μL aliquot of ThT solution 
added the fluorescence spectra acquired following the method described in above. The recorded 
fluorescence emission spectra of BSA solution with the inclusion of HCl are presented in Figure 2-31. 
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Figure 2-31 ThT fluorescence emission for aggregated BSA solution at different volume of 1M HCl. BSA solution 
(concentration = 0.2 mg/mL) was prepared in 150 mM PBS solution (pH 7.2). 
Similarly, it was observed that in acidic conditions the ThT fluorescence emission reduces with Emax 
recorded also ≈487 nm (Figure 2-31). However, in this instance, when HCl was added to alter the 
resulting pH in time, the decrease in ThT fluorescence emission was instant (Figure 2-32). 
 
Figure 2-32 Time dependence of ThT fluorescence emission at ≈487 nm in 150 mM PBS buffer containing 
albumin aggregates; arrow points out time when hydrochloric acid (9.8 mM) was added, changing the pH from 
7.2 to 1.75. Plot was adapted from (Hackl et al., 2015). 
From these observations, as shown in Figure 2-33, it is evident that in both acidic and alkaline 
conditions, pH shifts gives false ThT fluorescence emission measurements.  
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Figure 2-33 Schematic representation of the effects of Arginine and HCl on BSA solution.  
To avoid this effect, ArgHCl was used instead of Arg only. Various concentrations of Arginine 
hydrochloride solution was added to 1 mg/mL aggregated BSA solution (incubated at 45 ˚C for 48 
hours) and subjected to ThT assay. It was observed that the intensity of the ThT fluorescence emission 
remains the same irrespective of the concentration of ArgHCl. 
Also the fluorescence kinetics of ThT emission in a solution containing 1 mg/mL aggregated BSA and 1 
mg/mL ArgHCl was studied. As shown in Figure 2-34, it was observed that the recorded Emax remained 
constant. 
 
Figure 2-34 ThT fluorescence emission maximum at ≈487 nm in a combination of Arginine hydrochloride and 
BSA solution prepared with 150 mM PBS buffer.  
 
In summary, Figure 2-33 shows that the inclusion of Arginine shifts the pH of the sample solution to 
alkaline and HCl will be required to counter this shift in other to avoid any pH impact on ThT 
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fluorescence emission. In view of this, it will be prudent to use Arginine Hydrochloride for ThT assays 
in future studies to prevent false positive or negative observations. 
  
2.1.7.2.4 Effects of included excipients on ThT fluorescence emission 
The aim of this short study was to identify if the presence of other excipients may impact on ThT 
fluorescence emission between wavelengths of 440 nm and 600 nm. Up to 0.1 mg/mL of sugar or 
polyol was added to 0.1 mg/mL BSA solution prepared in 150 mM, pH 7.2. The ThT emission spectra 
recorded is as shown in Figure 2-35. 
 
Figure 2-35 The effects of sugars or polyol on the ThT fluorescence emission of 0.5 % w/v BSA solution 
recorded at 25 °C.   
Samples containing BSA showed relatively high emission when compared to those with sugars only. 
The position of the emission maxima originating from the protein based solutions does not shift in 
wavenumber. It is also observed that when the concentration of sucrose was 0.01 mg/mL, the 
emission recorded was highest while it was lowest at 0.05 mg/mL. As this follows no logic, to get 
consistency, in the future work, each sample will be repeated up to three times (n=3*3). Furthermore, 
it is essential to keep the temperature constant as has been described in earlier sections that 
tryptophan, tyrosin and phenylanaline residues are very sensitive to their local environment. Hence, 
slight changes in temperature will result in a significant change in the fluorescence emission of ThT.  
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2.1.7.3 Concluding Remarks  
The results have shown that ThT absorbance/fluorescence is strongly dependent on the pH of the 
solution. For both acidic and basic pH a significant decrease in ThT absorbance at 413 nm (UV-vis 
spectroscopy experiment) and ≈487 nm fluorescence emission was observed. The main difference 
between acidic and basic pH effect on ThT absorbance/fluorescence has been shown in the kinetics 
of the ThT signal quenching. At low pH the effect has step-like decrease in signal, whereas at basic 
pH the ThT signal decreases gradually over time. 
Since arginine will be used in this project to study its effect on protein aggregation, the pH becomes a 
critical parameter. To avoid the variation in pH at the presence of arginine, the material L-arginine-HCl 
will be used. In this material the presence of HCl will compensate the change in pH. 
Also it is worth to mention that excipients (sucrose, trehalose and mannitol), which will be used in the 
following chapter (4) does not possess the fluorescence properties and does not affect the ThT UV-
Vis/fluorescence signals.  
2.2 General summary 
Different analytical technologies have been used to indirectly or directly study the process of protein 
unfolding, aggregation and/or denaturation. In this chapter, four of such analytical technologies were 
used to qualitatively or quantitatively study the formation of protein aggregates or particle size 
growth. These technologies were dynamic light scattering, Thioflavin T assay, UV-vis spectroscopy and 
Fourier Transformed infra-red spectroscopy. 
Using lysozyme or BSA as the model protein, solutions in PBS or Tris buffer with the optimal 
concentrations were prepared and studied according to well defined protocols as mentioned in the 
experimental work sections.   
The sensitivity of the dynamic light scattering technology was initially validated using standard latex 
beads with particle sizes of 20 nm, 90 nm and 300 nm. In addition BSA was thermally aggregated and 
the particle size growth analysed using this technology as a validation for future BSA studies. It was 
identified from these studies that, the distribution of each particle population is weighted against 
different parameters (i.e. intensity, volume, surface area and number) with each weighting possessing 
its distinct advantages and disadvantages. These distinctive properties originate from the indirect 
mathematical extrapolations of the original cumulant data recorded by the technology. However, to 
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compare the particle size with one which was measured by a different technology, the z-Average is 
recommended although in real systems, there is the more than one particle size population. 
In non-agitated BSA solution, two distinct particle size populations were observed at ≈7.8 nm and 
≈40 nm. However, it was observed that after incubation at 40 °C, there was a shift in particle size 
population from 40 nm to ≈100 nm and further grows >1000 nm. Furthermore, the particle size 
distribution observed at ≈7.8 nm shifts to ≈20 nm at 58 °C. These observations affirm the already 
published aggregation temperature of BSA between 58 °C and 64 °C. Thus, also confirming these 
conditions can be utilised promote aggregation in future studies. 
UV-Vis spectroscopy was also used to determine particle size growth following thermal aggregation 
of BSA/lysozyme. It was concluded that, the apparent absorbance or optical density at 360 nm is only 
a useful tool for studying denaturants or aggregates but cannot be used as a quantitative tool to 
estimate the degree of aggregation since it is as a result of baseline shift (upwards as particle size 
grows and hence optical density increases). 
ThT assay have also been widely used to study amyloids and was in the work used as an indirect 
method of studying the presence of aggregates. This approach was useful because in an unfolded, or 
denatured or an aggregated protein molecule, the sensitive core containing tryptophan, tyrosin and 
phenylamine can easily change its orientation to bind with the aggregate to fluorophore.    
The results indicated that the conditions of measurements were extremely important have shown that 
ThT absorbance/fluorescence is strongly dependent on the pH of the solution and temperature of the 
sample solution. At pH of 7.2 and 25 °C, ThT fluorescence emission of BSA/lysozyme solution were 
recorded in 0.5 nm increments by exciting the sample at 445 nm and recording the emission between 
455 nm and 650 nm with an excitation and emission slit widths set at 2.5 nm and 5 nm respectively. 
In all samples, an emission maximum was recorded ≈487 nm. This was only observed in samples that 
had been initially incubated at harsh conditions to induce aggregation.  
The presence of arginine or lysine was discovered to have altered the pH of the ThT/sample solutions 
thereby affecting the recorded emissions. To compensate for these shifts in pH, HCl has to be included 
to sample.  For instance L-arginine-HCl and L-lysine-HCl should be used instead of L-arginine and L-
lysine. However, the inclusion of sugars or polyols (as it will be shown later) showed no effect on the 
ThT emissions originating from aggregated BSA/lysozyme in solutions.   
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Relative FTIR, the technology was used to study solid protein powder that had been incubated under 
varied relative humidity conditions to enhance moisture uptake. The amide III band was used to 
analyse changes in the secondary structure of the protein molecule. From these initial studies, 
qualitative analysis of this band indicated changes in the recorded spectra in terms of shape and 
broadness. For quantitative analysis, it was expected that the proportion of β-sheets will increase as 
the α helices decreased following relatively harsh incubation conditions (e.g. in samples incubated at 
97% RH for 5 days) but the estimated areas ascribed to secondary structures showed rather the 
opposite. This was attributed to the crude way of estimating the area under the curves without 
accounting for the overlapped areas. As a result, this technology was deemed only useful for 
qualitative study. 
The FTIR technology was also used to study protein solution samples. The recorded IR spectra for the 
solution samples were dominated by the presence of water and therefore the amide III IR band was 
not distinctive. It is also expected that following on from freeze drying highly hygroscopic arginine and 
lysine, without a closed system (i.e. purged closed unit over the ATR module used to measure solid 
samples), the IR bands that will be recorded may also be masked by the absorbed atmospheric 
moisture. Therefore, the technology will not be used for future studies.   
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Chapter 3. Effect of mechanical 
stresses on the native structure of 
proteins 
3.1 Background 
Based on previous studies, protein molecules are known to have the most thermodynamically stable 
conformation under physiological conditions (Vendruscolo et al., 2003). For a globular protein, the 
internal core is mostly hydrophobic amino acid residues, held together by van der Waals forces, 
hydrogen bond, hydrophobic interactions and disulphide bonds. However, the exterior is mostly 
comprised of charged and polar side chains. In a solution containing protein with higher exterior 
charge, strong forces of repulsion between adjacent macromolecules are expected. The total charge 
of protein is dependent on the pH of the solution. At isoelectric point (i.e. where charge is 0) (Figure 
1-3), the protein is more prone to aggregation. 
Changing the physiological conditions (pH, temperature, pressure, denaturants, etc.) or application of 
different types of stress (i.e. mechanical stress or shear) can lead to alteration in conformation, i.e. 
unfolding of macromolecules, and as a result aggregation of proteins. In this chapter, the focus was 
on mechanical stresses used in the pharmaceutical industry during the pre-formulation and 
manufacturing of protein based medicinal products.   
One core process in all protein based formulation is the process of mixing (agitation). Different 
methods of agitation are used in the biopharmaceutical industry, each depending on its efficacy and 
anti-disruptive nature. These agitation technologies employed are generally dependent on shearing 
(e.g. mixing in barrels, tubes or syringes), shaking (e.g. mechanical vibrations, sonication) and/or 
stirring (e.g. magnetic stirrer at varied rotating speed and capacity). The sensitive native structure of 
protein as shown in Figure 1-2 can easily be disrupted during the implementation of these critical 
manufacturing process which could result in poor therapeutic efficacy and production efficiencies 
(Morozova-Roche and Malisauskas, 2007). Disruptions of the macromolecules can be observed as 
unfolded, misfolded, aggregated or denaturated proteins.  
Shear mixing occurs at the interface of layers moving with different velocity against each other. The 
structural unfolding protein molecules occurs as a result of higher fluid flow rates created by velocity 
gradient in moving liquids as it passes via tubes, pumps or ultrafiltration systems.  
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Shear stresses originating from fluid flow may have a deleterious impact on the native structure of the 
protein. However, the literature reports of varying observations on the effect of shear force on native 
structure and function. For instance, under prolonged shear stress, <0.3% reversible aggregation in 
solution was observed in IgG molecules (Bee et al., 2009b). These authors ascribed this observation to 
air entrapment, surface effects, and particulate contamination as the potential source for propagation 
of aggregation and not shear alone. In contrast, another study reported no changes in the protein 
conformation of cytochrome c under shear up to a shear rate of 2 x 10⁵s⁻¹ (Jaspe and Hagen, 2006). A 
significant conclusion that may be drawn is that shear stress in fluid formulations are most likely not 
able to possess the ability to directly damage proteins but other interfacial phenomena are critically 
important. In particular, creation and movement of gas-liquid interfaces can be very deleterious 
(Thomas and Geer, 2011). 
When stirring or shaking are used as the mechanism of agitation, gas-liquid and solid-liquid interfaces 
are intensively produced (Bee et al., 2009b, Biddlecombe et al., 2009) via the formation of 
microbubbles especially in gas-liquid interface. This is deleterious to the structure of proteins since it 
disrupts its native structure and thermodynamically stable state resulting in the formation of protein 
aggregation or denaturation. Another agitation technology widely used in low viscosity liquids is 
sonication. This technology is dependent on high frequency sound waves that causes intensive 
agitation and may be used in reducing the size of macromolecules i.e. peptides or protein molecules 
(Soto et al., 2002), as well as deaggregate protein molecules in a process called cavitation10 (Chen et 
al., 2001, Jarrett et al., 1993, Soto et al., 2002, Ramirez-Alvarado et al., 2000). It was reported that, in 
macromolecules, sonication can be used to disrupt the structural integrity of proteins with molecular 
weight between 13.7 kDa and 66.4 kDa (Stathopulos et al., 2004).  
During the process of stirring, the stress used for agitation is thought to originate from all the three 
phenomena i.e. gas–liquid and liquid–solid interfaces, shear and cavitation phenomenon (Colombie 
et al., 2001, Di Stasio and De Cristofaro, 2010). 
Various mechanisms have been proposed for the formation or propagation of protein aggregation 
(Philo and Arakawa, 2009). Relative to mechanisms that causes aggregation/denaturation during the 
process of protein agitation, the method of agitation determines the aggregation mechanism although 
                                                          
10 Cavitation occurs when acoustic power inputs are high enough to allow multiple productions of microbubbles 
at nucleation sites in a fluid. The bubbles grow during the rarefying phase of the sound wave and then collapse 
during the compression phase leading to a passage of a violent shock wave through the solvent. 
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none of the suggested mechanism in the literature precludes the occurrence of other mechanisms, 
i.e. no mechanism acts alone.  
The external surface of macromolecules is self-complementary and can readily self-associate to form 
reversible small oligomers. In majority of biopharmaceutical proteins for instance Granulocyte-colony 
stimulating factor (G-CSF) (Krishnan et al., 2002a, Raso et al., 2005), irrespective of the concentration 
of the molecules, the formation of aggregates is triggered by shear stress which leads to a 
conformational change (Alford et al., 2008a, Chi et al., 2003) causing  non-native macromolecules to 
bind with each other irreversibly.  
Increasing the protein concentration results in the formation of larger oligomers which are usually 
initiated by hydrophobic interactions, and may become irreversible sometimes due to covalent bonds 
e.g. disulphide linkages (Cromwell et al., 2006, Andya et al., 2003) or by non-disulphide crosslinking 
pathways such as dityrosine formation (Malencik and Anderson, 2003).  
Cysteine residues are the major sites for free radical reactions in bovine serum albumin and has been 
associated with the formation of human serum albumin proteinaceous microspheres  (Grinstaff and 
Suslick, 1991, Gouveia, 2012) via sonication. In the case of low or high shear stress, the opposing two 
layers when in contact may cause structural protein unfolding (which is an unstable state) and as a 
result exposes the hydrophobic regions of the amino acid residues to solvent (water), causing 
hydrophobic interaction with another protein molecules. Generally, the conformational changes 
observed in different domains of a protein molecule induced by a site specific binding are due to either 
a rearrangement of hydrophobic, electrostatic or van der Waals interactions. However, theoretically, 
energy involved in protein aggregation/denaturation, normally as a result of some thermodynamic 
factors could be derived from mechanical shear forces (Christof et al., 2009, Cha et al., 2011). 
A complete or partial unfolding of the three dimensional native structure of a protein molecule is 
generally required for the formation of protein aggregation. Amongst the many suggested 
mechanisms, there seems to be a formation of a precursor molecule before the onset of aggregation 
(Philo and Arakawa, 2009, Borzova et al., 2016). The precursor results from the formation of an 
irreversible oligomer or an unfolded polypeptide chain.  
The trend within the pharmaceutical industry is the packaging of biopharmaceutical drugs e.g. 
monoclonal antibodies at high concentration in prefilled syringes for patient use. At least 20  
pharmaceutical companies manufactures prefilled syringes as preferred delivery device for at least 50 
injectable drugs and vaccines (Makwana et al., 2011). Though this approach may be advantageous for 
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instance by minimizing drug waste, improve product stability properties and drug dosing, the major 
drawback is the deleterious effects of forcing strongly charged layers of proteins past narrow tube 
especially syringe barrel. This approach has the potential of resulting in shear stress even under low 
shear conditions (Simon et al., 2011, Sing and Alexander-Katz, 2010).  
Generally, fluids in motion within a pipe (solid boundary walls) will experience a shear stress. At the 
boundary, under no-slip condition (Lauga et al., 2007), the speed of the fluid is zero, but at some point 
away from the boundary the flow speed gradually increases up to bulk fluid speed (Figure 3-1). For all 
Newtonian fluids in laminar flow, the shear stress is proportional to the strain rate in the fluid where 
the viscosity is the constant of proportionality. 
 
 
Figure 3-1 A typical laminar flow profile for a Newtonian Fluid indicating a zero velocity at the pipe wall and 
increases parabolically with flow, reaching its maximum at the pipe's centre. 
The studies on effects of shear stress on the native protein structure have presented contrasting 
observations. Although force calculations have indicated that very high shear rates would be 
necessary to deform most proteins, the common conclusion is that, shear force alone is not enough 
to cause aggregation (Thomas and Geer, 2011). Furthermore, it have been reported that small globular 
proteins are insensitive to shear stress alone (Jaspe and Hagen, 2006). Some literature have ascribed 
the protein aggregation or formation of aggregation species to mainly the constant renewal of the 
gas-liquid interface but not as result of shear force or liquid-solid interface (Wiesbauer et al., 2013, 
Jaspe and Hagen, 2006, Thomas and Geer, 2011). Thus, it has become necessary to understand when 
the onset of precursor formation or aggregation may actually occur during the implementation of any 
agitation mechanism.   
Highest shear stress Bulk fluid speed 
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3.2 Aim and Objectives 
The aim of this study is to understand how the different types of agitation implemented in pre-
formulation, manufacturing and/or dosing of protein based drug will impact the native structure of 
the protein molecule leading to aggregation or/and denaturation.  
Objectives 
 Using bovine serum albumin (BSA) as the model protein, formulate four sets of protein based 
solutions with optimised formulation conditions (pH, concentration) and measuring 
technologies (temperature, concentration, pH, equipment vibrations). Each formulation type 
must however be agitated with different mechanism, i.e. no shearing (by manual gentle 
rotation until well dissolved), low shearing (magnetic stirring at low revolutions per min), high 
shearing (by agitating through a hypodermic needle and syringe) and mechanical shaking (by 
sonication). 
 For each set, measure the change in particle sizes due to protein unfolding or aggregating 
using light scattering technology and UV-vis turbidimetry. 
  Complement the observations from the previous two technologies with the impact of ThT 
fluorescence emission as the agitation mechanism is altered or the duration of agitation in 
each formulation set is increased. 
 Compare qualitatively and quantitatively the recorded data from each technology and 
correlate with the possible mechanism of aggregation.   
 
 
3.3 Experimental Work 
3.3.1 Materials 
Bovine serum albumin (BSA), Tris buffer salt and potassium nitrate (both ACS reagent grade) were 
purchased from Sigma-Aldrich Co, Dorset, UK. All materials were used for analysis without any further 
purification. A triple filtered (filter pore size 0.22 µm) 10 mM TRIS buffer (pH 7.2) was used to prepare 
four sets of 4 mg/mL BSA solution.  
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3.3.2 Method – Sample Preparation 
Control sample – Stock solutions of 4 mg/mL BSA solution were prepared in a triple filtered 10 mM 
TRIS buffer (pH 7.2) directly in a regular glass cuvette to prevent particulate contamination. The 
cuvette was immediately capped and sealed with parafilm. The cuvette was gently rotated manually 
until all the BSA particulates were dissolved into the filtered medium. The control samples were 
incubated at 4 °C for 20 minutes to ensure maximum dissolution of all protein solids before particle 
size analysis. To ensure no variation in concentrations, UV-vis absorbance at 280 nm was recorded 
and the concentration determined from the calibration plot presented in Figure 2-14. The recorded 
results were in agreement with each other (data not shown).   
Stirring - Stock solution of 4 mg/mL BSA was prepared in a 50 mL beaker and covered with parafilm. 
The solution was mixed using low shear magnetic stirring at a speed of 130 RPM (0.6 RCF). The sample 
was agitated continuously for up to 60 minutes in intervals of 10 minutes. The agitated samples were 
incubated at 4 °C for 20 minutes to ensure maximum dissolution of all protein solids before particle 
size analysis.   
Shearing through needle – 4 mg/mL solutions of BSA were prepared by adding directly the solvent 
and solute into regular glass cuvettes and sealed with a parafilm. The solutions were manually agitated 
via repeated inversion for up to 60 seconds and allowed to settle for further 60 seconds. The samples 
were subjected to high shear stress via the passage through a hypodermic needle (attached to a 10 mL 
syringe) with an internal diameter of 0.04 cm and length of 9 cm. The total shear produced in the 
syringe and needle was estimated as has been reported earlier (Charm and Wong, 1970). The amount 
of shear stress on protein molecule can be expressed as the product of shear rate (s) and residence 
time (t) as presented in Eqn. 3-1. 
 𝑺𝒉𝒆𝒂𝒓 𝒔𝒕𝒓𝒆𝒔𝒔 =  𝒔 ×  𝒕 = 𝟖/𝟑 × 𝒍 × 𝒓 Eqn. 3-1 
where l is the length (mm) and r is the radius (mm) of the capillary tube. In this work, the relationship 
between the number of sample solution expulsions from the syringe and shear stress is as presented 
in Table 3-1 and henceforth all data will be presented shear stress.  
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Table 3-1 Theoretical estimates of shear stress experienced by BSA solution agitated using syringe.  
Number of Ejections from syringe Ejection Cycle (double ejection) Calculated shear stress (Pa)  
5 10 4.8 
10 20 9.6 
20 40 19.2 
30 60 28.8 
40 80 38.4 
50 100 48.0 
To ensure no variation in concentrations, UV-vis absorbance at 280 nm was recorded and the 
concentration determined from the calibration plot presented in Figure 2-14. The recorded results 
were in agreement with each other (data not shown).   
Mechanical Shaking - 4 mg/mL solutions of BSA was prepared directly in a regular glass cuvettes, 
capped immediately and sealed with parafilm. Samples were placed in a bath sonicator with a 
frequency of 20 kHz, and the power output set to deliver an average value of 30W. Ice was added to 
the water in the bath to maintain the temperature below 20 °C. Each cycle consisted of 120 seconds 
sonication followed by 60 seconds incubation. The agitated samples were further equilibrated for 20 
minutes at 4 °C before particle size analysis. To ensure no variation in concentrations, UV-vis 
absorbance at 280 nm was recorded and the concentration determined from the calibration plot 
presented in Figure 2-14. The recorded results were in agreement with each other (data not shown).   
3.3.3 Data acquisition and analysis 
Particle size analysis of protein macromolecules (control and agitated) were analysed with dynamic 
light scattering (DLS) (Zetasizer Omni, Brookhaven). The measurements were carried out at an angle 
of 173 ° (back scattering), which is advantageous compared to 90 ° angle measurement as a large area 
(proportion of the sample in cuvette) is analysed. Continuous sampling was taking for up to 120 
seconds to ensure a true representation of the sample at a temperature of 25 °C. All measurements 
were repeated at least five (5) consecutive times. 
The data was initially analysed using the non-negatively constrained least squares (NNLS) 
(Tscharnuter, 2000) and further fitted with multi modal distribution. In principle, when different 
distribution of sizes is present, the measured effective diameter (or Z-average) is a mean average 
diameter weighted by the intensity of light scattered by all the distributions. This is represented 
mathematically as Eqn. 3-2. 
116 | P a g e  
 
 𝟏
𝐃𝐳
 =  
∑ 𝐟𝐢 𝐃𝐢
𝟔𝐏(𝛉)𝐃𝐢
−𝟏
∑ 𝐟𝐢𝐃𝐢
𝟔 𝐏(𝛉)
 Eqn. 3-2 
Where Dz is the z-average (effective diameter), fi is the number of particles, Di is the diameter and P 
(θ) is the scattering angle of the particle. 
However, in the case where more than one (1) distribution band originating from more than one (1) 
particle size population, the effective diameter takes into account all the distributions. Therefore, in 
this work, the data presented will be the weight average diameter of individual populations since this 
approach considers directly the distribution of interest. Similarly, the polydispersity index, which is a 
measure of the broadness of the distribution also takes into account all the distribution broadness. 
Hence, the broadness of distribution will also be estimated as the FWHM as described in Chapter 2. 
This may be used as a quantitative tool for relative analysis of the effects of agitation in time (low 
shear and mechanical vibrations) or shear intensity (high shear).  
Turbidimetry measurements (UV-vis 360 nm) were carried out using Evolution 60S (Thermo Fisher 
Scientific) to complement the observations made from particle size analysis. Samples were measured 
at 25 °C following the method discussed in Chapter 2. For non-agitated BSA solution, the samples were 
measured (directly without any agitation) in intervals of 10 minutes for up to 120 minutes  and in each 
instance incubated at 4 °C. For agitated BSA solution, the cuvette was gently rotated manually to avoid 
bigger sized particles settling at the bottom of the cuvette. The apparent absorbance of the samples 
was measured using regular plastic cuvette with 1 cm path length in triplicates and used for further 
analysis.  
Thioflavin T Assay - Fluorescence spectroscopy was used to detect the presence of protein aggregates 
in the agitated solution. BSA sample solutions were measured using LS55 spectrofluorometer (Perkin-
Elmer, UK) connected to a water bath to maintain the sample temperature. Aliquots of 2 mL individual 
4 mg/mL BSA sample solutions were placed into a regular glass cuvette with 1 cm path length and 20 
µL of a 1 mM of Thioflavin T solution added to the solution. The solution was equilibrated at 25 °C for 
five minutes before samples were measured. The solution was excited at 445 nm (2.5 nm excitation 
slit) and an emission spectra acquired between the wavelengths of 455 nm to 550 nm (5 nm emission 
slit).  
The data presented from each measurement was a cumulated average from three repeated (n=1x3) 
analysis of the same sample to reduce signal to noise ratio. Measurements were carried out in 
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triplicates and the averages used for analysis (n=3x3). As described in earlier sections, the intensity 
and positional shift of the local maxima for each data were analysed for all types of agitation/stress. 
3.4 Results 
3.4.1 Non Agitated BSA solution 
Particle size analysis - In all non-agitated samples studied (repeated measurements), two distinct 
distributions were observed as shown in Figure 3-2. The estimated mean of the first distribution is 
centred on 7.8 nm (± 0.58 nm) with full width at half maximum (FWHM) of 2.42 nm (±0.43 nm). The 
recorded intensity of this distribution relative to other observed distribution was 100%. This intensity 
was automatically normalised by the instrument software since the amplitude was highest in the 
measurements. 
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Figure 3-2 Light scattering intensity vs. particle size of non-agitated 4 mg/mL BSA solution. Data has been 
shifted 100 units upwards for clarity. Measurements were carried in non-defined time intervals over a period 
of six (6) hours. 
The second population is centred on 40.55 nm (± 4.88 nm) with FWHM 10.56 nm (±2.2 nm). The mean 
relative amplitude (intensity) of this population was also estimated to be 44.2% (±5.1%). The actual 
population maxima and broadness measured as FWHM is presented in Table 3-2. 
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Table 3-2 Shows the estimated intensity peak population of each population of particles (centroid) and the 
full width half maximum of the control samples each containing 4 mg/mL BSA. 
 
Population 1 Population 2 
 
Repea
t 
Particle 
Size 
(nm) 
Relative 
Intensity 
I1 (%) 
FWHM 
(nm) 
% 
Broadness 
Particle 
Size 
(nm) 
Relative 
Intensity 
I2 (%) 
FWHM 
(nm) 
% 
Broadness 
Ratio 
I2/I1 
1 7.55 100 2.64 34.95 39.30 39.30 12.40 31.55 0.39 
2 8.13 100 2.76 33.99 33.98 33.98 10.06 29.59 0.34 
3 7.90 100 2.73 34.62 37.30 39.17 11.03 29.58 0.39 
4 8.60 100 2.67 31.04 35.76 50.29 9.83 27.49 0.50 
5 8.20 100 2.80 34.17 38.00 47.87 11.11 29.23 0.48 
6 8.78 100 2.81 31.97 41.44 51.07 9.35 22.56 0.51 
7 7.49 100 2.05 27.42 44.00 46.47 11.83 26.89 0.46 
8 8.15 100 2.43 29.76 40.72 44.55 8.80 21.62 0.45 
9 7.85 100 2.29 29.22 48.20 47.09 11.50 23.85 0.47 
10 8.54 100 2.64 30.87 44.81 42.61 10.95 24.43 0.43 
11 8.94 100 2.88 32.22 50.33 43.83 10.08 20.03 0.44 
12 8.67 100 2.84 32.79 52.73 51.86 10.64 20.19 0.52 
13 8.57 100 2.77 32.34 40.46 40.03 8.15 20.14 0.40 
14 7.45 100 2.02 27.07 36.57 46.30 9.82 26.85 0.46 
15 7.91 100 2.80 35.38 39.39 49.85 8.36 21.23 0.50 
16 7.91 100 2.91 36.83 38.39 45.26 9.31 24.26 0.45 
17 8.03 100 2.65 32.95 45.01 45.35 10.23 22.73 0.45 
18 8.06 100 2.93 36.34 45.01 44.91 8.16 18.12 0.45 
19 8.11 100 2.72 33.57 48.50 38.70 18.83 38.83 0.39 
20 8.13 100 2.48 30.50 36.90 40.46 10.52 28.51 0.40 
21 6.93 100 1.96 28.23 38.10 54.86 9.34 24.50 0.55 
22 7.99 100 2.46 30.77 39.90 45.03 12.33 30.91 0.45 
23 7.85 100 2.40 30.58 43.30 44.28 12.42 28.67 0.44 
24 7.56 100 2.29 30.35 42.30 43.57 12.24 28.94 0.44 
25 7.52 100 1.51 20.10 38.60 36.72 13.14 34.05 0.37 
26 7.22 100 1.77 24.48 35.20 52.50 9.13 25.92 0.53 
27 7.24 100 1.94 26.76 38.40 47.68 10.86 28.27 0.48 
28 6.81 100 1.84 27.07 34.50 48.95 8.09 23.44 0.49 
29 6.69 100 1.91 28.50 34.70 38.29 8.07 23.25 0.38 
30 6.87 100 1.92 28.00 36.90 38.32 5.84 15.83 0.38 
31 7.83 100 2.41 30.72 33.40 45.72 9.76 29.23 0.46 
32 7.33 100 1.90 25.94 45.10 41.81 9.72 21.55 0.42 
33 7.14 100 1.97 27.60 37.50 39.87 8.61 22.96 0.40 
34 7.49 100 2.05 27.42 44.00 36.47 9.64 21.91 0.36 
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Assuming that the distribution of scattered angle (from particle) is uniform i.e. P (Ɵ) is 1, then Eqn. 3-2 
can be simplified as shown in Eqn. 3-3. 
 
𝑫𝒛  =  
∑ 𝒇𝒊 𝑫𝒊
𝟔
∑ 𝒇𝒊𝑫𝒊
𝟓
 Eqn. 3-3 
where Di is the diameter and fi is the number of particles in a homogeneous solution  
It can be observed from Eqn. 3-3 that, intensity of larger molecules or aggregates are weighted six (6) 
more times than smaller molecules. Hence, although Figure 3-2 shows the two distinctive peaks, the 
second population observed at 40.55 nm (± 4.88 nm) maybe relatively insignificant if the plots are 
presented based on number, surface area or volume weighting as is observed (Figure 3-3). In all the 
different types of parameters (intensity, volume, surface area and number measured by the 
equipment), a local maximum of the low diameter population at 7.9 nm (±0.46 nm) with relative 
intensity of 100% is observed. 
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Figure 3-3 Recorded particle size population weighted by volume (a) surface area (b) and number of non-
agitated BSA solution. Measurements were carried in non-defined time intervals (≈1 hour increments) over a 
period of six hours. Each plot is the average 7 repeated measurements. 
 
Turbidimetry studies - The absorbance recorded for non-agitated BSA is presented graphically in 
Figure 3-4. The UV absorbance at 360 nm showed a small value (average 0.007 a.u. (± 0.0009)) that 
indicates negligible amount of aggregates of minute sizes in the control BSA solution. The estimated 
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gradient for a plot of the apparent absorbance at 360 nm against time was -5 x 10-7 also indicating a 
negligible variation in the apparent absorbance at 360 nm recorded during the study period.  
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Figure 3-4 UV/Vis absorbance of 4 mg/mL BSA solution at 360 nm recorded over a period of 120 minutes. The 
data presented is the average of three repeated measurements (n=9) and is fitted with 95% confidence bands 
(blue). 
 
Thioflavin T assay - The results of ThT assay for non-agitated BSA solution is presented in Figure 3-5 
and indicates maxima centred at 484 nm.  
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Figure 3-5 Recorded ThT assay of 4 mg/mL non-agitated BSA solution initially incubated at 4 °C over a period 
of 120 minutes. Samples were measured at 25 ˚C during the incubation period. (n=3) 
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As explained in Chapter 2, individually solutions of BSA or ThT does not absorb significantly in this 
wavelength range when compared to a ThT/aggregate complex.  In all repeated measurements, the 
mean intensity of the emission was ≈54 a.u. at 484 nm. Similarly, from the plot of the emission maxima 
against time as shown in Figure 3-6, the gradient of the linear fit was estimated as -2 x10-4. This 
confirms observations from the other technologies that there is no significant particle growth during 
the period of the measurements. 
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Figure 3-6 The emission maximum recorded at 484 nm against incubation time for 4 mg/mL BSA in triple 
filtered 10 mM TRIS buffer (pH 7.2). The plot is fitted with 99% confidence bands (blue). (n=3x3) 
The gradient of this plot also indicates there is no variation in the samples during the incubation 
period. 
 
3.4.2 Agitated BSA Solution 
3.4.2.1 Stirring  
Particle size analysis – The particle size measurements of the BSA samples indicated two distinctive 
populations. As shown in Figure 3-7, the average particle size of population 1 was estimated to be 
8.4 nm which was slightly higher than non-agitated BSA solution (i.e. 7.4 nm).  
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Figure 3-7 Light scattering intensity vs. particle size (nm) of 4 mg/mL BSA solution agitated by low shear 
magnetic stirring. Data has been vertically shifted up by 100 units for clarity.  
However, the broadness (FWHM) of this population increased from ≈2.45 to 10.2 as the agitation time 
increased (Table 3-3). Furthermore, the relative intensity of the distribution reduces significantly from 
100% to ≈37%. Percent (%) broadness was estimated for each averaged diameter using Eqn. 3-4. 
 
% 𝑩𝒓𝒐𝒂𝒅𝒏𝒆𝒔𝒔 =  
𝐹𝑊𝐻𝑀
𝐷𝑖𝑎𝑚𝑒𝑡𝑒𝑟
 × 100  Eqn. 3-4 
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Table 3-3 Quantitative analysis of population 1 and 2 of 4 mg/mL BSA solution agitated by magnetic stirrer 
with speed ≈130 RPM (0.61 RCF). (n=8)   
 Population 1 Population 2  
Time / 
mins 
Particle 
Size 
(nm) 
Relative 
Intensity 
I1 (%) 
FWHM 
(nm) 
% 
Broadness 
Particle 
Size 
(nm) 
Relative 
Intensity 
I1 (%) 
FWHM 
(nm) 
% 
Broadness 
Ratio 
I2/I1 
0 7.9 100 2.7 34.51 36.9 38.9 11.2 30.28 0.39 
10 8.3 100 2.5 30.62 50.5 55.8 15.2 30.03 0.56 
20 7.9 100 2.4 30.19 53.1 63.5 16.6 31.28 0.64 
30 8.2 100 3.2 39.03 89.1 67.1 32.0 35.94 0.67 
40 8.3 100 3.4 41.34 102.4 63.4 45.4 44.35 0.63 
50 8.6 96.8 4.6 53.52 292.9 100 165.8 56.61 1.03 
55 8.3 68.6 4.9 58.96 267.6 100 148.8 55.59 1.46 
60 9.7 37.4 10.2 104.62 503.9 100 333.6 66.20 2.68 
 
The second (2nd) population centred on ≈37 nm shifts to ≈ 504 nm with increasing stirring time. 
Similarly, the broadness of the population increases from ≈11 nm to ≈334 nm as the relative intensity 
increases from ≈39% to 100% (Figure 3-7 and Table 3-3).  
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Figure 3-8 Estimated ratio between relative intensity of the two observed particle size distributions recorded 
for 4 mg/mL BSA solution agitated by a magnetic stirrer over a time period of 60 minutes. (n=3) 
A plot of the ratio between the intensities of population 2 and population 1 is presented in Figure 3-8. 
It indicates a possible three different aggregation trends. From the plot, there is a slight increase in 
ratio trend shown in samples agitated within the initial 20 minutes. Samples agitated between 20 
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minutes and 40 minutes are relatively stable and does not vary in ratio. However, samples agitated 
after 40 minutes shows a significant increasing trend.   
The volume, surface area and number of particles in agitated BSA solution is also plotted against the 
particle size and presented in Figure 3-9. Similarly to non-agitated BSA study samples, this plot shows 
a single distribution with a maximum ≈8 nm. 
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Figure 3-9 Recorded volume (a) surface area (b) and number (c) weighted distributions plotted against particle 
size of BSA solution agitated by magnetic stirring. Data has been shifted up 100 units for clarity.  
It also reveals that as the duration of agitation increased, broadness of the population increased. There 
is also a reduction in particle size from an average of 6.9 nm (stirred up to 55 minutes) to 4.9 nm for 
samples stirred for 60 minutes. In all datasets (volume, surface area and number), the relative 
amplitude remains 100% as there is only one population of particles. The presence of this single 
distribution also indicates that relative to the number, surface area and volume of aggregates, the 
observed second distribution does not have an equally dominant effect on the size distribution. 
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Table 3-4 Quantitative analysis of population 1 and 2 of 4 mg/mL BSA solution agitated by magnetic stirrer 
with speed ≈130 RPM (0.61 RCF). (n=8) 
 
Volume Weighting Number Weighting 
 
Time 
(mins) 
Particle 
Size (nm) 
Relative 
Intensity 
(I1) 
FWHM 
(nm) 
% Broadness 
(%) 
Particle 
Size (nm) 
Relative 
Intensity 
(I2) 
FWHM 
(nm) 
% Broadness 
(%) 
0 7.2 100 2.49 34.60 7.1 100 2.29 32.20 
10 7.6 100 2.27 30.01 7.3 100 2.24 30.83 
20 7.0 100 2.67 38.11 7.0 100 2.14 30.57 
30 7.4 100 2.40 32.67 7.1 100 2.55 35.70 
40 6.1 100 2.57 42.05 6.8 100 2.57 37.75 
50 6.9 100 2.85 41.06 6.5 100 2.85 43.72 
55 6.4 100 2.74 42.73 6.1 100 2.74 44.58 
60 5.2 100 2.53 48.47 4.9 100 2.63 53.48 
 
Turbidimetry analysis of the same sample shows relative increase in absorbance at 360 nm indicating 
small increase in aggregation as the agitation time increases (Figure 3-10). 
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Figure 3-10 UV/Vis absorbance of 4 mg/mL BSA solution at 360 nm for samples agitated via magnetic stirring 
over a period of 60 minutes. The data presented is the average of three repeated measurements and fitted 
to 2nd order polynomial function with 95% confidence bands. 
Thioflavin T Assay – As explained in Chapter 2, in the absence of aggregate-like strands, the recorded 
emission of ThT is relatively insignificant. As can be observed in Figure 3-11, the emission of buffer 
alone when compared to samples agitated is very low.    
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Figure 3-11 ThT assay of 4 mg/mL BSA recorded for samples initially agitated using magnetic stirring over a 
period of 60 minutes. The various colours represents the different times and corresponding data measured. 
The data presented is the average of three repeats. (n=3x3) 
From Figure 3-11, it is observed that irrespective of the agitation time, the peak position is observed 
at ≈484 nm similar to what was initially observed in non-agitated BSA solutions (Figure 3-5). However, 
increasing the agitation time also increases the maximum emission intensity from ≈ 55 a.u. to 110 a.u. 
(Figure 3-11), perhaps indicating the formation of some aggregates.  
The increasing Emax at ≈484 nm is plotted against the duration of agitation as presented in Figure 
3-12 and indicates a nonlinear relationship. The estimated R2 from the data was 0.98 indicating a good 
fit to second and order polynomial equation.  
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Figure 3-12 The Emax recorded at ≈484 nm against agitation time for 4 mg/mL BSA solution. The data 
presented is the average of three repeats and fitted to 2nd order polynomial function with 95% confidence 
levels. (n=3x3) 
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3.4.2.2 Shearing in hypodermic needle 
Particle size analysis – Shear stress exerted on the protein molecules is expected to have deleterious 
effects on their physical properties. The particle size analysis for samples subjected to stress indicates 
the presence of two separate populations and in some cases even a third population (Figure 3-13).  
10 100 1000
0
100
200
300
400
500
600
700
 
 
In
te
n
s
it
y
Log Diameter (nm)
Control
19.2 Pa
9.6 Pa
28.8 Pa
38.4 Pa
48 Pa
4.8 Pa
 
Figure 3-13 Light scattering intensity vs. particle size (nm) of 4 mg/mL BSA solution agitated by shearing in a 
hypodermic syringe to yield varied shear stress. Data has been vertically shifted up by 100 units for clarity.  
Shear stress was estimated from Figure 3-13 and the data presented in Table 3-5.  
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Table 3-5 Quantitative analysis of population 1, 2 and 3 of 4 mg/mL BSA solution agitated by syringe and a 
hypodermic needle over varied shear stress. (n=8) 
 
Population 1 Population 2 Population 3 
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0 7.9 100 2.71 34.5 36.9 38.9 11.2 30.3         0.389 
4.8 7.1 53.5 4.60 65.0 321.8 100 197.1 61.3         1.871 
9.6 7.8 30.2 4.85 62.5 364.5 100 209.6 57.5         3.308 
19.2 8.0 26.4 5.47 68.0 301.1 100 221.3 73.5 1047.1 33.4 626.2 59.8 5.055 
28.8 8.3 13.7 5.88 71.1 247.5 100 191.8 77.5 963.0 25.1 335.7 34.9 9.099 
38.4 5.0 8.2 3.04 61.3 178.0 100 125.3 70.4 813.8 93.1 571.2 70.2 23.644 
48         141.3 100 46.1 32.6 1095.8 58.2 326.0 29.7   
 
The ratio between relative intensities measured in population 1, 2 and 3 is presented in Figure 3-14 
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Figure 3-14 Ratio between the relative intensities of the three observed particle size distributions recorded 
for 4 mg/mL BSA solution agitated in a hypodermic needle. The data has been fitted with 5% standard error 
bars. 
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Similarly, the data relating to volume, surface area and number of particles are also presented in 
Figure 3-15.  
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Figure 3-15 Recorded volume (a) surface area (b) and number (c) weighted distributions plotted against 
particle size of BSA solution agitated using high shear in hypodermic needle. Data has been shifted up 100 
units for clarity.  
It is observed that, the population identified at ≈8 nm ascribed to the dimers and trimers of the native 
protein molecule disappears after the application of shear stress of 48 Pa. These observations 
complement the results which have been presented in Figure 3-13. 
Turbidimetry analysis – The turbidimetry data is presented in Figure 3-16 and shows a sharp increase 
in absorbance after shear stress >10 Pa is applied.  
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Figure 3-16 UV/Vis absorbance of 4 mg/mL BSA solution at 360 nm agitated via shear in a hypodermic needle 
with fixed length but varied repeated solution expulsions to produce varied shear stress. The data presented 
is fitted to 2nd order polynomial function with 90% confidence bands. (n=3x3) 
Thioflavin T Assay – Figure 3-17 shows the graphical presentation of the effects of shear stress on 
fluorescence emission measured in ThT assay. The assay indicates no shift in the local maxima of the 
emission. However, there is a significant increase in emission as shear stress is increased when 
compared to control samples showed in Figure 3-5.   
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Figure 3-17 ThT assay of 4 mg/mL BSA recorded for samples initially agitated by repeated expulsions through 
a hypodermic needle i.e. simulation of increasing pipe length. The data presented is the average of three 
repeats (n=3x3). 
A plot of the increasing Emax at ≈484 nm against the shear stress presented in Figure 3-18 shows an 
exponential relationship with an estimated R2 of 0.99 indicating a good fit. 
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Figure 3-18 The Emax recorded at ≈484 nm against agitation time for 4 mg/mL BSA solution. The data 
presented is the average of three repeats and fitted to 2nd order polynomial function with 95% confidence 
bands. (n=3x3) 
3.4.2.3 Sonication 
Particle size analysis of mechanically shaking BSA solution is presented in Figure 3-19. It is observed 
that generally, as the agitation duration increased, up to three particle size populations emerged 
(Figure 3-19). 
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Figure 3-19 Light intensity (d) vs. particle size (nm) of 4 mg/mL BSA solution agitated by mechanical vibration. 
Data has been offset 100 units vertically for clarity.  
Table 3-6 shows the mathematical analysis of the plot presented above. 
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Table 3-6 Quantitative analysis of population 1, 2 and 3 of 4 mg/mL BSA solution agitated by mechanical 
agitation over varied periods of time. (n=8)  
  Distribution 1   Distribution 2 Distribution 3 
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0 7.9 100 2.7 34.5 36.9 38.9 11.2 30.3 0.0       0.389 
5 6.4 100 1.4 21.3 22.2 63.5 4.9 22.2 0.0       0.635 
10 7.4 17.5 5.5 74.5 122.2 44.6 82.4 67.4 957.8 100 695.5 72.6 8.251 
20 7.6 20.8 6.0 78.8 111.7 36.0 84.0 75.2 1049.2 100 749.0 71.4 6.536 
30 7.3 19.4 6.1 84.1 108.6 35.0 91.1 83.9 1179.1 100 1031.1 87.5 6.947 
40 7.7 15.6 5.5 70.9 215.2 36.2 182.6 84.8 1328.4 100 1072.6 80.7 8.707 
50 7.5 19.4 7.5 100.2 230.6 32.0 236.4 102.5 1870.3 100 1615.5 86.4 6.823 
60 7.1 18.0 6.7 94.8 280.9 28.8 243.3 86.6 2201.7 100 1853.5 84.2 7.158 
The ratio between relative intensities measured in population 1, 2 and 3 is presented in Figure 3-20. 
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Figure 3-20 Ratio between the relative intensities for the recorded three particle size populations recorded in 
a 4 mg/mL BSA solution agitated using ultra sonication at increasing times. The data has been fitted with 5% 
standard error bars. 
Figure 3-21 shows the volume of BSA particle size as a function of the log diameter. The plot shows a 
distinctive distribution with local maxima located at ≈7 nm. A second population was also observed 
≈2000 nm after 10 minutes of continuous mechanical shaking. This can be ascribed to aggregated BSA 
molecules. 
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Figure 3-21 Recorded volume (a) and number (b) weighted distributions plotted against particle size of BSA 
solution agitated using sonication. Data has been shifted up 100 units for clarity.  
Unlike the observations presented in the volume plots, the number plot shows only one population of 
particles with the distribution maxima observed at ≈6.7 nm. The broadness of this distribution 
increases with time but the relative amplitude does not change from 100%. 
Turbidimetry – Figure 3-22 shows the UV-vis absorbance at 360 nm. The graph indicates a 2nd order 
polynomial relationship between the absorbance and the agitation time.  
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Figure 3-22 UV/Vis absorbance of 4 mg/mL BSA solution at 360 nm for samples agitated via mechanical 
shaking over a period of 60 minutes. The data presented is the average of three repeated measurements. 
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Thioflavin T assay – Figure 3-23 also shows the plot of ThT fluorescence emission against the duration 
of the agitation. Similar to previous observations, there is no shift in the emission maxima but an 
increase in emission intensity as the agitation duration increased.   
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Figure 3-23 ThT assay of 4 mg/mL BSA in triple filtered 10 mM TRIS buffer (pH 7.2) recorded for samples 
initially agitated via mechanical shaking over a period of 60 minutes. The data presented is the average of 
three repeats (n=9). 
 
A plot of the emission maximum at 382 nm is presented in Figure 3-24. It shows a significant increase 
in fluorescence emission in samples agitated for >10 minutes but relatively low increase in emission 
in samples stressed for <10 minutes.  
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Figure 3-24 The emission maximum recorded at ≈482 nm against duration of agitation of a 4 mg/mL. The 
data presented is the average of three repeats (n=9).  
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3.5 Discussions 
The particle size investigation performed with dynamic light scattering for both agitated and non-
agitated samples indicated two distinct (in some cases three) distributions obtained by intensity 
measurement. However, data presentations relating to number and volume analysis showed one 
distinctive distribution in majority of the studies. It was earlier suggested that in the pharmaceutical 
industry, there is a stronger preference for data that has been reported on a volume basis for most 
applications (Burgess et al., 2004).  
Although DLS technology detected the presence of various size population, however as seen from Eqn. 
3-5 to Eqn. 3-8, each method of data presentation has its own limitations (degree of sensitivity).  
 
𝑰𝒏𝒕𝒆𝒏𝒔𝒊𝒕𝒚 =  (
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𝟔
 Eqn. 3-5 
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 Eqn. 3-6 
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 Eqn. 3-7 
 
 
𝑵𝒖𝒎𝒃𝒆𝒓 =  (
𝑵𝟐
𝑵𝟏
) ∝ (
𝑹𝟐
𝑹𝟏
)
𝟎
 Eqn. 3-8 
where I is intensity, V is volume, S is surface area and N is number. R1 and R2 is the average radius of 2 
populations of particles. 
Analysis of DLS data provides various sets of average values with a probability distribution of the 
hydrodynamic radius (Rh). The intensity-weighted hydrodynamic radius (Rh) acquired through the 
cumulant analysis of the autocorrelation function in the scattered intensity is the most direct, 
reproducible, and numerically stable measure of the protein aggregate size. This is because, the 
intensity-weighted hydrodynamic radius does not depend on other mathematical extrapolations and 
assumptions of scattering but directly obtained from the initial part of the autocorrelation function 
where the signal-to-noise ratio is largest.  
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As mentioned in earlier sections, z-average estimated by DLS equipment is the average radius over 
the various size populations measured. However, in the case of protein stability studies, it may not be 
a good representation of the actual size variations originating from native trimers, dimers, oligomers, 
unfolded protein molecules and aggregate/denaturant size, especially in the case of bi-modal or multi 
modal distribution.  
Furthermore, the intensity weighted Rh has the scattered intensity proportional to the particle size to 
the power six, and therefore biased toward larger size (Eqn. 3-5). In a dispersion of protein particles 
with radius R1, assuming half of these particles were aggregated with varying radius R2, then Rh will be 
significantly shifted to R2. Rh estimated from intensity weighted presentation is naturally weighted 
according to the scattering intensity of each size population making it the most sensitive probe for 
quantitative and qualitative analysis of protein particle stability. 
The number-weighted distribution N1 has no bias toward a particular size and this makes it insensitive 
to varying size population relating to protein aggregates when relatively small proportion of the 
population are involved in aggregates and relatively large proportion of single particles are present. 
In any of the agitated samples presenting two bimodal distributions, there are two peaks with area A1 
and A2.  
If there are two populations with 10 times difference in radius (5 nm and 50 nm) and equal amount of 
particles, then as can be observed from Figure 3-25,  If a number weighted distribution of the 2 particle 
populations was plotted, then only 2 peaks centred at 5 nm and 50 nm with 1:1 ratio would be 
observed.  When converted to a volume weighted distribution, then similarly 2 peaks would be 
observed but a ratio of 1:1000 as the volume of a sphere is 4/3π (d/2)3. To further convert this into an 
intensity weighted distribution will result in a 1:1000000 ratio between the 2 peaks as a result of the 
intensity of scattering being proportional to d6 from Rayleighs approximation. 
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Figure 3-25 Comparing the relative percentage intensity (in class) of combined two populations of spherical 
particles with diameters 5 nm and 50 nm present in equal number (proportions). The plot shows the recorded 
presentation as (a) number, (b) volume and (c) intensity. Image was adapted from (Malvern Instruments, 
2014). 
Therefore, volume-weighted distribution and z-average are biased towards particle with larger size. 
The proportion of areas in bi-modal distributions is dependent on the type of weighting to determine 
Rh (i.e. intensity, volume, surface area or number). The minimum relative % amplitude which can be 
measured by the DLS Instrument is 0.01% which indicates that the ratio A1/A2 which is less than 
100/0.01 = 10000 cannot be recognised.  
In protein aggregation studies, number and volume weighted Rh may be useful to characterize the 
particle sizes and relative proportions of the different populations.  A single weighting Rh may not be 
enough to completely describes the sample (i.e. Rh and proportions). However, as mentioned in 
Chapter 2, there is an inherent error that tickles down from converting intensity weighted data to 
volume, surface area and number weighted data. Four major assumptions must be made and 
accepted before such conversion can be estimated; 
 all the aggregates can are spheres 
 the sample solution is homogeneous 
 there is no error in the intensity weighted data  
 the refractive indices of all populations were known (i.e. real and imaginary refractive index).  
a) b) c) 
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This error trickles down to number and volume distributions, hence, they will be ideal for qualitative 
analysis rather than quantitative. It must be noted that the intensity cannot be used as absolute values 
but for relative comparison only. 
In a monomeric state, based on the diffusion coefficients of BSA which is used directly to estimate the 
hydrodynamic radius, the shape of BSA can be approximated by prolate spheroids with dimensions of 
9.5 × 5 × 5 nm3 (𝑅𝑚 = ∛9.5 × 5 × 5 = 6.19 nm). However, there is the potential for the presence of 
an appreciable number of compact dimers whose shape can be approximated by an oblate spheroid 
having dimensions of 11 × 11 × 5 nm3  (𝑅𝑑 = ∛11 × 11 × 5 = 8.46 nm)(Jachimska et al., 2008).  
In view of this, it is expected that particles that are larger than dimers may be presented and will 
therefore result in a second population when reporting on the basis of intensity. In this work, two 
populations were observed for non-agitated BSA solution (Figure 3-7). The local maxima observed at 
7.8 nm (± 0.58 nm) corresponds to the average hydrodynamic diameter of BSA monomer and dimer 
as has been previously shown elsewhere (Jachimska et al., 2008, Folta-Stogniew and Williams, 1999). 
The second population identified at 40.55 nm (± 4.8 nm) may be ascribed to oligomers, aggregates or 
unfolded proteins (Folta-Stogniew and Williams, 1999). From these recorded positions, based on Eqn. 
3-5, the proportion (number) of this population can be estimated. In this instance, as R1 is 7.8 and R2 
is 40.55 then 
𝑉2
𝑉1
= (
40.55
6.19
)
3
= 281 BSA molecules. In volume weighted presentations, a single 
population centred ≈8 nm was observed. As this sample was freshly prepared, the size of aggregates 
observed ≈ 40 nm in intensity weighted presentation is insignificant. Furthermore, it also shows that 
the size of these aggregates is > 103 of the total volume of mono particles. It is important to note that 
the shape and position of the 1st population did not change in time (for the 6 hours duration) as shown 
in Figure 3-9. The insignificant shifts of both populations by one or two units are an inherent variation 
in the measurements due to dynamic light scattering measurements by the equipment but not any 
pre-treatment of the BSA solution.  
For control BSA samples, the data acquired from turbidimetry analysis and ThT assay affirms the 
general conclusion that the non-stressed BSA molecules under storage of optimal conditions are able 
to retain its distinctive structure, i.e. almost no presence of aggregates or denaturated molecules 
(Figure 3-4 and Figure 3-6). The negligible and probably dynamic formation of aggregates is still 
present in this solution and does not change in time and does not lead to irreversible growing of 
aggregates 
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In contrast, after exposure to the various stress from the different agitation approaches (techniques), 
aggregation or denaturation was observed in these BSA solutions. The positional shifts, in DLS 
measurements recorded intensity and broadness of the observed population as a function of the 
duration of agitation stress is presented in Table 3-3, Table 3-5 and Table 3-6.  
From the intensity weighted presentation relating to low shear agitated BSA samples, although the 
distribution centred on 7.8 nm (± 0.58 nm) was reduced after sixty (60) minutes of agitation, the 
position of this distribution did not shift significantly over this period (Figure 3-7). However, the size 
population becomes broader as represented in Figure 3-26 (a).  
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Figure 3-26 Plot of the average particle size populations against time (shear stress or number of repeats) 
recorded with DLS for 4 mg/mL BSA solution non-agitated (a), agitated with low shear (magnetic stirring) 
(b), high shear (in hypodermic needle) (c) and mechanical vibrations (sonication)(d). The fitted error bars are 
estimated full width half maxima. 
Since the size of the protein aggregates increased from 36.9 nm to 503.9 nm (≈ 12 times increase) that 
means a decrease in mono particles and/or number of large aggregates (from 211 to 5.4 x 105 BSA 
particles). Taking into account that intensity is directly proportional to R6, then if the size of the 
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monomers were reduced, intensity weighted presentations will still show the presence of this 
population but broader (i.e. increased FWHM).  
On the basis of volume and number (Figure 3-9) weighted presentations, it was observed that only 
one population associated with hydrodynamic size of BSA was present. This size distribution reduces 
to ≈5 nm indicating the agitation process is either causing the native BSA molecule to partially unfold 
or fragment or reduce the proportion between mono and dimeric molecules to monomers.  
In intensity weighted presentation for high shear samples, 3 trends are observed (Figure 3-13). The 
position of the 2nd population initially with size ≈36 nm (in control samples) is increased to particles 
sizes ≈ 320 nm in samples exposed to 4.8 Pa and 9.6 Pa. The average size (i.e. position) and amplitude 
of this 2nd population in both samples is similar (inherent shifts). As the shear stress is increased above 
19.2 Pa, the 2nd population further splits into 2 distinct populations (2nd and 3rd population onwards); 
particle sizes ≈300 nm with amplitude of 100% and ≈1000 nm with amplitude of 33% respectively. 
What is significant in this recording is that, as the shear stress is increased (to 48 Pa), the particle sizes 
in the 2nd population reduces to ≈140 nm without any change in amplitude whiles the particle in the 
3rd population records an average of 1000 nm with varying amplitude. 
The implications of sonication have also been presented from Figure 3-19 to Figure 3-24 and Table 
3-6. Figure 3-19 indicates insignificant changes in the properties of samples agitated for up to 5 
minutes. The data shows a particle size reduction from 7.86 nm to 7.43 nm for first population and 
36.86 nm to 22.18 nm for the second population. This partially indicated initial reduction of 
aggregation of protein molecules with relatively weak interactions. It is well known that for small 
molecules, sonication process is used to accelerate dissociation between two molecules i.e. to 
separate molecules or small particles from agglomerates (or large particles) (Stathopulos et al., 2004, 
Wang et al., 2013). The obvious disadvantage with sonicating protein macromolecules is the potential 
to cause the native conformation to unfold and/or misfold, which may invariably lead aggregation. In 
samples agitated for 10 minutes and above, three distinct populations were observed. The first 
population is observed in all the samples at the average global maxima 7. 4 nm (± 0.5 nm) (average 
centroid 8.3 nm ± 0.8 nm) irrespective of the duration of agitation. However, the relative intensity 
from 100% (freshly prepared and 5 minutes agitated samples) is reduced to 18.5% (± 1.8%). The 
broadness (FWHM) of this population also increases from 2.0 nm (± 1.0 nm) to 6.2 nm (± 0.8 nm) in 
those samples sonicated for > 5 minutes. These observations may be ascribed to size reduction of the 
trimers, dimers and unfolded oligomers generally considered to have contributed to this observed 
population. Indeed it was reported that, in proteins and peptides, sonication can be used to disrupt 
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the structural integrity of proteins with molecular weight between 13.7 and 66.4 kDa (Stathopulos et 
al., 2004). 
Sonication is generally known to alter the physicochemical properties of a protein molecule due to the 
effects of the frequency of wave motion through the process of cavitation. BSA contains one free thiol 
and seventeen (17) disulphide linkages which has the potential to undergo free radical reactions 
leading to formation of a non-native protein structure. Wei et. al showed that the increased in β sheet 
formation for BSA (which is predominantly α helix protein) was due to cysteine-mediated free radical 
reactions which were induced by ultraviolet light (Wei et al., 2003). Furthermore, whiles it is accepted 
that physical shearing causes structural changes to proteins, it has been suggested that the secondary 
structure of proteins remain undisturbed under such duress (Carrion-Vazquez et al., 2000). This is 
detrimental in the sense that it enhances intermolecular interactions and sonication-induced 
aggregation.  
The deleterious effects of a high intensity sonication process such as what was used in this project has 
been well studied previously using dynamic light scattering, blue native PAGE, circular dichroism 
spectroscopy and FTIR analysis and reported in the literature with complementary observations 
(Gülseren et al., 2007). The study concluded that the surface activity (surface charge particularly at 
basic pH) of BSA increased with minute changes observed in the core structure of BSA. The implosion 
effects of cavitation consequently leads to ionization or charge transfer on the BSA molecules. The 
observations made in particle size analysis was ascribed to the reduction in the amount of free 
sulfhydryl groups in BSA (Gülseren et al., 2007). DLS analysis showed BSA particle size increased up to 
3.4 times after 90 minutes of sonication. Furthermore, blue native PAGE data indicated no significant 
increase in the oligomeric state with the proportion of free sulfhydryl groups decreased. Circular 
dichroism spectroscopy and FTIR analysis indicated changes in the secondary structure of BSA. 
The formation of unfolded or protein fragments resulting from agitation may not usually be followed 
by precipitation as has been reported elsewhere (Wiesbauer et al., 2013). The observations 
particularly relative to shaking are in part indicative of a possible nucleation and growth aggregation 
mechanism as well as the already suggested cavitation (free radical reaction, local temperature 
increases and vibrations) mechanism. 
Turbidimetry analysis of protein solution is generally used to determine the relative changes in the 
native molecule size. Similarly, in this work, a direct comparison of the absorbance at 360 nm between 
the control samples and the agitated sample showed an increase in UV-vis absorbance. This is ascribed 
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to the potential occurrence of partially unfolded BSA molecules or/and molecule 
denaturation/aggregation. During the process of agitation, at the air–liquid interface where BSA 
molecules aligns and unfold, the hydrophobic regions are exposed for charge-based interactions which 
results in the formation of bigger, non-native BSA molecules (i.e. aggregates and agglomerates). 
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Figure 3-27 Comparing the UV/Vis absorbance at 360 nm for a protein solution containing 4 mg/mL BSA 
agitated via different mechanism. Data have been fitted on a log scale (at y-axis) for clarity. 
The turbidimetry analysis for all samples studied (Figure 3-27) showed that there is an increase in 
aggregates as the agitation duration increased. In high shear samples, (shearing in syringe and 
hypodermic needle) there was up to ≈147 folds increase in absorbance whiles for low shear (magnetic 
stirring) and mechanical vibrations (sonication) samples, there was an increase ≈1.5 folds and ≈2.9 
folds respectively when compared to the control samples. Thus comparatively, the degree of 
structural changes in samples prepared by low shear or mechanical vibrations was significantly low in 
relation to those from high shear. Nevertheless, there are clear indications of aggregates in all 
samples.  
During the process of freezing (in freeze drying), the solute concentration is dramatically reduced 
resulting in the formation of clusters through the association and dissociation of aggregated 
molecules. In a supersaturated system, then these associated molecules may grow to critical sizes that 
may act as nuclei for a nucleation process. As reported earlier, some biopharmaceutical formulations 
are susceptible to aggregate via the mechanism of nucleation and growth mechanism (Philo and 
Arakawa, 2009, Auer et al., 2007).  
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Although, the sensitivity of UV-vis may be relatively low for identifying the presence of possible 
protein aggregates, a non-native BSA molecule may act as a nuclei and rapidly grow into larger 
particles. During the agitation process, stirring into the bulk solution aggregated/denaturated BSA 
particulates from the surface or entrapped bubbles of the solution may also increase nucleation sites. 
Furthermore, the mass transfer of other non-exposed material to the air-liquid interface results in the 
exposure of more molecule to this potentially denaturing environment.  
The ThT assay shows that during agitation, the emission from the high shear samples significantly 
increased (14.5 times) compared to mechanical vibrations (6.4 times) and low shear (2.1 times) (Figure 
3-28) which indicates that concentration of aggregation and/or size of the aggregates significantly 
increased for samples agitated with high shear. 
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Figure 3-28 Comparing the fluorescence emission maximum recorded for 4 mg/mL BSA solution agitated via 
different mechanism. 
For low shear, there is only 1 population of aggregates which gradually grows in size from 40 nm to 
500 nm and intensity (ratio between I3+I2 and I1 increase from 0.39 to 2.68) as shown in Figure 3-7 and 
Table 3-3. Since the stress applied is relatively weak, the aggregates are able to grow without 
disintegration into smaller size aggregates. Again the first population doesn’t disappear although 
becomes slightly wide but with approximately the same average size. 
At the same, both high shear and sonication, the aggregated particles split into 2 populations. This is 
due to very high stress produced by these methods and applied to aggregates, which leads to 
disintegration of large size particles. The difference between these 2 methods are; 
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1. The intensity (i.e. amount of aggregates) of 2nd population in shear stress experiment is higher 
than the 3rd population, whiles in the sonication experiment, the 3rd population showed a 
much higher intensity. 
2. For high shear stressed samples (in hypodermic needle) particle size of 2nd population 
systematically reduced from ≈350 nm to ≈140 nm where as in the 3rd population, the size of 
aggregated particles does not change significantly, but increased in intensity (amount of 
particles) relative to the 2nd population. 
Sonication method showed the reduction in average diameter of particle size. Sonication process 
stimulates the formation of bubbles from air/dissolved in the liquid. From the samples sonicated for 
10 minutes, it appears this duration was enough to withdraw majority of the gas bubbles from the 
small volume BSA sample solution. At this stage, the formation of bubbles led deaggregation of 
particles with sizes ≈40 nm (2nd population observed in the freshly samples, which later is reduced to 
20 nm). Although it has been suggested that the formation of interfaces (i.e. bubble formation) can 
stimulate formation of aggregates (Stathopulos et al., 2004), in this work, it results indicates some 
reduction in aggregate size (at least in the initial 5 minutes of the agitation process). 
The correlation between the three technologies used in this study shown in Figure 3-29 indicates that 
ThT assay methodology was relatively sensitive while turbidimetry measurements were the least 
sensitive.  
Control Low Shear Mechanical High Shear
0
20
40
60
80
100
 
N
o
rm
a
li
s
e
d
 t
o
 1
0
0
%
Method of Agitation
 Emax at 483 nm
 Turbidimetry at 360 nm
 (I
3
+I
2
)/I
1
 
Figure 3-29 Comparing the three technologies used to record aggregation in 4 mg/mL BSA agitated using low 
shear, high shear and mechanical approaches. The plot presented is the recorded data at the highest 
duration/shear. 
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Although less sensitive than DLS, UV/Vis spectroscopy is also a good tool to detect the presence of 
large particles perhaps with a bigger hydrodynamic radius when compared to the native molecule in 
a protein samples. 
3.6 Conclusion 
In this chapter, the effects of mechanical stresses on protein native structure was studied. The 
strongest deleterious effects of agitation on the native structure of protein was observed in samples 
subjected to high shear from mixing in hypodermic needle. This was considered a simulated real 
conditions in industry during ampoule or vial filling and during mixing in prefilled syringes for use by 
patients. For long pipe filling systems, it is important to understand the force the relative effects when 
applied to the formulation (in liquid). Very high levels of pressure can create high shear stress and 
produce protein aggregates. Reducing the length of the pipe and filling speed as well as increasing the 
diameter of the pipe are advantageous in reducing potential for aggregation/denaturation. 
Although the degree of aggregation in samples prepared by low shear agitation (magnetic stirring) is 
relatively low compared to the other agitation methods, it is essential for the manufacturer or protein 
user to know that the presence of any particles may act as a nuclei resulting in nucleation and growth 
mechanism of aggregation. This experimental setup can be a useful tool to monitor flow-induced 
protein aggregation with high reproducibility since all flow materials experience varied degrees of 
shear. 
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Chapter 4. Effects of some amino acids 
on the stability of freeze dried 
biopharmaceutical formulation 
4.1 Introduction 
Biopharmaceutical formulations are prepared following distinctive design steps to achieve the 
required dose and stability profile of the active protein molecule. Different protein molecules require 
alternative formulation approach and usually present various technical challenges. Traditionally, the 
ideal pharmaceutical route of administration has been the oral route and about 60% of all the 
pharmaceutical prescribed medications are developed for this method of administration (Thakur and 
Kashi, 2011, Thakur and Sardana, 2011). Relative to biopharmaceutical products, this route is 
disadvantaged due to physical and enzymatic degradation of the active protein (polypeptide) drug 
molecule, drug interactions with membranes and gastrointestinal barriers and potential liver 
deactivation during first pass metabolism in the liver increasing risks of toxicity and side effects.  
As such, biopharmaceutics have predominantly considered parenteral administration as an obvious 
route of administration with a vast majority of the available biopharmaceuticals administered via the 
intravenous, subcutaneous or intramuscular route. Indeed, as mentioned in Chapter 1, a majority of 
biopharmaceutical therapies is administered via the parenteral route. For the purposes of getting a 
relatively long shelf life and fast therapeutic onset, biopharmaceutics to be administered via the stated 
routes are prepared by freeze drying.   
Freeze drying is one of the most common pharmaceutical processes used for manufacturing solid 
protein pharmaceuticals (Wang, 2000a, Fox, 1995) and has been used to improve the storage stability 
of both globular and fibrous proteins. However, the process itself generates many stresses especially 
from freezing and dehydration that can destabilize the native structure of the protein molecule. The 
typical stresses produced at freezing stage are related to increased ionic strength, changed pH, phase 
separation and thawing.   
Freeze dried protein based formulations are generally amorphous cakes with a relatively high porous 
matrix. The porosity of the matrix is a highly desirable characteristic since it enhances the 
reconstitution of such formulation for quick use. The physical and biological quality of the freeze dried 
product can be assessed on a microscopic and macroscopic scale to ascertain and predict its future 
150 | P a g e  
 
properties and life span. The ideal freeze dried protein based product is observed to have a consistent 
texture, an intact matrix, creamy to white appearance and a non-reduced volume. The freeze dried 
product may be rejected if any signs of matrix collapse or shrinkage, i.e. a reduction of the final volume 
of the cake when compared to the volume of the initial frozen matrix is observed visually. Such an 
occurrence is typically ascribed to the use of non-optimal or a poor freeze drying parameters during 
the primary drying stage, poor formulation type or due to high moisture content in the final dried cake 
(Pikal and Shah, 1990). 
Although the freeze drying approach has been widely used for formulating peptide and protein based 
drugs, there is a significant effect of the process parameters on the final product itself. Furthermore, 
the various excipients selected to stabilise the product may not interact well with each other and/or 
may even compromise the stability of the protein molecule itself. Different proteins tolerate these 
stresses at various degrees. For instance, ovalbumin at neutral pH when freeze-thawed showed no 
observable denaturation (Koseki et al., 1990, Vemuri et al., 1994). In contrast, 60% loss of L-
asparaginase (10 mg/mL) activity in 50 mM sodium phosphate buffer (pH 7.4) (Izutsu et al., 1994), and 
aggregation of recombinant hemoglobin (Kerwin et al., 1998) have been recorded.  
During the freezing stage, there is a phase separation into ice and cryo concentrated solution (Padilla 
et al., 2011, Crowe et al., 2004, Padilla and Pikal, 2011). This high concentration of particulate system 
may induce aggregation and in some cases are irreversible. Even if refolding occurs, the proteins may 
not be correctly reverted to its native structure and instead will assume a partially folded or misfolded 
state for a longer period (Clark, 2001, Clark, 1998). As a result of alteration of protein structure, 
irreversible aggregation of macromolecules can also occur. Therefore, it is apparent that either protein 
structure must be stabilized to minimize aggregation or unfolded protein structures must be kept in 
soluble state. To allow for the inclusion of bulking excipients to enhance the physical stability of the 
final product, the active component (protein) may be present at a relatively low concentration 
(Abdelwahed et al., 2006b). The selection of the bulking agents is such that it may also act as a cryo 
protectant or a lyo protectant (Fu et al., 2004, Mohammed et al., 2007b, Wang, 1999, Wang, 2000a, 
Liao et al., 2004).  
Although several protectants have been developed to maintain the protein structure and function 
during freezing, it has been argued that only disaccharides protect protein from drying damages 
(Carpenter and Crowe, 1988, Carpenter and Crowe, 1989, Yancey et al., 1982, Crowe et al., 1984). The 
most widely used cryo protectants are trehalose (Chacón et al., 1999, Crowe et al., 2004, Crowe et al., 
1996, Liao et al., 2002, Carpenter et al., 1986, Crowe et al., 1984), sucrose (Abdelwahed et al., 2006a, 
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Liao et al., 2002, Carpenter et al., 1986), lactose and mannitol (Townsend and Deluca, 1988, Crowe et 
al., 1987). Their ability to supress aggregation has in part been attributed to preferential exclusions 
and formation of weak, nonspecific bonds (Xie and Timasheff, 1997b, Xie and Timasheff, 1997a). 
Townsend et al. (1998) proposed that lyo protectants formed a rich water source environment around 
the protein molecule because during the freeze drying process, the protein configuration is altered 
resulting from the loss of bridging water in the molecule (Townsend and Deluca, 1988). Similarly, it 
has also been proposed that, during the freezing stage of freeze drying, cryo protectants replaces the 
dehydrated water molecules by forming hydrogen bonds with the amine in protein molecules and 
thereby helping to retain the native state of proteins (Ashwood-Smith, 1987, Vemuri et al., 1994, 
Anchordoguy et al., 1987, Allison et al., 1999).  
From the literature, trehalose seems to be a preferable cryo protectant potentially due to its less 
hygroscopicity when compared to inverted sugars (e.g. fructose and glucose). It also lacks internal 
hydrogen bonds which allows for the flexible formation of hydrogen bonds with proteins during 
freeze-drying and has a higher Tg′ (-28.5 ˚C) (Crowe et al., 1996, Crowe et al., 1992). However, the 
degree of protection is dependent on their concentrations in the formulation. 
Previous studies have proposed the use of combinations of amino acids with other excipients or alone 
to stabilise the protein structure through mechanisms associated with cryo and lyo protection e.g. 
preferential exclusion (Jensen et al., 1996) or reduce proteins chemical degradations (Kanazawa et al., 
1994) but mostly in solutions (Hamada et al., 2009, Ain-ai, 2009). Studies has shown the individual 
inclusion of lysine hydrochloride, glycine, sodium aspartate, glutamate and histidine in a protein 
formulation of rhKGF in 10 mM potassium phosphate buffer (pH 7.0) and 5% mannitol at 45 °C 
inhibited the aggregation process to various degrees (Zhang et al., 1995). In a separate study, the 
presence of sodium aspartate or lysine hydrochloride significantly improved the stability of mL-PEPC 
incubated at 40 °C (Jensen et al., 1996). Furthermore, Kanazewa et al. (1994) showed that 2.5 mM of 
histidine completely inhibit the oxidation-induced inactivation of papain by ascorbate/Cu(II)/O2 
system. It was inferred that this was achieved possibly through the formation of a Copper - Histidine 
complex (Kanazawa et al., 1994). A study of 15 amino acids tested, showed that l-arginine 
hydrochloride exhibited the best results in preventing the formation of aggregates (Shiraki et al., 2002, 
Das et al., 2007). The interaction of arginine hydrochloride and multivalent counter ions increases the 
hydrogen bonding network for proteins when frozen or freeze-dried which reduces the mobility of 
molecules and hence stabilizes the proteins (Izutsu et al., 2005). 
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Although promising as a protein stabiliser in solutions, arginine hydrochloride has a poor hygroscopic 
(Chan et al., 2005) characteristics and has therefore precluded its use in freeze dried protein 
formulations. Furthermore, in the presence of trehalose, the stabilising properties may be inhibited. 
However, mannitol which is used widely as a cryo protector in freeze dried protein formulations have 
shown good ability to resist moisture uptake. There are many reservations though on the use of 
mannitol because it may crystallize to different polymorphic forms. The release of water from the 
hemihydrate form (Mehta et al., 2013) of freeze dried mannitol during storage may cause degradation 
of moisture sensitive drug product. In the presence of protein, it has been shown that the protein 
promoted formation of δ mannitol while preventing the formation of mannitol hemihydrate (Liao et 
al., 2007).  
So far, fewer studies have been done on the feasibility of using a combination of amino acid and 
cryo/lyo protectant to maintain the stability of protein formulations which are initially freeze dried 
but intended for reconstitution before use. Indeed, amino acids have been used extensively in the 
pharmaceutical manufacturing industry as  disintegrants  (Fukami et al., 2006), bulking agent (Akers 
et al., 1995, Akers et al., 1994, Joyce and Witchey-Lakshmanan, 2013, AlHusban et al., 2010), lubricants 
in oral tablets (Rotthauser et al., 1998, AlHusban et al., 2010) and as cryo protectants in some freeze-
dried formulation (Mohammed et al., 2007b, AlHusban et al., 2010).  
Amino acids are biological molecules characterised by a common backbone of an amine and carboxyl 
terminal attached to a central carbon atom. There are 20 various types of essential amino acids. This 
variety originates from the different side R groups being attached to a central carbon atom. The 
physicochemical characteristics of the amino acid are dependent on the side chain and specific for 
each amino acid. Four different groups are attached to the α carbon as shown in Figure 1-1. As a result, 
α carbon is a chiral carbon atom except in the case of the simplest amino acid, glycine. Therefore, all 
amino acids except glycine occur in two various stereoisomers, the L and D form. However, during 
translation in the ribosome (Lubec and Rosenthal, 1990), only the L- form is present in natural proteins 
(Figure 1-1). 
Amino acids are crystalline solids with high range of melting temperatures from ≈200 °C to 300 °C 
(Rodante and Marrosu, 1990, Rodante et al., 1992, Grunenberg et al., 1984, Patil and Muskan, 2009). 
This is because the dominant interaction within individual molecules is ionic rather than hydrogen 
bonds and other intermolecular interactions.  
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In this section, two of the essential amino acids will be considered; l-arginine and l-lysine. These two 
amino acids were chosen because they are most prominent amino acids used as a protectant against 
protein aggregation in solutions. Both of them are water soluble and share some similarities in their 
physicochemical characters (Table 4-1). 
Table 4-1 summarises some similarities and differences between the physicochemical characters of L-arginine 
and L-lysine. Data was adapted from (Kyte and Doolittle, 1982, Ager, 2007). 
Physicochemical 
Property 
L- Arginine HCl L-Lysine HCl 
Side Chain (R- group) 
 
 
Polarity of side chain Polar Polar 
Relative deprotonation 
to each other  
Hard to deprotonate because it has a 
positive charge delocalised over the 
guanidine group 
Low to deprotonate because its 
positive charge is delocalised at 
the Epsilon amino group 
Relative stability to each 
other  
Stable than lysine due to deprotonation 
properties and high pKa (12.48) 
Less stable than arginine due to 
deprotonation properties and 
low pKa (10.53) 
Charge on R- group at 
pH 7.4 
Positive charge Positive charge 
Isoelectric point (pI)  10.76 9.74 
Hydrophobicity11 -4.5 -3.9 
 
  
                                                          
11 Refers to the relative hydrophobic nature of an amino acid residue. A highly positive hydrophobic index 
indicates a more hydrophobic amino acid at the region of the protein.  
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4.2 Aim 
The aim of this section is to study how L-arginine hydrochloride and L-lysine hydrochloride can protect 
the native structure of model protein (bovine serum albumin) in freeze-dried protein based 
pharmaceutical formulation to improve its stability. In the first stage of this study the optimal 
composition of 2 or 3 excipients systems as freeze-dried cakes will be developed.  In the second stage 
the protein will be added to the selected formulations, then freeze-dried and protein aggregation will 
be assessed after reconstitution. 
4.3 Objectives and Chapter overview  
Objectives: 
 Develop and characterize two-excipient freeze dried formulations comprising an amino acid 
(ArgHCl or LysHCl) and a sugar or polyol) at different ratios to understand the moisture 
resistance, mechanical and thermal properties of amino acids in combination with different 
excipients.   
 Develop and characterize three-excipient freeze dried formulations containing an amino acid 
(ArgHCl or LysHCl), selected disaccharide (trehalose) and polyol (mannitol) produced with 
different proportions of excipients to select the best composition according to their 
physicochemical properties. 
 Produce and characterise a final four-excipient freeze dried formulations comprising of a 
model protein (BSA), and the best 3-component systems selected for manufacture of the 
protein-based formulation.  
 Measure the degree of BSA aggregation in reconstituted BSA based freeze dried cakes using 
UV-Vis and fluorescence spectroscopies (relative quantitative or qualitative characterization). 
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Chapter overview  
The overview of this chapter is summarised schematically in diagram presented in Figure 4-2. 
 
 
Figure 4-1 Graphical representation of the objectives and systematic approach to accomplishing the aims of 
this chapter.  
Freeze‐dried 2‐component systems:  Arg/Lys + Mann 
Arg/Lys + Treh 
Arg/Lys + Sucr Cake 
characterisation: 
  Visual appearance 
   Texture Analysis 
  Selection of excipient with the best moisture resistance   
Mannitol (Good moisture resistor and cryo protector but poor lyo protector) 
Selection of 2nd excipient (poly sugar) with good lyo protection 
properties 
  Freeze‐dried 3‐component 
systems: 
Arg/Lys + Mann + Treh 
Arg/Lys + Mann + Sucr 
Cake characterisation 
Visual 
Texture Analysis 
Internal structure 
(SEM) 
Moisture sorption 
Cake shrinkage 
Moisture sorption over 
time 
TGA 
Optimal excipient compositions 
BSA + Arg/Lys + (Mann + Treh)  Freeze‐dried 4‐component systems:  
BSA + (Mann + Treh) 
Protein aggregation: Absorbance at 360 nm, ThT fluorescence  
Moisture sorption: 
   Gravimetry 
       TGA 
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4.4 Experimental Work 
4.4.1 Materials 
Bovine serum albumin (BSA), L-arginine hydrochloride (ArgHCl), L-lysine hydrochloride (LysHCl), 
trehalose dihydrate, lactose monohydrate and D-mannitol were purchased from Sigma-Aldrich Co, 
Dorset, UK. The Tris buffer salt (ACS reagent grade) was purchased from Sigma-Aldrich Co, Dorset, UK. 
Polycrystalline sucrose was obtained from Fluka. Unless otherwise specified, all materials and 
reagents used were of analytical grade. All materials were used for analysis without any further 
purification. 
4.4.2 Methods 
4.4.2.1 Buffer preparations 
Tris buffer with molarity of 15 mM and pH 6.8 was prepared by dissolving 2.423 g of Tris base in 850 mL 
of double distilled water. The solution was stirred continuously for up to 15 mins using a magnetic 
stirrer (130 rpm). The pH of the solution was adjusted by the drop wise inclusion of 1 M and/or 0.1 M 
hydrochloric acid (HCl) and the buffer was made 1 L using double distilled water. The pH of buffer 
solution was recorded with a Thermo-Scientific Orion semi micro electrode connected to a Mettler 
Toledo MP 220 pH meter calibrated with standard buffers (Fisher Scientific) of pH 4, 7, and 12.  
4.4.2.2 Solution preparation 
4.4.2.2.1 The 2-component excipient systems  
Mannitol and sugar  
Individual stock solutions of lactose, sucrose, trehalose and mannitol, each with the concentration of 
0.1 mg/mL were prepared with Tris buffer (15 mM and pH 6.8) and mixed according to the ratio 
presented in Table 4-2. Samples were freeze-dried using the freeze drying protocol described in Table 
4-7 and Figure 4-2. 
  
157 | P a g e  
 
Table 4-2 The volume of each component used to achieve the required ratios of sugar-mannitol for 
compatibility studies.    
Excipient 1 
 
Sugar / 
Mannitol Ratio 
Stock 
solution 
(mg/mL) 
Vol. (1) / mL Excipient 2 
Stock solution 
(mg/mL) 
Vol. (2) 
/ mL 
Lactose 30:70 0.1 0.6 Mannitol 0.1 1.4 
Lactose 50:50 0.1 1.0 Mannitol 0.1 1.0 
Lactose 70:30 0.1 1.4 Mannitol 0.1 0.6 
Lactose 100:0 0.1 2.0 Mannitol 0.1 0.0 
Sucrose 30:70 0.1 0.6 Mannitol 0.1 1.4 
Sucrose 50:50 0.1 1.0 Mannitol 0.1 1.0 
Sucrose 70:30 0.1 1.4 Mannitol 0.1 0.6 
Sucrose 100:0 0.1 2.0 Mannitol 0.1 0.0 
Trehalose 30:70 0.1 0.6 Mannitol 0.1 1.4 
Trehalose 50:50 0.1 1.0 Mannitol 0.1 1.0 
Trehalose 70:30 0.1 1.4 Mannitol 0.1 0.6 
Trehalose 100:0 0.1 2.0 Mannitol 0.1 0.0 
  0.1  Mannitol 0.1 2.0 
 
Amino acid and saccharide 
A two component excipient systems made up of amino acid and disaccharide were formulated.  As 
mentioned earlier, ArgHCl and LysHCl have strong hygroscopic characteristics and have therefore 
precluded its use in freeze dried protein powders. In this section, 2 component formulations 
containing ArgHCl or LysHCl and one of the following excipients (mannitol, trehalose, sucrose or 
lactose)  were prepared as solutions with different proportions between excipients (i.e. amino acid 
content was 10, 20 and 40%). Then solutions were freeze dried and cakes were characterised relative 
to its moisture sorption, mechanical properties and general appearance.  
The stock solutions of the ArgHCl, LysHCl, lactose, sucrose, trehalose and mannitol were prepared 
separately with concentration of 0.1 mg/mL. The solutions were combined as shown in Table 4-3 to 
make a total volume of 2 mL per each vial with 0.2 g total solid content. Samples were freeze-dried 
using the freeze drying protocol described in Table 4-7 and Figure 4-2.  
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Table 4-3 2-component samples preparation for a combination of amino acid (ArgHCl or LysHCl) and 
saccharide (polyol or sugar). Concentration of all stock solutions 0.1 mg/mL.  
Formulation % Ratio Solid content (g) Total Solid (g) Volume per vial (mL)  
ArgHCl or 
LysHCl : 
Polyol or 
Sugar 
ArgHCl 
or 
LysHCl 
Polyol 
or 
Sugar 
ArgHCl or 
LysHCl per 
vial 
Polyol 
or 
Sugar 
per vial 
Total Solid 
per vial 
ArgHCl 
or LysHCl 
per vial 
Polyol or 
Sugar per 
vial 
Total 
Solution 
in vial 
(mL) 
0/100 0 100 0 0.2 0.2 0 2 2 
10/90 10 90 0.02 0.18 0.2 0.2 1.8 2 
20/80 20 80 0.04 0.16 0.2 0.4 1.6 2 
40/60 40 60 0.08 0.12 0.2 0.8 1.2 2 
100/0 100 0 0.2 0 0.2 2 0 2 
 
4.4.2.2.2 The 3-component excipient systems 
The three component excipients systems including ArgHCl or LysHCl (20% wt.), mannitol and either 
trehalose or sucrose were prepared and freeze dried according to Table 4-7 and Figure 4-2. Separate 
stock solutions of LysHCl, ArgHCl, mannitol, sucrose and trehalose were prepared using 15 mM Tris 
buffer pH 6.8. For ArgHCl or LysHCl stock solution concentration was 0.04 g/mL whiles for polyol and 
sugars, the concentration of the stock solution was 0.16 g/mL. The total volume required for each 
component is presented in Table 4-4. Samples were freeze-dried using the freeze drying protocol 
described in Table 4-7 and Figure 4-2. 
Table 4-4 Summary of sample preparation for a combination of ArgHCl or LysHCl, Sugar and Mannitol. 
Formulation Solid per vial (g) Volume per vial (mL) 
 
20% ArgHCl or 
LysHCl and 80% 
Sugar/ 
Mannitol 
ArgHCl 
or 
 LysHCl 
Sugar 
Mannit
ol 
ArgHCl 
or 
LysHCl 
Sugar Mannitol 
Total 
Volume 
Notation 
(e.g. 
Sucrose) 
20 + 80 (0 + 100) 0.04 0 0.16 1 0 1 2 S0 
20 + 80 (20 + 80) 0.04 0.032 0.128 1 0.2 0.8 2 S20 
20 + 80 (30 + 70) 0.04 0.048 0.112 1 0.3 0.7 2 S30 
20 + 80 (40 + 60) 0.04 0.064 0.096 1 0.4 0.6 2 S40 
20 + 80 (50 + 50) 0.04 0.08 0.08 1 0.5 0.5 2 S50 
20 + 80 (60 + 40) 0.04 0.096 0.064 1 0.6 0.4 2 S60 
20 + 80 (70 + 30) 0.04 0.112 0.048 1 0.7 0.3 2 S70 
20 + 80 (80 + 20) 0.04 0.128 0.032 1 0.8 0.2 2 S80 
20 + 80 (100 + 0) 0.04 0.16 0 1 1 0 2 S100 
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4.4.2.2.3 The 4-component protein-based formulations 
Two sets of four component systems including protein and excipients were prepared and freeze 
dried; then a comparative analysis was performed to study the effect of amino acid on stability of 
protein. Set 1 included amino acid and comprised of BSA (50% wt.), ArgHCl or LysHCl (10% wt.), and a 
combination of mannitol with trehalose or sucrose (40% wt.). Set 2 did not include amino acid and 
was made up of BSA (55% wt.), and 45% wt. of a combination of mannitol and trehalose or sucrose.  
Stock solutions of 0.1 g/mL BSA, 0.1 g/mL ArgHCl, 0.1 g/mL LysHCl, 0.16 g/mL trehalose, and 0.16 g/mL 
mannitol were prepared separately. All solutions were prepared using 15 mM Tris buffer pH 6. The 
volumes required to prepare Set 1 and 2 are presented in Table 4-5 and Table 4-6 respectively. The 
two sets were freeze dried according to Table 4-7 and Figure 4-2. 
Table 4-5 Summary of SET 1 sample preparation for a four component protein and excipient formulation. 
Set 1   With ArgHCl or LysHCl                                               50% BSA + 10% Lysine + 40% Excipients(T/M) 
 Solid, g Volume, ml  
Sugar/M 
Ratio 
BSA 
ArgHCl/ 
LysHCl 
Sugar 
Mann
itol 
BSA 
ArgHCl/ 
LysHCl 
Tre 
Mann
itol 
Buffer 
Name 
(e.g.Treh) 
30/70 0.1 0.02 0.024 0.056 1 0.2 0.15 0.35 0.3 T20+ 
40/60 0.1 0.02 0.032 0.048 1 0.2 0.2 0.3 0.3 T40+ 
50/50 0.1 0.02 0.04 0.04 1 0.2 0.25 0.25 0.3 T50+ 
60/40 0.1 0.02 0.048 0.032 1 0.2 0.3 0.2 0.3 T60+ 
80/20 0.1 0.02 0.064 0.016 1 0.2 0.4 0.1 0.3 T80+ 
 
Table 4-6 Summary of SET 2 sample preparation for a four component protein and excipient formulation. 
Set 2   Without ArgHCl or LysHCl                                               55.6% BSA + 44.4% Excipients(T/M) 
 Solid, g Volume, mL   
Sugar/M 
Ratio 
BSA Sugar 
Mannit
ol 
BSA Tre 
Mannit
ol 
Buffer 
Name 
(e.g.Treh) 
30/70 0.111 0.027 0.062 1.112 0.167 0.389 0.333 T20- 
40/60 0.111 0.036 0.053 1.112 0.222 0.333 0.333 T40- 
50/50 0.111 0.044 0.044 1.112 0.278 0.278 0.333 T50- 
60/40 0.111 0.053 0.036 1.112 0.333 0.222 0.333 T60- 
80/20 0.111 0.071 0.018 1.112 0.444 0.111 0.333 T80- 
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4.4.2.3 Freeze drying cycle 
The sample solutions (Table 4-5, Table 4-6 and Table 4-7) were freeze dried in a GEA LyoSMART freeze 
dryer using a 10 mL clear glass vials (Schott). The vials were filled with 2 mL (10 % wt. solution i.e. 0.2 
g per vial total solids weight) of the appropriate solutions and freeze dried using cycle developed on a 
GEA LyoSMART freeze dryer (Table 4-7 and Figure 4-2).  
Table 4-7 The optimised freeze drying protocol using GEA LyoSMART freeze dryer. 
Step Temperature 
(°C) 
Duration 
(hours) 
Pressure 
(mBar) 
Stage Stage 
0 +20 1 1000 Hold Hold to equilibrate solutions. 
I −38 1 1000 Ramp Ramp  to freezing temperature 
II −38 15 1000 Hold Freezing  
III −35 1 0.1 Ramp Ramp to primary drying temp and pressure 
IV −35 40 0.1 Hold Primary drying 
V +20 6 0.1 Ramp Ramp  to secondary  drying temp 
VI +20 10 0.1 Hold Secondary  drying  
A plot of the freeze drying protocols including timelines, temperature and pressure changes is 
presented graphically in Figure 4-2. 
 
Figure 4-2 Graphical representation of the optimised freeze drying protocol using GEA LyoSMART freeze dryer. 
The loaded vials were arranged in a close hexagonal packing profile in the centre of the shelf to reduce 
the impact of radiation from the walls of instrument. Upon completion of each cycle, the vials were 
stoppered under vacuum and either used immediately or crimped with aluminium seals and stored in 
a desiccator with specified (low %RH) conditions.  
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4.4.2.4 Visual characterisation of the freeze dried cake 
Freshly prepared cakes were visually inspected relative to their physical appearance of the entire cake 
before any other analysis. This characterisation considered cake shrinkage, matrix collapse, colour and 
visible cracks.   
4.4.2.5 Morphology of the freeze dried cake 
The internal structures of the freeze dried cakes, at different magnifications (0.5k, 1k, 2k and 5k), were 
visualized using a Carl Zeiss EVO HD scanning electron microscope (Cambridge, UK). Powder samples 
were mounted on 12.5 SEM pin metal stubs using 12 mm carbon tabs (Agar scientific). Preliminary, all 
materials were gold plated to avoid a surface charging by electron beam. 
4.4.2.6 Shrinkage studies of pre-incubated freeze dried cakes 
The freeze dried cakes were incubated at 75% RH and room temperature (≈23 °C). At defined time 
intervals (up to seven days), the bottom of the vials containing the cake was scanned by a conventional 
flat-bed scanner set to 300 dpi resolution and the diameter of the solid phase within the vial was 
measured repeatedly (on the image) and average value was calculated. It should be noted that, these 
estimates are relative, they do not account for the density of the freeze dried cake nor the state (i.e. 
viscous liquid or solid mass). 
All estimates of diameter were normalised to the diameter of a freshly freeze dried cake of the same 
formulation in order to calculate a shrinkage parameter (whereby 100% represents no shrinkage). 
4.4.2.7 Moisture sorption studies 
Freeze-dried samples were placed in open aluminium foil boats and incubated at specific 
temperatures and relative humidities (RH). The specified values (75% or 97%) RH were achieved by 
selecting the appropriate salt as presented in Table 2-10. Then the foil boats with samples were placed 
in oven at 80 ˚C for specified time. Then the foil boats with samples were placed in oven at 80oC until 
they were dry. The weights of the samples were measured gravimetrically over time and the moisture 
uptake was calculated using Eqn. 4-1. 
 
% 𝑀𝑜𝑖𝑠𝑡𝑢𝑟𝑒 𝑐𝑜𝑛𝑡𝑒𝑛𝑡 =  
𝑊𝑚 − 𝑊𝑑
𝑊𝑑
∗ 100 Eqn. 4-1 
where Wm and Wd are the weights of the moist and dry powders, respectively. 
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4.4.2.8 Thermal characterisation of the freeze dried cakes 
The residual moisture content and moisture content after storage was estimated using 
thermogravimetric analysis (TGA). Sample with weight between 5 and 15 mg was loaded into a TGA 
aluminium pan (without holes in the lid) and hermetically sealed. The samples were loaded into the 
crucible and the aluminium pan was manually pierced immediately before the measurements to help 
escape of trapped gas during heat application. The sample was heated from 25 °C to 300 °C at a heating 
rate of 10 °C/min under nitrogen atmosphere using Pyris TGA (Perkin Elmer, Wellessey, USA) 
equipment to monitor the decreasing sample weight. The moisture content was estimated using Eqn. 
4-2. 
 
% 𝑀𝑜𝑖𝑠𝑡𝑢𝑟𝑒 𝑐𝑜𝑛𝑡𝑒𝑛𝑡 =  
𝑊1 − 𝑊2
𝑊2
∗ 100 Eqn. 4-2 
where W1 is the initial weight of sample and W2 is the weight of sample after moisture evaporation. 
The onset and end temperatures for moisture evaporation were determined using the Pyris software. 
4.4.2.9 Mechanical properties of the cake 
TA (compression mode, “hold until time” program) was used to evaluate the mechanical properties of 
the freeze dried cakes directly in glass vials. Freshly opened vials were placed on the texture analyser 
(TA.XT PLUS; Stable Micro Systems, Surrey, UK) and a stainless steel cylindrical P/6 probe was used to 
penetrate the cake to a depth of 3 mm (Figure 4-3). 
   
a    b 
Figure 4-3 (a) A general diagram of a TA probe set up to penetrate a freeze dried cake as was done in this 
experiment. (b) Schematic presentation of the “stress vs. time” plot recorded during compression by the 
probe step and the hold on step. Image was adapted from (Hackl and Ermolina, 2016). 
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After compression step the probe was held at the 3 mm depth position for 20 s (“hold on” step) and 
force relaxation (the decrease in force) was measured during next 20 s (“hold time”). The equipment 
was calibrated with 100 g standard weights. The following experimental parameters were used: pre-
test speed 1 mm/sec, test speed 0.1 mm/sec, depth of probe penetration 3 mm, and a trigger force 
0.2 g. A typical stress vs. time curve indicating the compression effects and hold on step is presented 
in (Figure 4-3). 
Stress values were calculated from Eqn. 4-3.  
 
𝑆 =  
𝐹𝑚
𝐴
 Eqn. 4-3 
where S is stress (g/cm2), Fm is the force (g) and A is the probe area (20.27 cm2).  
Stress relaxation (springiness) was then calculated as the ratio between the force at the beginning and 
end of the hold time with the probe held at the 3 mm depth. 
4.4.2.10 Differential scanning calorimetry 
Differential scanning calorimetry (DSC) measurements were carried out using a Perkin–Elmer Jade DSC 
(USA). Sample with weight between 5 and 10 mg was placed into an aluminium DSC pan and crimped 
with vented lids. DSC thermogram was recorded for samples heated from -60 °C to 315 °C at 20 °C/min 
and then cooled down to ≈ 0 °C, again at 20  °C/min.  
 
4.4.3 Protein Aggregation studies 
4.4.3.1 Incubation and Concentration measurements 
The freshly prepared samples were divided into two portions; one portion was incubated at 25 ˚C and 
75 % RH for 24 hours while the other half was also incubated at 45 ˚C and 75 % RH for 24 hours. After 
incubation, approximately half of the content (≈0.1 g) of each vial was reconstituted in ≈2 mL 
individually using double distilled water. The concentration of each vial was ascertained using UV/Vis 
spectrophotometry following the method described in Chapter 2 and adjusted to the sample with the 
lowest concentration to avoid the effects of concentration variations reported in Chapter 2. 
164 | P a g e  
 
4.4.3.2 Turbidimetry measurements of reconstituted 4 component excipient formulation 
The UV/Vis spectrum for the reconstituted solutions containing 50% wt. BSA, 10% wt. ArgHCl or LysHCl 
and 40% wt. trehalose and mannitol varying proportions was recorded between the wavelengths of 
250 nm and 400 nm. Data was acquired using a Thermo-Scientific UV/Vis Evolution 60S 
spectrophotometer at room temperature (25 °C). In all measurements, quartz cuvettes with path 
length of 1 cm were used for measurements.  
4.4.3.3 ThT Assay of reconstituted 4 component excipient formulation 
Fluorescence spectroscopy was used to measure the ThT emission when bound to protein 
amyloids/aggregates. Individual samples were placed into a cuvette and measured with excitation 
(445 nm); excitation slit (5.0 nm), emission slit (5.0 nm) and scan speed (100 nm/minute) and the 
emission recorded between 455 nm and 600 nm. To each sample, 20 μL of ThT.  
4.5 Results, Discussions and Concluding Remarks 
4.5.1 Two (2) Component formulation - Assessing sugar-polyol compatibility 
4.5.1.1 Visual Characterisation 
Visual observation indicated that, the freeze dried cakes comprising of sugar and mannitol showed 
acceptable cake characteristics as presented in (Figure 4-4). The initial criteria of acceptance were 
appearance, colour, intact cake matrix, no shrinkage or collapse. 
    
0:100    30:70   50:50   70:30   100:0      30:70   50:50   70:30   100:0      30:70   50:50   70:30   100:0      
    
Mannitol Lactose/Mannitol Sucrose/Mannitol Trehalose/Mannitol 
Figure 4-4 Images (top) and scans (bottom) of the freeze dried cakes containing different ratios of mannitol 
and sugar (decreasing from left to right). 
In this study, the visual inspection also has shown that cakes have a highly porous structure with a 
spongy like appearance. However, the texture of the cakes was slightly dependent on the individual 
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characteristics and proportion of the sugar incorporated. Furthermore, all the freshly prepared cakes 
showed no shrinkage, had the required white colour appearance, no cracks and well defined matrix.  
 
4.5.1.2 Moisture Content/Uptake 
The variations in moisture content of a freshly prepared freeze dried cake and after incubation at 75% 
RH can give an indication of the stability profile of the cake during storage. Combination excipients 
with high affinity for moisture will invariably collapse or devitrify and further lead to aggregation.   
The residual moisture in dry cakes and total moisture after incubation are presented in Table 4-8. In 
all samples, as the concentration of the sugar content increased, the moisture content also increased. 
Sample containing mannitol alone indicated the lowest moisture uptake after 7 days whiles sucrose 
samples accumulated the highest moisture.  
Table 4-8 Estimated moisture content in freeze dried cake incubated at 75% RH and room temperature for 
7 days. 
Sample Name Residual Moisture / % Measured Moisture / % 
Lactose 100% 3.92 6.23 
Lactose 70% 2.14 5.02 
Lactose 50% 2.76 3.58 
Lactose 30% 3.39 2.31 
Lactose 0% (Mannitol 100 %) 0.14 0.54 
Sucrose 100% 1.09 16.10 
Sucrose 70% 1.27 9.04 
Sucrose 50% 3.36 13.10 
Sucrose 30% 4.43 8.61 
Sucrose 0% (Mannitol 100 %) 0.14 0.54 
Trehalose 100 % 3.06 10.70 
Trehalose 70 % 2.10 5.63 
Trehalose 50 % 3.82 6.02 
Trehalose 30 % 2.27 4.05 
Trehalose 0% (Mannitol 100 %) 0.14 0.54 
A plot of the measured moisture content against the concentration of sugar in the freeze dried cake 
incubated at 75% RH for 7 days is presented in Figure 4-5.  
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Figure 4-5 Comparing the estimated moisture content in freshly prepared freeze dried cake and after 
incubation at 75% RH and room temperature for 7 days. (n=3x3) 
 
4.5.1.3 Cake Shrinkage 
Cake shrinkage studies was used to predict the potential for future moisture uptake and collapse. Two 
dimensional images of the freeze dried cake are presented in Figure 4-7 as a function of time. 
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Sample Name 0 hr  1 hr 4 hrs 7 hrs 24 hrs 168 hrs 
Lactose 100% 
      
Lactose 70 % 
      
Lactose 50 % 
      
Lactose 30 % 
      
Lactose 0% 
(Mannitol 100%) 
      
Sucrose 100% 
      
Sucrose 70% 
      
Sucrose 50 % 
      
Sucrose 30 % 
      
Sucrose 0% 
(Mannitol 100%) 
      
Trehalose 100% 
      
Trehalose 70 % 
      
Trehalose 50 % 
      
Trehalose 30 % 
      
Trehalose 0% 
(Mannitol 100%) 
 
     
 
Figure 4-6 Scans of the bottom of the different freeze dried sugar/mannitol compositions incubated at 75% RH 
for up to 7 days. 
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Generally, in mannitol only, no shrinkage was observed during the 7 days period of incubation. Similar 
observations were also made in cakes containing 30% lactose and 30% trehalose during the incubation 
period. . In cake with 30% sucrose, the shrinkage started at 7 hours.  As the percentage of sugar 
increases the shrinkage started earlier. For example in 100% and 70% sugar samples, the collapse of 
cake was explicit at 4 hours.   
In Figure 4-8 the relative reduction in diameter (i.e. normalised by diameter of non-shrunk mannitol 
cake) are presented for all 3 combinations of excipients.  Within four hours, there is a sudden drop in 
the relative shrinkage diameter in samples containing 70% and 100% lactose (Figure 4-6 and Figure 4-
8). There is no further shrinkage observed until completion of this study. In comparison to 30% and 
50% lactose, minimum shrinkage was observed during the study period.   
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Figure 4-7 Relative diameter of the varied combinations of freeze dried sugar/ mannitol stored at 75% RH for 
up to 7 days.  
Similar observations were made in samples containing trehalose. Freeze dried cakes of 100% trehalose 
showed a micro collapse within the first hour and a maximum shrinkage between 4 and 7 hours (Figure 
4-6). However, in 30%, 50% and 70% trehalose, the inclusion of mannitol seems to have reduced the 
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rate at which collapse occurs and extend of shrinkage possibly with just micro collapse occurring. This 
therefore makes these three concentrations a better candidate for further studies.   
The most intensive collapse was observed in samples containing 100% and 70% sucrose with micro 
collapse revealed within the initial 4 hours and an explicit collapse after 7 hours of the study (Figure 
4-6). Moreover the 100% sucrose was converted to a viscous liquid after 24 hours of incubation. The 
diameter of cake containing 70% sucrose was gradually reduced within 7 hours and then no changes 
were observed. In samples containing 50% and 30% sucrose, the shrinkage occurs to lesser extend 
and slightly later (after 4 h of exposure to 75% RH). The presence of mannitol could not compensate 
the strong moisture sorption properties of sucrose.   
4.5.1.4 Mechanical Properties 
Using Texture Analysis, the mechanical properties of the freshly freeze-dried cakes were studied by 
measuring their resistance to penetration of a cylindrical probe into cake and stress relaxation at 3 mm 
penetration depth. The experimental procedure and parameters are described in Experimental work 
chapter. The experimental results (TA force profiles) are presented in Figure 4-8 from which the 
maximum force during cake penetration was estimated (see Figure 4-10). Based on the recorded 
maximum force which is a direct indication of the hardness of the cake, the stress values were 
estimated using Eqn. 4-3 and a plot against the % wt. sugar concentration presented in Figure 4-10.  
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Figure 4-8 Force vs. time profiles of the 2-excipient freeze-dried cakes consisting of varying proportions of 
sugar and mannitol recorded by Texture Analysis. Also presented are cakes comprised of the pure materials 
(1-component systems).   
The textural analysis data (Table 4-9) shows that generally, all samples containing only sugars recorded 
the highest penetration force (150 g – 242 g). The inclusion of mannitol is observed to reduce the 
maximum penetration forces with the minimum value (48 g) obtained for pure mannitol cake (as 
shown in Figure 4-9). It is well known that freeze-dried mannitol is usually in crystalline state (Ohrem 
et al., 2014, Yoshinari et al., 2002), except through the use of specific freeze-drying cycle, when the 
unstable hemi-crystalline state of mannitol can be achieved (Startzel et al., 2016). In our study the 
crystalline state of mannitol was confirmed in DSC experiment (Section 4.5.2). Although mannitol is in 
crystalline state, the cake is very porous and consists of poor contacting crystals and therefore 
mechanically is not strong. In contrast the freeze dried sugars (trehalose, lactose and sucrose) are in 
amorphous state and molecules have relatively strong interactions to demonstrate the stronger 
mechanical properties. Indeed, pure freeze-fried sucrose has shown the strongest mechanical 
properties. The stress vs composition profiles for lactose and trehalose are quite similar (Figure 4-10).    
The major observation is the non-monotonic behaviour in force as a function of composition. This 
non-monotonicity was observed at about 50 - 70% of sugar in 2-component systems. Similar non-
monotonic effect was observed in these cakes in experiment for moisture uptake presented above 
(Figure 4-5). The good correlation in results obtained by 2 methods shows that mixture of the 
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excipients can give a synergetic or antagonistic effect and should be studied at the pre-formulation 
stage of the formulation development.     
Table 4-9 Maximum force required to penetrate 3 mm depth of freeze dried mannitol: sugar with different 
ratios.  
Sample ID Maximum Force / (g) 
Lactose 100% 183.2 
Lactose 70% 119.3 
Lactose 50% 120.5 
Lactose 30% 106.9 
Lactose 0% (Mannitol 100%) 46.0 
Sucrose 100% 242.2 
Sucrose 70% 170.0 
Sucrose 50% 112.8 
Sucrose 30% 111.5 
Sucrose 0% (Mannitol 100%) 46.0 
Trehalose 100% 152.2 
Trehalose 70% 83.0 
Trehalose 50% 84.7 
Trehalose 30% 132.5 
Lactose 0% (Mannitol 100%) 46.0 
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Figure 4-9 Maximum force required to penetrate 3 mm depth of a two component freeze dried cake. 
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Figure 4-10 Estimated stress (g/cm2) based on Eqn. 4-3 in a freeze dried 2 component formulation system 
containing various ratio concentrations of mannitol and sugars. (n=3). 
The importance of this study was to ascertain the compatibility and interactions between different 
excipients, which will help in strategies applied for the development of 3-component formulations.  
4.5.1.5 Concluding Remarks 
In conclusion, mannitol alone showed a good ability to resist moisture uptake. Also the cakes with 
large amount of mannitol show better appearance (no cracks and good adhesion to vial’s wall) 
However, the mechanical strength (hardness recorded and stress estimated) were the lowest amongst 
the samples studied and therefore in real pharmaceutical finished products are more likely to crumble 
during any mechanical stress (i.e. transport). The inclusion of mannitol in the 2 component 
formulation reduced the recorded hardness but not as much to cause crumbling.  Thus, mannitol is a 
good candidate for the final formulation for moisture protection and good appearance, but in 
moderate quantities due to poor mechanical properties. 
Generally, sucrose samples recorded very high moisture uptake, which makes this excipient not 
optimal for the final formulation, although the mechanical properties (maximum stress) for pure and 
70% sucrose cakes were the best among other disaccharides under investigation.  Nevertheless, the 
inclusion of the mannitol (up to 70%) makes the mechanical properties of all 3 disaccharides similar. 
Thus, sucrose is not good moisture protector and possess the mechanical properties similar to lactose 
and trehalose. 
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Lactose and trehalose samples showed a moderate affinity to moisture and with similar and relatively 
good mechanical properties in the presence of small amount of mannitol. Nevertheless, it is worth to 
note, that lactose was previously observed to have a discolouration effect (getting brown) during 
moisture loss studies indicating a possible Maillard reaction. (Labuza et al., 1998, Qiu et al., 2005, 
Szalka et al., 2014, Wirth et al., 1998). Therefore, due to proposed experiments including incubation 
of final samples at high relative humidity conditions, all lactose formulations may be withdrawn from 
this study.  
 
4.5.2 Two (2) Component formulation (Stabiliser + Moisture resistor)  
A 2 excipient system made up of ArgHCl/LysHCl and sugar/polyol was freeze dried according an 
optimised protocol. The freeze dried cake was characterised based on their ability to resist moisture 
uptake, mechanical profile, matrix integrity and physical appearance. The major requirement of the 
included sugar/polyol, is to resist or minimise the moisture uptake by the hygroscopic ArgHCl or LysHCl 
if freeze dried alone. 
4.5.2.1 Visual Characterisation  
A typical appearance of a freeze dried cake for ArgHCl and sugars or polyol produced for this work is 
presented in Figure 4-11.   
 
Figure 4-11 Images of the different ratios (increasing ratio left to right) of freeze dried cake containing ArgHCl 
and polyol or sugar.  
The bottom of the cake was also scanned to identify any imperfections (Figure 4-12). Visual inspection 
of the cake indicated a system with well-defined matrix, absence of any visible shrinkage, highly 
porous with a spongy like appearance without cracks and adhered to the vials. 
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Figure 4-12 Scanned images of the bottom of freeze dried cake containing different ratios of ArgHCl (top) / 
LysHCl (bottom) and sugar or polyol (increasing ratio left to right). 
It was also observed that in samples containing sucrose and ArgHCl, the cakes adhered to the vial 
slightly stronger compared to the other samples. The cakes were disintegrated in 1 mL water with the 
average dissolution time recorded below 5 seconds. 
4.5.2.2 Moisture Loss/Uptake 
The moisture uptake behaviour of all the freeze dried cakes of the 2 component formulation 
containing ArgHCl and LysHCl in combination with sugar/polyol (sucrose, lactose, trehalose or 
mannitol) was measured to identify an ideal ratios of ArgHCl/LysHCl and sugar/polyol with the 
strongest moisture resistance properties after incubation at various harsh conditions. Different 
concentrations of ArgHCl or LysHCl in formulations (up to 40 % wt.) were used to enhance the moisture 
sorption by freeze dried cakes making the difference between formulations more expressed. The 
moisture sorption properties of a freshly prepared freeze dried cakes were quantified by estimating 
the moisture content after storage at 75% RH for 24 hours. The estimated moisture content is 
presented in Figure 4-13. 
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Figure 4-13  Percentage moisture content in freeze dried cakes containing a combination of ArgHCl or LysHCl 
and sugar or mannitol. The samples were incubated at 75% RH for 24 hours.  
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The data presented in Figure 4-13 indicates that as the % wt. of ArgHCl or LysHCl composition 
increases, the moisture content also increased. ArgHCl also showed to have a relatively high 
hygroscopicity when compared to LysHCl. In both sets of formulation, sucrose samples absorbed more 
moisture whiles mannitol resisted moisture uptake.  
Similarly, in samples prepared with ArgHCl, increasing the ArgHCl concentration results in an increase 
of the moisture content Figure 4-13. Once again the highest % moisture content was recorded in 
sucrose combinations with ArgHCl. In ArgHCl/trehalose combinations, there was an increase from ≈4% 
to 7% moisture content when ArgHCl concentration was increased to 10% wt. However, there was no 
significant increase in % moisture content in samples containing >10% wt. ArgHCl concentrations. In 
contrast, the % moisture content increase in ArgHCl/mannitol combinations was relatively low (almost 
insignificant) even with the inclusion of 40% wt. ArgHCl. 
 
Moisture kinetics - The kinetic profile of moisture uptake was studied for samples with 40% wt. LysHCl 
after incubation at 75% RH and the data presented Figure 4-14.  
0 20 40 60 80 100 120 140 160 180 200 220 240
0
2
4
6
8
10
12
14
16
W
e
ig
h
t 
(%
)
Time (mins)
 Lys100
 LS40
 LT40
 LL40
 LM40
  
Figure 4-14 Estimated % weight of samples containing 60% wt. LysHCl and 40% wt. sugar or polyol incubated 
75% RH with time. (n=3) 
Figure 4-14 indicates that moisture sorption containing mannitol (noted as LM40) was 
relatively low when compared to the other sugars. Indeed in LM40 samples, the maximum 
moisture gain was recorded after 25 minutes of incubation of which 67% of the moisture was 
lost after at the end of the study. The presence of sucrose, lactose and trehalose increased 
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the moisture uptake properties of the formulation significantly with the highest moisture 
uptake recorded in lactose containing samples.  
Thermogravemetric analysis – To investigate further the level to which mannitol is able to provide 
moisture resistance characteristics to the formulation, the moisture uptake by samples containing 405 
wt. ArgHCl or LysHCl cakes were incubated at 97% RH, room temperature, for over 2 days and % 
moisture loss measured with TGA. A typical example of the recorded TGA spectra for samples 
containing ArgHCl and mannitol is presented in Figure 4-15 below.  
 
Figure 4-15 TGA thermogram of 100% wt. mannitol only and a combination of 60% wt. mannitol and 40% wt. 
Arg cakes incubated for 2 days (top) and 5 days (bottom) at 97% RH and room temperature. Thermograms 
were recorded from 25 °C to 250 °C at a rate of 10 °C/min.  
In all freeze dried cakes (except those containing mannitol) the exposure to extreme moisture 
treatments (97% RH over 24 hours) resulted into a transition from solid cakes to very viscous liquids 
or liquids with small solid particles embedded. Example of this behaviour are shown in Figure 4-17 for 
mannitol and lactose cakes. Although formulations containing 60% wt. concentration appear to have 
shrunk, they nevertheless remained as solid, “cake-like” structure after the extreme storage 
conditions.  
The moisture content values calculated from the thermograms of ArgHCL/mannitol only is presented 
in Figure 4-16. In samples containing mannitol alone, equally ≈7% wt. and ≈15% wt. of absorbed 
moisture was estimated after incubation at 97% RH for 2 and 5 days respectively. In the presence of 
40% wt. ArgHCl, samples incubated for 2 days recorded ≈20% wt. moisture uptake while those after 5 
days recorded ≈35% wt. (Figure 4-16) which were significant increases.   
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Figure 4-16 Estimated % moisture content recorded in formulations containing 40% wt. ArgHCl and 60% wt. 
mannitol incubated at 97% RH for 2 and 5 days. 
At temperatures >220 °C, water desorption is responsible for the weight loss observed, whist at higher 
temperatures, weight loss occurs due to the decomposition of the material. 
 
Figure 4-17 Comparing the moisture uptake of sugar alone and in combination with ArgHCl or LysHCl. Sample 
contains 40% ArgHCl or LysHCl and 60% of sugar/polyol and was incubated at 97% RH for 2 days. 
The moisture content of the cakes were analyzed after incubation at 97 % RH and 24 °C for 24 hours 
(Figure 4-18). More importantly, the inclusion of LysHCl into mannitol formulation increased moisture 
sorption by just 14.2% while in sucrose is was >67%. 
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Figure 4-18  Estimated % moisture content of freeze dried cakes containing only 40% wt. LysHCL and sugar or 
polyol incubated at 97% RH for 24 hours. (n=9) 
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The presence of arginine also changes the profiles of moisture evaporation (Figure 4-15), increasing 
the onset and end temperatures as well as the total temperature interval of moisture evaporation, 
both in the mannitol only and ArgHCl/Mannitol combination cakes.  
Generally, the results indicates that the cakes containing ArgHCl or LysHCl uptake significantly more 
moisture and retain water more strongly than the pure mannitol cakes (i.e. the loss of water extends 
to higher temperatures in the TGA thermograms or incubation at 80 ˚C) (Figure 4-13). Overall, all the 
various approaches to monitoring moisture uptake by the freeze dried cakes complements 
observations that mannitol is able to strongly resist moisture uptake by the hygroscopic ArgHCl and 
LysHCl. In contrast, in combination formulations containing sucrose, trehalose or lactose, the cakes 
were converted into highly viscous liquids. 
 
4.5.2.3 Thermal properties studied by DSC 
The DSC thermogram of freeze dried mannitol only, mannitol only as purchased and a freeze dried 
cake with combination of 40% wt. ArgHCl to 60% wt. Mannitol which were initially incubated at 75% 
RH for 2 days was recorded and the data presented in Figure 4-19. These samples were selected out 
of the entire combinations studied because from moisture sorption studies, freeze dried cakes of 
amino acids and mannitol combinations possess the ideal characteristics to be studied further for next 
stage. The highest combination of ArgHCl was selected since any impact of ArgHCl on mannitol will be 
significant.  
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Figure 4-19 DSC thermograms for (a) freeze dried 60% mannitol and 40% arginine incubated at 75% RH and 
room temperature for 48 hours (b) freeze dried mannitol only and (c) freshly purchased mannitol only. 
Samples were heated from -60 ˚C to 315 °C and then cooled down to 0 ˚C at a rate of 20 °C/min. 
The thermal profile of both freeze dried and purchased mannitol only indicated an endothermic peak 
between 160 ˚C and 170 °C on the heating curve and an exothermic peak between 90 ˚C and 100 °C 
on the cooling curve. The former observation is ascribed to mannitol melting which conforms to the 
literature work (Hulse et al., 2009b) whiles the later observation is as a result of re-crystallisation. The 
presence of a melting peak on the heating curve and a crystallization peak on the cooling curve 
indicates the crystalline state of the freeze-dried mannitol. 
Upon the inclusion of 40% ArgHCl, it is observed that the single sharp endothermic peak is split into a 
double exothermic peak (Figure 4-19). The literature reports of the presence of existence of three 
polymorphic forms of mannitol; α, β and δ forms based on the classifications of Walter-Levy similar to 
what has been extensively studied and presented in the literature (Hulse et al., 2009a, Burger et al., 
2000). In this work, the presence of more than one thermal transition on the DSC thermograms for 
60% mannitol: 40% ArgHCl probably originates from a water-induced polymorphic transition.  
In previous work, it was shown that moisture-induced polymorphic transition from the δ to β form 
results in an increase of the specific surface area of the sample (Yoshinari et al., 2002). The newly 
increased specific surface area β polymorphic form has been shown to possess greater hygroscopicity. 
The inclusion of ArgHCl also resulted in the two melting peaks shifting from 166 ± 1 °C to 147 ± 1 °C 
with an insignificant increase in the second minor thermal transition which has been corresponds to 
the β form of mannitol. Furthermore, in the same sample, the exothermic crystallization peak on the 
cooling curve is missing.   
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4.5.2.4 Mechanical Properties  
The mechanical properties of the freshly prepared freeze dried cakes were analysed as described in 
section 4.4.2.9. Typical force curves for the dry cakes is presented in Figure 4-20 and Figure 4-21.  
 
Figure 4-20 Mechanical properties of freshly prepared freeze-dried 2 component formulation containing 60% 
wt. sugar/polyol and 40% wt. ArgHCl or sugar polyol only (a, b and c) studied by Texture Analysis. For all curves 
time from 0 to 6 sec indicates probe movement into the cake and 6 to 16 sec, a hold time. The stress (g) were 
estimated according to Eqn. 4-3 (d). 
From Figure 4-20, in all measurements, the measured curve in <2 seconds (sucrose and lactose 
formulations) or <1 second (mannitol formulation) indicates an almost linear upward increase. This 
could be ascribed to an increasing resistance as the probe penetrates the cake and therefore requiring 
the application of more force. As the force increase, it builds more pressure at the point of contact 
with the cake. Unable to resist any more pressure, the cake crushes and as a result the force required 
to penetrate the now crushed cake is reduced. The series of crushes (and stress releases) are 
responsible for the “noisy” jagged profiles of the force time curves (Hackl and Ermolina, 2016) 
between 2 and 6 seconds.  
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Figure 4-21 Mechanical properties of freshly prepared freeze-dried 2 component formulation containing 
various concentrations of sugar/polyol and LysHCl studied by Texture Analysis. For all curves time from 0 to 
30 secs indicates probe movement into the cake and 30 to 50 secs, a hold time.  
Generally, the strength/hardness of a freeze dried cake is directly proportional to the maximum force 
recorded owing to the fact that a stronger material will require more force/pressure to penetrate. 
Figure 4-20(d) presents the estimated stress in 2 component formulation containing 60% wt. 
sugar/polyol and 40% wt. It was observed that, although the recorded hardness of ArgHCl/mannitol is 
higher than in mannitol alone, the estimated stress values are still very low (below 1 kPa) indicating 
that 40% wt. ArgHCl  to 60% wt. mannitol freeze dried cakes are very soft.  
As observed all formulation types, mannitol alone forms very soft and easy penetrable cakes (with 
maximum force < 50 g) while cakes formed by sucrose, lactose and trehalose are much harder 
(maximum force in the 1000 to 2500 g range) as also shown in Figure 4-8 and in the literature (Hackl 
and Ermolina, 2016). In the presence of disaccharides, ArgHCl or LysHCl increases the cake hardness 
with the highest effect observed in ArgHCl/trehalose combination formulations and ArgHCl/SUC 
recording relatively weak effect. For instance in ArgHCl/trehalose, the relatively weak cake for TREH 
alone is observed to be even stronger than ArgHCl/sucrose cake when 40% wt. of ArgHCl was included 
in both trehalose and sucrose cakes. The results show that in the wide range of ArgHCl and LysHCl 
concentrations (0% to 40% wt.) the strength/hardness of the two component formulation freeze dried 
cakes depends mainly on the type of sugar/polyol. 
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Freeze dried cakes containing 40% wt. ArgHCl and 60% wt. sugar/polyol was incubated at 97% RH for 
1 hour incubation and the hardness measured from textural analysis measurements. The estimated 
hardness indicated that, mannitol and ArgHCl/mannitol combinations remained very soft and easily 
penetrable.  
 
Figure 4-22 Stress dependence on sugar content for two component system, containing Arginine and Sugar 
(Lactose, Sucrose) or Arginine plus Mannitol. 
The incubation at high moisture conditions resulted in an equally higher impact on the ArgHCl/SUCR 
formulation, with approximately twice the force required to penetrate a freshly prepared cake needed 
to also penetrate the ArgHCl/sucrose incubated cakes. This observation may probably be due to the 
formation of a crystalline crust on the cake surface (as evidenced by an increase in surface lustre) 
resulting from the high moisture incubation conditions. This may even propagate through the matrix 
of the cake, thereby increasing the hardness of the cake.  
Figure 4-20 (a, b and c) and Figure 4-21 also shows that during the “hold time” (from 30 or 6 seconds 
respectively), the penetration force can either remain almost constant or gradually decrease with time 
(stress relaxation). The former was observed in the lactose, sucrose and trehalose cakes whiles the 
phenomena of stress relaxation was observed in mannitol cakes. Stress relaxation (or springiness) is 
defined as the decrease in stress with time in a strained material and exemplifies the elastic 
characteristics of a material. The higher the recorded stress relaxation, the more elastic the material. 
The data recorded and presented in this section of the project indicates that only freeze dried cakes 
containing mannitol showed elastic characteristics. The inclusion ArgHCl increased the elasticity of 
ArgHCl/ mannitol and Lys/mannitol cakes but has no effect on the elastic properties of lactose, sucrose 
or trehalose combinations with ArgHCl cakes. 
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4.5.2.5 Concluding Remarks 
These studies have demonstrated that ArgHCl/mannitol and LysHCl/mannitol freeze dried cakes have 
uniform matrix, perfectly adheres to vials, easily soluble and possess relatively the best moisture 
resistivity characteristics with low mechanical strength. The presence of ArgHCl or LysHCl does not 
alter the cake appearance significantly. In contrast, ArgHCl/sugar combination formulations resulted 
in the formation of significantly stronger cakes but had worse moisture resistivity properties. Based 
on this study, mannitol was selected to be included in the final protein-based freeze dried formulation. 
Mannitol has various advantages and become one of the most popular excipient in solid dosage forms 
although they are not cost efficient (Ohrem et al., 2014). Mannitol has very low hygroscopicity which 
helps to improve powder flow (Costantino and Pikal, 2004). Mannitol moisture protection properties 
and compatibility with moisture sensitive active ingredients have been reported previously (Fakes et 
al., 2000, Gad, 2008). As observed in the earlier parts of this work, unlike lactose, mannitol does not 
also undergo Maillard reaction. 
 
4.5.3 Three (3) Component formulation (Stabiliser + Moisture resistor + Cryo/Lyo 
protector) 
Although mannitol has good cryo protection properties, it has poor protein stabilising and lyo 
protection characteristics because of its ability to crystallise during freeze drying  (Costantino and 
Pikal, 2004). Due to the different stresses applied to proteins during the freezing and drying stages, it 
is essential to include a combination of cryo- and lyo- protectants when developing a freeze dried 
protein based product. Therefore in this section, the selection of a disaccharide to act as a lyoprotector 
would be explored. For this purpose a 3-component freeze-dried systems comprising of 20% amino 
acid (ArgHCl or LysHCl), and 80% of combination of polyol (mannitol) and sugar (trehalose or sucrose) 
with different proportions were prepared according to Table 4-4 and analysed.     
4.5.3.1 Visual Characterisation 
A visual inspection of freeze dried three component formulations indicated that the resulting cakes 
maintained a uniform shape and an intact matrix, highly porous with a spongy like white appearance 
without cracks. In both ArgHCl and LysHCl formulation, samples containing higher proportions of 
mannitol (> 40 % wt.) adhered tightly to the Schott vials whiles those containing < 30 % wt. did not 
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adhere so greatly to the vial walls. This was the case for both the ArgHCl-mannitol-trehalose, ArgHCl-
mannitol-sucrose, LysHCl-mannitol-trehalose and LysHCl-mannitol-sucrose formulations. Samples 
with intermediate and low mannitol content (≤ 40 % wt.) showed small cracks at the surface of the 
cake closer to the vial walls. These minor defects were more pronounced in freeze dried cakes 
containing sucrose. 
4.5.3.2 Cake Shrinkage  
The vials containing freeze dried cakes with proportions of 20 % wt. ArgHCl (or LysHCl), and 80% of 
mannitol plus trehalose (or sucrose) were incubated at 75 % RH and 22 ˚C for up to 14 days. The 
bottom of each vial was scanned (Figure 4-23, Figure 4-28) and the average relative diameter of each 
cake was estimated presented in Figure 4-29.  
 
Figure 4-23 Scans of the bottom of moisture-induced shrank cakes of freeze dried 3 component formulation 
containing 20% wt. ArgHCl, mannitol and sugar (either trehalose (T) or sucrose (S)) incubated at 75% RH and 
room temperature for up to 14 days. 
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Figure 4-24 Scans of the bottom of moisture-induced shrank cakes of freeze dried 3 component formulation 
containing 20% wt. LysHCl, mannitol and sugar (either trehalose (T) or sucrose (S)) incubated at 75% RH and 
room temperature for up to 7 days. 
The scanned images showed that in both ArgHCl and LysHCl sets, moisture induced shrinkage for some 
samples began immediately within the first hour of incubation. The cake shrinkage was found to be 
dependent on the formulation (concentrations of excipient). In samples containing only mannitol, 
after incubating samples for at least one week, the freeze dried cakes remained intact without changes 
in their diameter. All the freeze dried cakes containing sugars indicated a reduction in diameter by the 
end of the incubation period with the highest shrinkage being observed in samples containing sucrose.  
Generally, after 24 hours of incubation, in both LysHCl and ArgHCl samples, the higher the 
concentration of sugar content (i.e. lower proportion of mannitol), the bigger the estimated shrinkage. 
In all the samples studied, sucrose based formulations recorded highest shrinkage with some cakes 
turning into viscous liquids. Therefore for instance in S80 where the solid cake had converted into a 
viscous liquid, the % cake shrinkage was assigned zero. Furthermore, the results (Figure 4-23 and 
Figure 4-24) indicate that on average, the onset of cake shrinkage in samples prepared with sucrose is 
earlier than those with trehalose from day 1 day 7.  
 
Viscous liquid 
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Figure 4-25 Estimated cake diameter of a 3 component formulation containing ArgHCl (top) or LysHCl 
(bottom), mannitol and trehalose or sucrose after incubation at 75% RH and room temperature for up to 7 
days. 
Samples T48, T56, T64 and T80 in both LysHCL and ArgHCl cakes showed less (between 5 and 10%) 
reduction in diameters while mannitol rich formulations remained unchanged. This result also 
confirms that formulations containing more sugar (sucrose or trehalose) than mannitol in the 
presence of ArgHCl or LysHCl are very sensitive to moisture and a brief exposure to moisture can result 
in cake shrinkage.  
  
4.5.3.3 Moisture uptake  
In open vials, the 3 component freeze dried cakes containing ArgHCl were incubated at 75% RH and 
room temperature for 21 days and the total moisture uptake was assessed gravimetrically during the 
incubation period. The measured moisture content is plotted against the sugar content and presented 
in Figure 4-26. 
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Figure 4-26 Estimated % moisture content in a three component formulation incubated at 75% RH for 21 days 
at room temperature. The sample contained 20% wt. ArgHCl and 80% various combinations of mannitol and 
sugar (either trehalose or sucrose). 
Figure 4-26 shows that sucrose samples absorbed significantly more moisture than in trehalose 
samples. It was also observed that moisture uptake increases with increased content of sugar for both 
sets of samples, except in 80% wt. trehalose sample where slight reduction was revealed. The 
correlation between moisture uptake and % wt. of sugar is nonlinear. In both sugars, samples 
containing between 30% wt. and 60% wt. indicates no increase in their moisture sorption properties. 
Thus, the plot can be split into three groups; group 1 and 3 includes samples with < 30% wt. and >60% 
wt. sugar where there is highest impact of moisture sorption  and between 30% wt. 60% wt. were the 
effects of moisture sorption is insignificant. This observation correlates with the results obtained r in 
shrinkage studies for these three component formulations (Figure 4-25). Furthermore, after 2 days of 
incubation, samples containing high sugar % wt. concentrations (i.e. T56, T64, T80, S56 and S64) were 
noticeably hard solid structures whilst S80 sample form viscous liquid or liquid with embedded hard 
crystals. Perhaps, in this instance, humidification-induced crystallisation of amorphous sugars takes 
place. 
Moisture uptake with time - The kinetic profile of moisture uptake was studied for samples with 20% 
wt. LysHCl and 80% combination of mannitol and trehalose or sucrose (40% wt. or 50% wt.) during 
incubation at 75% RH for up to ≈6 and half hours and the results presented in Figure 4-27. High 
moisture uptake occurred within 25 minutes of incubation after which there was no significant 
increase in moisture sorption till about 4 hours of incubation where there was a slight increase again 
in all samples. 
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Figure 4-27 Estimated % moisture uptake of samples containing 40% wt. LysHCl and various % wt. proportions 
of sugar and polyol incubated at 75% RH with time. (n=3) 
Thermagravimetric Analysis - The total moisture content in TREH containing samples were studied 
with TGA after incubation after incubation at 75% RH for 7 hours (Figure 4-28)  
   
  
Figure 4-28 Typical thermograms for 3 component formulation containing 20% wt. ArgHCl , 20% trehalose 
/80% mannitol (a) 20% wt. ArgHCl , 50% trehalose/50% mannitol (b) and 20% wt. ArgHCl , 80% trehalose /20% 
mannitol (c). The estimated moisture content is plotted against sugar content (d). 
The data presented confirms further that moisture sorption in trehalose containing samples are 
relatively. In this instance samples containing 64% wt. (T80) recorded the highest moisture content of 
<5%, a mere increase of <1% from T20 samples.    
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The moisture release profile of 20% wt. ArgHCl and various trehalose/mannitol ratios (from 0:100 to 
80:20) were incubated at 97% RH for 24 hours.  
 
Figure 4-29 Moisture release profile estimated from TGA analysis of 3 component formulation containing 20% 
wt. ArgHCl (1) mannitol 80% wt. (2) trehalose 20% wt. (3) trehalose 40% wt. (4) trehalose 50% wt. and (5) 
trehalose 60% wt. samples initially incubated at 97% RH for 24 hours. 
Figure 4-29 shows a typical release profile illustrating the sample weight loss upon heating. On the 
thermograms the first (low temperature) step is related to the moisture evaporation and the second 
step (> 200 °C) is ascribed to the sugar/polyol decomposition. The moisture uptake increases 
significantly when trehalose content in formulations increases. However, this relationship is nonlinear 
but has a plateau at T32-T48, thus confirming. Addition of trehalose to the formulations also shifts 
both onset and end temperatures towards higher temperatures indicating that more energy is 
required to evaporate water absorbed in comparison to the ArgHCl/mannitol cake.  
 
Figure 4-30 Delta T (ΔT) against TREH concentration in a 3 component formulation after incubation at 97% RH 
for 24 hours, where ΔT=Tend-Tonset. 
It should be noted that, while the onset temperature and end temperature increases, ΔT (where ΔT= 
is Tend - Tonset) remains almost constant (47 ± 2 °C) for all trehalose samples with % wt. < 50 and 
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increases rapidly to ≈80 °C only in the T80 formulation as shown in Figure 4-30. Overall, the TGA results 
show that the presence of trehalose increases both moisture sorption and moisture retaining by 
freeze dried 3-excipient cakes. 
4.5.3.4 Thermal properties studied by DSC 
The DSC thermograms of the combinations of ArgHCl/mannitol, ArgHCl/mannitol/trehalose and 
ArgHCl/trehalose freeze dried cakes were recorded and are presented in Figure 4-31. 
 
Figure 4-31 DSC thermograms for freeze dried three component formulations containing 80% wt. mannitol 
and 20% wt. ArgHCl (M80), 64% wt. mannitol-16% wt. trehalose and 20% wt. ArgHCl (T16), 40% wt. mannitol-
40% wt. trehalose and 20% wt. ArgHCl (T40), and 80% wt. trehalose- 20% wt. ArgHCl (T80). Samples were 
heated from -60 to 315 °C and then cooled down to 0 ˚C at 20 ° C/min. 
 
The DSC thermogram indicates double peak ≈150 °C for M80 which is consistent with the crystalline 
forms of β and δ mannitol. However, in T80 samples, this peak is absent in this temperature region. 
The presence of the endothermic melting peak in all 3-component mannitol containing formulations 
(e.g. T206 and T50) as shown in Figure 4-31 confirms that, in these three component formulations, 
mannitol exist in its crystalline form.  
In samples containing trehalose, the endothermic peak observed ≈250 °C is ascribed to the melting of 
trehalose followed by degradation. After the process of freeze drying, trehalose is generally expected 
to be in the amorphous form. However, the presence of an exothermic (devitrification) peak identified 
between 80 ˚C and 90 ˚C is a good indication that the amorphous trehalose content is probably 
partially converted into the crystalline state which is melted at 250 ˚C. As the amount of trehalose 
increases, the height and area of the melting peak at 250 ˚C increases.  
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Similarly, the absence of any endothermic peak that can be ascribed to melting of ArgHCl indicates 
that, ArgHCl is perhaps also in the amorphous state. Similar observations have been published 
previously (Ohtake et al., 2011, Mattern et al., 1999). This is significant because the formation of 
hydrogen bond which stabilises the protein molecule during stress conditions depends on the physical 
state of the additives. In the amorphous state, there is enough flexibility to allow for the formation of 
the hydrogen bonds whiles it is not relevant in the crystalline state. It should be noted that absorbed 
moisture can promote a conversion of some amorphous materials (including freeze dried trehalose) 
into the crystalline state (Fakes et al., 2000).  
 
4.5.3.5 Mechanical properties 
The mechanical attributes of all the freeze dried three component formulation system were 
characterised by measuring their resistance to penetration by a probe using Textural Analysis. As 
shown in Figure 4-32 and Figure 4-33, the “force vs. time” curves illustrate an increase in force upon 
a probe penetrating the cake.   
300
600
900
1200
1500
1800
2100
0 10 20 30 40 50 60 70 0 10 20 30 40 50 60 70 0 10 20 30 40 50 60 70
300
600
900
1200
1500
1800
2100
0 10 20 30 40 50 60 70
0
300
600
900
1200
1500
1800
2100
0 10 20 30 40 50 60 70 0 10 20 30 40 50 60 70
0
300
600
900
1200
1500
1800
2100
 
 Sucrose 0%
 Sucrose 16%
 Sucrose 24%
 Sucrose 32%
 Sucrose 40%
 Sucrose 48%
 Sucrose 56%
 Sucrose 64%
 Sucrose 80%
 Trehalose 0%
 Trehalose 16%
 Trehalose 24%
 Trehalose 32%
 Trehalose 40%
Time (secs)
F
o
rc
e
 (
g
)
 Trehalose 48%
 Trehalose 56%
Time (secs)
F
o
rc
e
 (
g
)
 Trehalose 64%
 Trehalose 80%
 
Figure 4-32 “Force vs. time” curves for ArgHCl-mannitol-sucrose (top) and ArgHCl-mannitol-trehalose 
(bottom) freeze dried cakes with different sucrose (trehalose) to mannitol ratios and 20% wt. ArgHCl. For all 
curves, between 0 seconds to 30 seconds, the probe penetrated sample whiles from 30 secs to 50 secs 
represents the “hold time”. 
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Figure 4-33 “Force vs. time” curves for LysCl-mannitol-sucrose (top) and LysHCl-mannitol-trehalose (bottom) 
freeze dried cakes with different sucrose (trehalose) to mannitol ratios and 20% wt. LysHCl. For all curves, 
between 0 seconds to 30 seconds, the probe penetrated sample whiles from 30 secs to 50 secs represents the 
“hold time”. 
The curves were presented in three different groups owing to their trends. From the plot, it can be 
observed that samples without sugar i.e. ArgHCl/mannitol recorded maximum forces ≈100 g which 
were extremely low relative to the other samples containing sugars. Thus these cakes were very soft 
and easily penetrated, whiles the presence of both trehalose and sucrose in the formulation 
significantly increased the mechanical properties.  
From Figure 4-32 the maximum force data were used to estimate the stress values according to Eqn. 
4-3 and is presented Figure 4-34. From the plot, it is observed that samples containing sucrose formed 
strong/hard cakes.  
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Figure 4-34 Estimated maximum stress (left) and stress relaxation (right) as a result of the varying proportions 
of mannitol-trehalose or mannitol-sucrose/ in the three component formulation system with 20% wt. ArgHCl. 
Stress values were estimated according to Eqn. 4-3. 
After the freeze dried cakes were incubated at 75 % RH and room temperature for 24 hours, ArgHCl 
formulations containing sucrose were observed to have become stronger when compared with the 
trehalose whiles those containing LysHCl remained almost the same. As it was mentioned earlier only 
cakes containing mannitol or ArgHCl/mannitol possess the characteristic of elasticity. Similarly, the 
stress relaxation of LysHCl samples was estimated and is presented in Figure 4-35. 
 
Figure 4-35 Estimated and stress relaxation as a result of the varying proportions of trehalose or sucrose in 
the three component formulation system including LysHCl and mannitol. Stress values were estimated 
according to Eqn. 4-3. 
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The data indicated non monotonic behaviour and cakes with proportion of 60% wt. sugars shows 
strong mechanical properties. 
This means that the texture of the freeze-dried cakes does not change monotonously with an increase 
in sugar concentration.  
 
4.5.3.6 Morphological structures of 3-excipient freeze-dried cakes 
The microscopic structure of the freeze dried samples containing ArgHCl, trehalose and mannitol were 
studied using SEM as presented in Figure 4-36 (The experiment for LysHCl samples was not performed 
due to the equipment unavailability).   
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Sample Name Arginine HCl + Mannitol + Trehalose Mannitol + Trehalose Only 
T16 
  
T32 
  
T48 
  
T64 
  
T80 
  
Figure 4-36 SEM images magnification of x1000 of freeze dried three component formulation containing a 
fixed 20% wt. ArgHCl and varying proportions of mannitol and trehalose. The sample is labelled according to 
its trehalose proportion. 
197 | P a g e  
 
In both sets of samples (with and without ArgHCl), there was no significant variation on the internal 
structure of the cake. In contrast, the internal morphology of the cake was affected by the choice of 
sugar and the ratio between the sugar and the polyol.  
As shown in Figure 4-36, the studies indicated that samples containing T48 and T64 samples yielded a 
thick mesh like matrix with smooth surfaces. However in T16, T32 and T80 samples, the SEM indicated 
they maintained some of their hexagonal morphology, thin sharp-edged pipe-like structure (flakes in 
T32 without ArgHCl). 
4.5.3.7 Concluding Remarks 
The inclusion of ArgHCl or LysHCl into any solid formulation requires the addition of another excipient 
which is able to resist the high moisture sorption of that formulation due to the strong moisture 
sorption properties of ArgHCl or LysHCl. In previous sections of this work, mannitol and various 
disaccharides were tested for their ability to resist moisture uptake by ArgHCl or LysHCl and provide 
sufficient mechanical properties. The disaccharide were also considered as potential lyo- protectors 
in a protein based freeze dried formulation. 
In all three component formulation systems studied in this project, all methods used to determine the 
moisture sorption or moisture content, the trehalose based formulations absorbs relatively less 
moisture irrespective of the % RH used in this work  as compared to sucrose-based samples.  
Analysis of the mechanical characteristics of the both trehalose and sucrose based cakes indicated 
that both formulation types produced cakes with sufficient hardness which is relevant in maintaining 
cake matrix and handling. On the basis of the moisture tolerance properties, trehalose was selected 
as the lyoprotector to be included in the next stage of studies (4-component system). 
 
4.5.4 Four (4) Component formulation (Stabiliser + Moisture resistor + Cyo/Lyo 
protector + Protein) 
The 4 component formulation system studied in this project included 50% wt. BSA, 10% wt. ArgHCl or 
LysHCl and a 40% wt. combinations trehalose and mannitol (i.e. with excipient proportions similar to 
3-component excipient system studied above) These protein-based freeze dried samples were 
compared to a 3 component excipient systems with adjusted proportions of 55% wt. BSA and 45% wt. 
proportions of trehalose and mannitol.  
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4.5.4.1 Moisture uptake studies 
After freeze drying, the protein-based cakes were incubated at 75% RH and room temperature or 
45 °C to accelerate the process of aggregation. 
 
Figure 4-37 An example of a four component freeze dried cakes incubated at 75% RH and room temperature 
for 24 hours.  
Figure 4-37 the moisture content of the incubation process ensured samples were exposed to the 
harsh condition. The moisture composition was measured gravimetrically using balance and by TGA. 
The moisture content in all the freeze dried cakes recorded after the incubation is presented in Figure 
4-40 and Figure 4-39 for the first hour and the entire 24 hours of incubation period.  
 
Figure 4-38 Total moisture uptake in ArgHCl component formulation incubated at 75% RH and room 
temperature for 24 hours measured by weighing balance. 
 
Figure 4-39 Total moisture uptake in LysHCl component formulation incubated at 75% RH and room 
temperature for first hour (a) and 19 hours (b) measured by weighing balance. 
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It was observed that, irrespective of the component or the proportion, the presence of amino acid 
(ArgHCl or LysHCl) resulted in cakes absorbing moisture more intensively, than without amino acids. 
For long time (19-24 hours) of incubation at 75% RH the moisture content in both ArgHCl and LysHCl 
based formulations increased as the content of sugar increased. However, the difference in moisture 
uptake between formulations with/without amino acid was ≈3.54% in ArgHCl formulations and ≈5% 
in LysHCl formulations. 
4.5.4.2 Kinetics of moisture uptake 
The kinetic study of the moisture uptake in time was performed for protein-based samples containing 
60% wt. of trehalose. The results are presented in Figure 4-40 for both amino acid samples. 
    
Figure 4-40 Moisture uptake for four component system containing 60% wt. trehalose with and without 
ArgHCl or LysHCl samples incubated at room temperature and 75% RH. These samples were recorded by 
weight using a balance. 
In T60 samples for both with and without ArgHCl or LysHCl, the recorded data indicated that the 
differences in % wt. moisture uptake were insignificant until after 100 minutes (Figure 4-40).  
4.5.4.3 Thermogravimetric Analysis 
The moisture content was also assessed by TGA. The moisture evaporation profiles of the 4-
component cakes are presented in Figure 4-41.  
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Figure 4-41 TGA thermogram of FD cakes incubated for 24 hours at 75% RH and room temperature. The 
thermogram was recorded between 20 °C and 320 °C at a rate of 10 °C/minute.   
The moisture content was estimated and plotted against the % wt. of trehalose (Figure 4-42). It is 
observed that the moisture content increases from ≈12% in T30+ (24% in cake) to 24% in T80+ (64% 
in cake). However in samples without ArgHCl, the moisture increase was ≈10% wt. in T30- to ≈13% wt. 
in T80-. 
T80+ – Blue line 
T80-  – Red line 
T60+ – Blue line 
T60-  – Red line 
T30+ – Blue line 
T30-  – Red line 
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The endset temperature was almost the same in samples containing <50% wt. trehalose with or 
without ArgHCl, but for sample with high content of trehalose, the endset temperature significantly 
increased in the presence of ArgHCl (T80+) (up to ≈250 ˚C) in comparison with sample without ArgHCl 
(T80-) (125oC). (Figure 4-42B).  
  
Figure 4-42 The % wt. increase recorded in protein based freeze dried four component excipient containing 
ArgHCl incubated for 24 hours at 75% RH and room temperature measured by TGA (a) and recorded T and 
endset temperature (b). 
Relative to samples incubated at 45 °C, none of these samples however contained more than 30 %wt 
moisture which is very significant to maintaining the matrix of the cake. As already seen, samples 
containining ArgHCl showed high affinity to absorb mositure compared to those without ArgHCl.  
 
Figure 4-43 Estimated % wt. moisture uptake of four component (Arg-based) system incubated at 75% RH and 
45 °C for 24 hours. The data was recorded using TGA. (Note % wt. of Trehalose has been recalculated relative 
to mannitol proportion) 
In samples without ArgHCl, the onset temperature increased as the proportion of trehalose increased. 
The end temperature and ∆t remained the same indicating the initial matrix formed had enough pores 
to absorb moisture without necessarity collapsing. Whiles in samples containing ArgHCl had similar 
onset temperatures, T60 and T80 showed high moisture uptake and resistnace. 
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Figure 4-44 The onset temperature (A) and the delta T and endset  temperature (B) against trehalose % wt. of 
freeze dried cakes incubated for 24 hours at 75% RH and 45 °C. Results are obtained in TGA experiment. 
 
The results obtained in TGA experiments have shown that the presence of arginine significantly 
retards the moisture evaporation from sample. This behaviour is related to the strong moisture 
sorption properties of arginine. 
 
4.6 Aggregation studies of reconstituted freeze dried cake of four 
component systems containing proteins 
In previous sections of this chapter the physicochemical properties of freeze-dried cakes of pure 
excipients, 2-and 3-component excipient system, as well as 4-component protein-based system were 
explored. The aim of this section of the chapter was to investigate the effect of the amino acids 
(arginine and lysine) on the aggregation of protein in freeze-dried formulation. For this purpose the 4-
component systems were reconstituted, then incubated at different temperatures to accelerate the 
process of protein denaturation/aggregation. The protein reconstituted and aggregation induced 
solutions were studied by UV-visual spectroscopy (Turbidity study) and fluorescence spectroscopy 
using ThT assay. 
4.6.1 Turbidity studies 
Turbidity studies relative to proteins is a qualitative and quantitate approach to estimating the degree 
of aggregation/denaturation in a protein formulation. Generally, aromatic amino acids show no 
absorbance at wavelengths > 300 nm, and therefore protein absorbance in theory should always be 
closer to zero (0). At the presence of the particles (i.e. aggregates) of the size comparable with 
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wavelength used in experiment, the absorbance is not equal to zero, as the particles scatter the light 
and non-zero apparent absorbance (optical density) is measured. The higher size of particles or/and 
concentration of them, the higher optical density will be recorded.    
Two sets of samples were prepared to study the stability profile of the BSA incorporated into the four 
(4) component formulation. In set 1, half of the samples in each vial was reconstituted after incubating 
at 75% RH and room temperature for up to 24 hours. In set 2, the freeze dried formulation was 
incubated at 75% RH and 45 ˚C for up to 24 hours and then reconstituted as described in Chapter 2. 
The concentration of the reconstituted samples were measured with UV/Vis spectroscopy and the 
concentrations were then adjusted such that each vial had the same concentration equivalent to the 
lowest one. The UV-vis absorption spectra between 200 nm and 400 nm of all samples were recorded 
before incubation at the pre-determined storage conditions and after every 24 hours of incubation 
for up to 21 days. 
The UV-vis optical density recorded for the reconstituted formulations containing ArgHCl is shown in 
Figure 4-45 (a-e) and Figure 4-48 (a-d). Generally, for cakes stored at room temperature, the recorded 
optical density, which signifies the protein aggregation due to misfolding/unfolding/ denaturation, 
was significantly higher for the samples without ArgHCl than for samples with ArgHCl.  
In samples with low content of trehalose (T30, T40 and T50) the effect of presence of Arginine on 
aggregation was observed after 8th days, whereas for high concentration of trehalose the effect of 
Arginine started earlier, i.e. after 2nd day. In samples containing 24% wt. trehalose and ArgHCl (sample 
T30+) (Figure 4-45 (a)), the beginning of protein aggregation was delayed till 13 days while without 
ArgHCl, aggregation started after 8 days. When the trehalose % wt. was increased to 40% wt. (sample 
T50+, Figure 4-45(c)), the onset of aggregation was reduced to 10 days. Indeed increasing the 
trehalose content reduced the protein aggregation to 3 days. A major observation made in samples 
containing 32% wt. trehalose and ArgHCl (T40) was that, though aggregation onset was 7 days, after 
10 days of incubation, there was a very strong gelation. Furthermore, the degree of aggregation in 
T40+ formulations did not increase significantly till the end of the experiments although between 7 
and 14 days, the recorded turbidity in T40+ was higher than T40- (Figure 4-45 (b)). In fact, in T40- 
(without ArgHCl) the degree of aggregation was much higher if gelation was considered as well. 
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Figure 4-45  UV/Vis absorbance at 360 nm of reconstitution four component protein cakes prepared with 
ArgHCl incubated at 75% RH and 25 °C measured after 24 hours for up to 21 days (A-E) and the ratio between 
absorbance at 360 nm for four component protein solutions without and with ArgHCl (F). 
Similarly in samples prepared with LysHCl, protein cakes without LysHCl recorded the highest degree 
of aggregation. The onset of aggregation in these samples were also earlier, generally after 3 days of 
incubation. In formulations containing 40% wt. (T50+) and 48% wt. (T60+) recorded protein 
aggregation onset after 8 days, although significantly early when compared to those prepared with 
ArgHCl.  
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Figure 4-46 UV/Vis absorbance at 360 nm of reconstitution four component protein cakes prepared with 
LysHCl incubated at 75% RH and 25 °C measured after 24 hours for up to 27 days. 
Furthermore, the ratio between samples containing no LysHCl and those with LysHCl was relatively 
low, indicating the suppression capability of protein aggregation when compared ArgHCl is also less. 
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Figure 4-47 The ratio between absorbance at 360 nm for four component protein solutions without and with 
LysHCl. 
The highest ratio between the presence and absence of LysHCl estimated in the four component 
systems was recorded in T30+ formulations indicated that increasing the trehalose composition 
decreased the ability to suppress onset of aggregation. Thus, the presence of trehalose in combination 
with ArgHCl or LysHCl retards/delays the aggregation. 
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It was envisaged that the presence of ArgHCl or LysHCl could help prolong the onset of aggregation 
even after storage at high % RH conditions. The turbidity measurements of the formulations incubated 
at 45 ˚C and 75% RH is presented in Figure 4-48. 
 
  
Figure 4-48 UV/Vis absorbance at 360 nm of reconstitution four component protein cakes incubated at 75% 
RH and 45 °C measured after 24 hours for up to 21 days (a-d). 
Generally in samples incubated at 45% RH, in all samples, irrespective of LysHCl or ArgHCl % wt. 
concentration, the onset of protein aggregation was at 3 and 5 day respectively. The ratio between 
aggregation onset in samples with and without ArgHCl (Figure 4-48) was ≈1 – no significant difference 
in recorded apparent aggregation. Samples prepared with LysHCl also showed similar characteristics. 
 
4.6.2 Fluorescence spectroscopic analysis 
Fluorescence spectroscopy was used in this work to study the aggregation of proteins after 
reconstitution of freeze-dried cakes using Thioflavin T (ThT) assay. The detailed explanation of this 
method was presented in Chapter 2. Briefly, ThT is a dye and its use is based on the differences in 
fluorescence characteristics of ThT in solution and when bound to amyloid fibrils. Free ThT in an 
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aqueous environment shows only weak fluorescence while upon binding to amyloid fibrils, a 
remarkable increase in its fluorescence occurs (Hackl et al., 2015, Groenning, 2010, LeVine III, 1999).  
In this work the ThT assay was applied to the four component systems which were incubated at room 
temperature and 75% RH for 10 days to obtain the aggregated proteins in solutions. The ThT 
fluorescence emission spectra of protein based reconstituted solutions with and without amino acids, 
as well as with and without ThT are presented in Figure 4-49. It can be observed that in all 
measurements, the emission revealed for samples without ThT was relatively low compared to 
samples with ThT. In all samples except T30, the samples containing ArgHCl indicated lower emission 
compared to those without ArgHCl. This observation confirms that the presence of ArgHCl suppresses 
the aggregation of proteins.  
 
  
Figure 4-49 ThT assay for protein based four component systems comparing the absence and presence of 
ArgHCl measured at 25 °C. Samples were incubated at room temperature and 75% RH for 10 days. (n=3x3) 
To estimate the effect of composition (i.e. content of trehalose/mannitol) on protein aggregation the 
ratios between emission for samples with and without ArgHCl (at 485 nm) was estimated and 
presented in Table 4-10. 
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Table 4-10 Ratio between ThT fluorescence emission at 485 nm for protein based four component systems 
with and without ArgHCl. Samples were incubated at room temperature and 75% RH for 10 days. 
Sample With ArgHCl 
Max Emission (E1)  
Without ArgHCl 
Max Emission (E2) 
E1/E2 
T30 188.78 236.26 0.79 
T40 190.01 237.59 0.79 
T50 196.26 249.29 0.79 
T60 269.88 399.03 0.68 
 
The most significant ratio was observed in T60 samples. The results confirm that the increase of 
trehalose content in the presence of ArgHCl in cake suppressed the degree of aggregation in 
reconstituted BSA freeze dried cakes incubated at room conditions. This result correlate with data 
obtained in turbidity experiment in the previous section. 
 
4.7 Conclusion 
A system containing LysHCl or ArgHCl and BSA alone showed in solutions a good stabilising property. 
However, in solid formulations, the highly hygroscopic LysHCl or ArgHCl uptakes atmospheric moisture 
quickly which affects the protein stability. The physicochemical characterisation for LysHCl or ArgHCl 
and sugar or mannitol formulations (2 component excipient system) indicated that, the presence of 
mannitol resisted level of moisture uptake by LysHCl or ArgHCl. Although can serve as a good cryo 
protectant, mannitol is ineffective as lyo protectant when compared to the other disaccharides. 
Therefore a third excipient was selected between sucrose and trehalose following extensive moisture 
sorption and mechanical characteristics studies. From these set of studies, sucrose was observed to 
enhance moisture sorption and yielded slightly stronger cakes. In contrast, the inclusion of trehalose 
did not significantly increase moisture sorption or the mechanical properties. In the final developed 
formulation, 50% wt. of BSA was added to a three excipient component formulation made up of 10% 
wt. ArgHCl or LysHCl, and 40% wt. of various combinations of mannitol and trehalose. Moisture 
kinetics and thermogravimetric analysis indicated that the presence of ArgHCl or LysHCl significantly 
retarded moisture evaporation from sample. The samples were split into two and reconstituted to 
equal concentrations. One set of the reconstituted protein based formulation was incubated at 75% 
RH and room temperature while the other half was incubated at 75% RH and 45 ˚C. The impact of the 
conditions of incubation on protein stability in the presence and absence of LysHCl and ArgHCl was 
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studied using turbidimetry and ThT assay. From these initial studies, it is suggested that the presence 
of LysHCl or ArgHCl in the right combinations has the capability of suppressing aggregation at room 
temperature but probably not much at elevated temperatures. When compared with LysHCl, ArgHCl 
has superior ability to impact on the aggregation process in freeze-dried formulations. The overview 
of this chapter and outcome is summarised schematically as shown in Figure 4-50.  
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Chapter overview after experiments 
The overview of this chapter is summarised schematically in diagram presented in Figure 4-2. 
 
 
Figure 4-50 In-depth graphical representation of section after completion of experiments using the defined 
systematic approach to accomplish the aims of this chapter. 
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Chapter 5. General Conclusion and 
suggestions for future work 
5.1 General Conclusions 
The aim of this project was to explore the aggregation of proteins that occur due to two key 
technological processes typically used in the pharmaceutical manufacture of protein based 
formulation: (i) mixing/agitation of protein in solution and (ii) freeze-drying of protein solution to get 
a protein solid dosage form. The project was divided into two sections; in Chapter 3 the effects of 
different mixing methods on the native structure of the protein molecule in solutions were studied, 
while Chapter 4 concentrated on the development of protein based formulation and impact of two 
selected amino acids on freeze dried protein-based formulation in solid state.  
The study of proteins in solution indicated that due to high level of sensitivity of proteins to the 
mechanical stresses, even the low-shear stress technique, like magnetic stirring at low rotational 
speed, can still produce small aggregates which may in time grow via the “nucleation and growth” 
mechanism of protein aggregation, especially when the agitation process is long. The least degree of 
the protein aggregation was observed in samples agitated through low shear agitation i.e. magnetic 
stirring in this study. As a result, the low shear agitation using magnetic stirrer with low rotational 
speed was selected as the least destructive mixing method to be implemented in Chapter 4 studies.  
Another method of agitation applied in our study was sonication, which is very popular technique for 
small molecules (i.e. for dissolution), but not much in preparation of the protein-based formulations. 
The study has shown that this type of agitation is destructive to proteins and can lead to aggregation 
of protein molecules. 
The highest effect of agitation stress on protein structure was observed in an experimental simulation 
of filling vials through pipes using needles and hypodermic syringe. The study indicated that, particle 
size growth ascribed to protein unfolding, misfolding or aggregation due to the application of such 
high shear stress was obtained relatively fast. This result is significant because such stress can occur 
during pre- and post-formulation stages in pharmaceutical industries where thin long pipes are used 
to transfer solutions within manufacturing systems, in pre-filled syringes intended for use by patients, 
or in reconstitution of protein based freeze dried drugs. Different levels of pressure are required for 
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solution movement in the thin pipes or hypodermic needles and can create high shear stress capable 
of causing the protein molecule to unfold, misfold and/or aggregate/denature.  
Although freeze drying approach helps to enhance the stability profile of an otherwise poor active 
drug or formulation, the stages involved in this technological process exposes the protein molecule to 
harsh stress conditions. While it was well known that arginine and lysine have been included in protein 
based liquid formulation to prevent aggregation, the application of these amino acids in freeze dried 
formulation were not comprehensively studied. In this work, protein based freeze dried formulations 
containing arginine or lysine were developed (through developmental stages of 2- and 3-component 
excipients freeze-dried) and the protein stability of the reconstituted formulation were studied under 
room and accelerated conditions. It was identified that 10% wt. of ArgHCl included in freeze-dried 
cakes have the ability to resist the onset of protein aggregation for up to few days at room conditions. 
Inclusion of 10% LysHCl in the protein formulation also had a positive impact on the shelf life, but with 
smaller effect when compared to ArgHCl. 
It was also observed that the various technologies used for these studies were sensitive to identify 
particle size growth relating to protein aggregation. DLS in particular gave a qualitative insight into the 
presence of various particle size populations including smaller particle size populations that had been 
created as a result of deaggregation by sonication. However, none of the technologies used in this 
study was sensitive to differentiate between monomers, dimers, oligomers, unfolded or misfolded 
structures and aggregates or give a direct quantitative estimation of the percentage of protein 
molecules aggregated in freshly prepared samples or samples subjected to stress. The project also 
presented some novel experimental data during both liquid and solid formulation studies. For instance 
it showed an unintended non-linear correlation of the physicochemical features in 2- and 3- excipient 
component systems as a function of their composition. These novel data obtained for solid (freeze-
dried) formulations are in agreement with the conclusion published previously for aggregation of 
proteins in solution. 
5.2 Suggestions for Future Work 
Various manufacturing processes are used to achieve a final biopharmaceutical formulation which is 
potent and have the ideal shelf life. From these studies, the data generated can be a useful knowledge 
tool for developing future projects.  
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The cryo and lyo protection properties of the selected sugar, polyol and ArgHCl/LysHCl combinations 
were assessed using BSA protein. Different amino acids in varying combinations with other excipients 
be utilised following such a systematic formulation development approach perhaps even much more 
robust if some chemeometrics and design of experiments (DoE) approaches are incorporated.   
The data recorded using DLS (Chapter 3) also showed the different levels of aggregation and molecular 
breakdown but lacked the sensitivity to differentiate the monomeric, dimeric and oligomeric forms of 
the protein molecule. Therefore, SEC-HPLC may be a useful tool especially in studying protein 
aggregation/denaturation originating from mechanical agitations (ultrasonication) at the early stages 
of agitation to prevent the formation of bigger aggregates which may otherwise block the columns or 
be eluded via the guard column and therefore sample not properly analysed.  
Although there are lots of published literature discussing in-depth the processes of freeze drying 
(freezing, annealing, primary and secondary drying), relative to proteins, these studies may only serve 
as guides due to the sensitive nature of the protein molecule. Therefore, freeze drying microscopy, 
dielectric relaxation spectroscopy and other robust tools may be used to study the effects of the freeze 
drying protocols on the molecule. 
Finally, this studies indicated the enhanced stability of the model protein in vitro. Consequently, it 
would be advantageous to use in vivo approaches to confirm these observed stability profiles 
especially because BSA is an efficient drug carrier for other proteins as has been reported in the 
literature. 
